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Abstract 
This work concerns the development of a flat plate perfusion model to study biofilms 
derived from human tongue biota. The model has been derived from a previous sorbarod 
model, via a flat plate model (used to study wound organisms), to the model described in 
this thesis. The specific technical objectives were; 1. To measure biofilm pH in real time, 2. 
To extend VOC analysis by SIFT-MS to six biofilms in parallel and 3. To enable photodynamic 
interventions and optical monitoring of bioluminescent and non-bioluminescent organisms. 
The specific scientific objectives were; 1. To validate the model by comparison of in vivo and 
in vitro case studies, 2. To characterise the in vivo biofilm ecology and compare with ecology 
in vitro, 3. To compare existing and novel anti-malodour preparations and biofilm disrupting 
agents (including D-amino acids) and 4. To assess and aid the development of a novel 
handheld surface plasmon resonance based device for measuring oral volatile compounds.  
The results demonstrated that the biofilms transplanted from human donors are 
stable and reproducible, and that profiles of volatile compounds are retained in the 
transplanted biofilm, with high and low malodour individuals producing high and low 
malodour biofilms (profiles are indistinguishable by χ2 analysis at p < 0.1). The model was 
used to evaluate a novel formulation which was shown to be more effective than similar 
active compounds and controls (p < 0.05). In a further experiment, exposure of biofilms to 
D-amino acids during the growth phase was shown to cause significant (P<0.05) effects on
microbial and EPS composition compared with controls.
Finally, the model in conjunction with SIFT-MS has been used to assess the 
performance of a novel surface plasmon resonance based biosensor. This biosensor has been 
shown to distinguish high and low malodour biofilms both in vitro and in vivo. 
In conclusion it has been demonstrated that the flat plate perfusion system is a 
stable, reproducible and accurate model covering many of the main aspects of a real tongue 
biofilm, and it has many advantages when compared with other published biofilm models.  
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1. Introduction
1.1 Microbial Biofilms 
It is over three centuries since Antony van Leeuwenhoek described the use of 
his improved microscope to view a sample of tooth plaque retrieved from an elderly 
Dutchman (Dobell and Leeuwenhoek 1960). He saw "an unbelievably great 
company of living animalcules, a-swimming more nimbly than any I had ever seen up to 
this time". Despite the amount of time passed, knowledge of the prokaryotic world remains 
meagre to say the least, with barely one percent of existing bacterial species formally 
described (Pace, 1997). Even within this tiny snapshot of the global microbiome, a large 
proportion of research has been focused on medically significant bacteria. Most 
pathogenic bacteria by their nature overwhelm mixed normal flora and predominate at 
the site of infection. Methods to identify or examine these bacteria have relied on primary 
isolation and study of a monoculture in vitro, on laboratory culture media. These modes 
of growth by bacteria are far removed from what is commonly seen throughout nature. 
For example, surveys of 16S rRNA genes reveal that although approximately 107 
bacteria exist in one gram of soil, only between 1 and 10% are cultivable 
(Colwell and Grimes 2000; Kaeberlein et al., 2002). It has been claimed that this 
is because the correct mix of nutrients or specific conditions that 
these organisms require has not been supplied, or that they are somehow 
in a 'dormant' state.  However, recent research has shown that some of them 
have lost the ability to produce crucial compounds such as siderophores and 
thus rely on their neighbours for growth (Lewis et al., 2010). The mixed culture is 
thus growing as a microbial aggregate within the soil. If we look wider at 
examples of microbial colonization throughout nature, we see that 
diverse complex bacterial communities are ubiquitous. Biofilms exist on  
1 
2 
abiotic surfaces such as rocks, minerals and air-water interfaces and almost all biotic 
ones. The human body itself is colonised by microbial biofilms over the majority 
of its epithelial surface. They are structurally and dynamically complex biological 
systems that share many attributes with both macro scale ecosystems and 
multicellular organisms (Stoodley et al., 2002).  
The first stages of biofilm development have been extensively studied 
both qualitatively and quantitatively. Any surface in contact with liquid containing organic 
matter will quickly gain a conditioning film of organic molecules (Bryers, 1987). Marshall 
et al., (1971) were the first to suggest a model based on the Derjaguin–Landau–
Verwey–Overbeek (DLVO) theory of colloid stability, which is itself a combination of 
the effects of Van der Waals attraction and the double layer force. This model 
has been subsequently developed to include both hydrophobic: hydrophilic 
and osmotic interactions to give the so-called extended DLVO theory (van Oss, 
1995). This theory is however a simplistic approximation of actual processes as it 
neglects entirely any dynamic effects that are due to directed processes by living 
organisms. It is these directed processes that have more recently been studied in 
various species. 
Following inoculation, binding and early colonisation, the biofilm develops and 
matures and nature of it changes in significant ways. Whilst growth has been stochastic in 
nature, it begins to become more deterministic, as organisms that are capable of 
interaction and are in close enough proximity begin communication with chemo-
attractants and pheromones through quorum sensing. This leads to changes in growth rate 
and gene expression and the biofilm begins to behave as a true community (Allison et al., 
1998). This has been seen in both motile gram negatives such as Escherichia coli and Vibrio 
spp. and non-motile organisms such as Staphylococcus aureus and Mycobacterium spp.  
(Stoodley et al., 2002). Microcolonies and water-channels can appear, and cells alter their  
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physiochemical processes to suit the micro-niches they inhabit; both by autogenic 
and allogenic succession (Marsh, 2000).  In fully mature biofilm, quorum sensing 
(McLean et al., 1997; Labbate et al., 2004; Parsek and Greenberg 2005) 
and horizontal gene transfer (Roberts et al., 1999; Hannan et al., 
2010) have been demonstrated, along with distinct organismal, ecological 
and functional organization (Wilmes et al., 2009). 
1.1.1 The monolayer biofilm 
The initial stage of the formation of complex microbial communities is usually the 
formation of a monolayer biofilm. This is defined as a biofilm where all cells or small clumps 
of cells are bound to a surface and none to other cells. Formation initially progresses 
stochastically with cells attaching, detaching and reattaching. In many species, type IV pili 
have been shown to be important in this process (Klausen et al., 2003) as have flagellae. In 
E.coli fimbrae such as curli have been shown to also have a role ((Vidal et al., 1998). In other 
species or variants, surface proteins such as esp (Toledo-Arana et al., 2001)  bap (Cucarella et 
al., 2001) and Ag43 (Klemm et al., 2004) have been shown to be involved in initial surface 
binding.  As more cells become permanently attached, the process becomes more 
deterministic. Moorthy and Watnick (2004) showed that in Vibio cholerae as type IV pilus 
attachment progresses, flagella expression is reduced. Van Dellen et al., (2008) suggested 
that this in turn caused a change in membrane potential that mediated the change from 
transient to permanant attachment. In E.coli the conditionally synthesised EPS adhesin PGA 
appears to mediate this transition (Agladze et al., 2005). In Caulobacter crescentus the 
flagellum cells are removed by a protease and replaced by a specific holdfast polysacccharide 
that binds tightly to the surface (Li et al., 2005).  
As time progresses, further spread of the monolayer biofilm occurs by both pilus 
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associated twitching motility and clonal growth (Klausen et al., 2003).Eventually 
surface colonies merge to form a confluent carpet of cells. In most cases, when 
sufficient nutrients and other favourable conditions are available, the biofilm will then 
go on to develop into a complex three dimensional matrix of cells and exracellular 
material. 
1.1.2 Extracellular Polymeric Substances (EPS) 
The matrix surrounding and produced by biofilm cells was originally thought to consist 
almost entirely of polysaccharides, and in fact the abbreviation EPS reflected this. The 
‘Extracellular Polysaccharides’ were seen as a combination of capsule, which was a simple 
extension of the cell wall, and slime, an amorphous, viscous substance surrounding the cells 
(Wilkinson, 1958). This misconception was for the most part due to the fact that cells were 
being examined either in simple plate culture or in the planktonic state. The glycocalyx, as it 
became known, was well described by Costerton and Irvin (1981) but even in this work 
and in another published the same year (Costerton et al., 1981), the group was 
beginning to notice other filamentous structures in the extracellular matrix. As techniques 
improved, the first indications that it might not be as amorphous as it first appeared 
then emerged (see Characklis and Wilderer 1989).  In the next decade, cryoscanning 
electron-microscopy (i.e. Cherepin, 1992) , Atomic Force Microscopy (Beech, 
1996) and transmission electron microscopy  (Jacques and Gottschalk, 1997) 
using monoclonal antibodies to stabilise the capsule) were all used to image 
biofilms, with varying degrees of success. In parallel to this work, non-microscopic 
techniques were providing evidence of the nature of the EPS. A number of 
studies used genetic mutants that either over or under-expressed 
polysaccharides (Danese et al., 2000) and alginates (Franklin and Ohman, 1996; 
Hentzer et al., 2001; Tielen et al., 2005) to examine the nature of the EPS matrix. 
Additionally, methods of mathematically modelling biofilms, (Wimpenny and Colasanti,  
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1997; Van Loosdrecht et al., 2002) suggested a heterogeneous mosaic model.  However, 
the underlying problem was that as the matrix consisted of over 90% water, any 
visualisation techniques which involved dehydration and fixation were bound to destroy 
much of the 3D structure being studied. Fortunately, it was around this time that Confocal 
Scanning Laser Microscopy (CSLM) was becoming more readily accessible. The 
technique, described in more detail later (section 2.5), facilitated an explosion in 
knowledge and further work (Lawrence et al., 1998; Wingender et al., 1999; Neu and 
Lawrence 2014a; Schlafer and Meyer 2015). It became apparent that not only was there a 
multitude more constituents to the EPS to be considered, but the function and 
purpose of the matrix was far more extensive than previously thought. 
It is now obvious that a complex three-dimensional structure is probably the most 
important defining characteristic of a biofilm. The EPS is a combination of 
polysaccharides, phospholipids, proteins, glycoproteins and nucleic acids. It not 
only aids adhesion, aggregation, cohesion and retention of water, but it protects 
the colony, facilitates absorption of organic and inorganic compounds and acts as a 
nutrient source between species. Perhaps most importantly, though, is the contribution 
to the ecology of the biofilm. Initially the presence of DNA in the matrix was thought 
to be merely a contamination from lysed cells, but evidence suggests that in certain 
species it is important in biofilm formation (Whitchurch et al., 2002) and in 
some cases is under the release of quorum sensing systems (Allesen-Holm et al., 
2006). Acylhomoserine Lactone (AHL) has also been frequently detected in the 
EPS matrix suggesting other quorum based intercommunication between 
bacteria (Tan et al., 2015). Factors such as this become unimportant at high maximum 
specific growth rate (µmax) as organisms tend to downregulate or switch off completely 
any mechanisms or pathways which are unnecessary when nutrients are in good supply and 
all conditions are favourable (Magasanik, 1961).
6 
1.1.3 Complex multilayer biofilms 
In the conventional model of biofilm growth and development (Figure 1.1) the thick 
biofilm may be removed by mechanical forces (liquid shear, or toothbrush or other abrasive 
forces) so that the biofilm continues to grow but reaches pseudo-steady state as parts grow, 
but other parts are rapidly removed.  
Figure 1.1: Conventional conception of “thick biofilm” 
When the removal process is due to fluidic shear, then the removal rate is close 
to being constant; however the biofilm matrix is heterogeneous due to (a) diffusion 
layers or gradients for gases (oxygen, carbon dioxide, ammonia) and (b) diffusion layers or 
gradients for carbon-energy nutrients. Mathematical modelling of diffusion and 
hydrodynamic flow can show how different microenvironments can favour the growth of 
some types (e.g. aerobes and anaerobes) and may account for pH changes that form 
across the depth of the biofilm. The conventional concept considers the substratum (e.g. 
tooth surface) and biofilm matrix and cells, to be two different entities or compartments. 
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The finding that perfusion biofilms behave differently to the conventional model (and the 
repercussions of that finding) suggest that specific conditions can allow for fairly constant 
steady state conditions to occur which can be maintained for several weeks. The perfusion 
biofilm can be described as a small vessel of tethered cells within a rapid moving steam 
of growth medium. The substratum (e.g. cellulosic strands) and the channels and voids 
are well integrated over the mm-cm scale and the term “biofilm matrix” now includes 
the substratum as well (figure 1.2).  
Figure 1.2: The perfusion biofilm 
In a thick film biofilm diffusion of rate limiting factors (oxygen and nutrients) will 
govern the growth rate and metabolism of the cells and are the most important factors that 
determine the behaviour or physiological state of the deeper parts of the biofilm. This ceases 
to be the case in a free-flowing loose matrix “perfusion” biofilm where the modelling 
becomes much simpler since perfusion rate replaces diffusion rate. The consequences of this 
are that the perfusion biofilm matrix can be considered to be homogeneous (at the mm-cm 
scale), and that all the cells in the system are formed from the inner attached layer that grows 
continuously (providing that the physicochemical conditions and flow rate remain constant). 
At each generation, daughter cells are pushed nearer to the micro-flow channels within the 
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matrix, and daughter cells are eventually sheared off. Fast growth rates may be achieved in 
practice (McKenzie, 2007) as well as in theory and it is most likely that the residence time 
for the mother layer is potentially many years, whilst the half-life of detached cells in the 
vessel is relatively short, especially at high flow rates. In contrast, a thick film biofilm will 
increase the diffusion barrier and favour an inner core of anaerobes and an outer core of 
aerobes, with facultative anaerobes throughout. Cells above the inner layer will continue to 
grow and multiply within the matrix volume, wherever they may be located in the matrix. 
The outside layers with shorter diffusion distance to the main nutrient source will grow 
faster than the inside layers.  
Diffusion barriers to the products of microbial metabolism, including acids, bases and 
hydrogen ions, will increase along with diffusion barriers to substrates. For substrates such 
as glucose or sucrose the acid production for oral streptococci and other fermentative 
species would soon create a pH gradient, with the inside layers having a lower pH than the 
outside layers (McKenzie, 2007). It should be noted that long or tubular perfusion 
matrix systems can also show marked gradients along the vertical down-flow axis 
(McKenzie 2007), but this is less so for a flat 1 cm2-sized matrix where all cells are 
subjected to all chemical components equally within a short period of time, maintaining 
overall homogeneity of the micromozaic of microbial aggregates or microcolonies.  
The tongue surface is composed of pits, crypts and fissures so that any biofilms that 
develop deep in a pit are growing constantly and the pressure of growth would tend to push 
cells towards the lumen end of the pit. However, the biofilm growing on the tongue surface 
will not have a distinct eternal layer of mother cells because the substratum itself (i.e. the 
mucosal epithelial cells) are slowly but constantly desquamating producing unattached cells, 
which may degenerate and lyse, to be ultimately ejected from the micro-vessel pit.  
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The concepts of compartments is also important in understanding biofilms: For a thick 
biofilm (such as a thick biofilm on the tongue surface and down crypts or pits) will have (1) 
bulk salivary phase, (2) a thin salivary surface film that will rapidly flow across the surfaces 
of the tongue and be rapidly replaced with a mean residence time measured in seconds 
rather than minutes, (3) the biofilm matrix volume contains fluid (called matrix fluid) which, 
in contrast to the abovementioned 2 layers has a much slower mean residence time. This 
slow removal of the inner matrix volume allows reaction products of the cells to build up to 
a high concentration, and any protein hydrolysis reactions (such as breakdown of 
glycoproteins) to go more to completion over a given unit of time (e.g. per hour). The matrix 
volume (matV) of a biofilm for a tongue with low microbial population (<107 cells cm-2) will 
be a thin biofilm, (matVthin) whilst a population of 108-109 cells would be denoted as a 
thick biofilm (matVthick). The biofilm area will remain the same, but its matrix volume will be 
thicker the higher the amount of biofilm components (cells, EPS and solutes). As with a 
chemostat the dilution rate, D = f/V and its units are expressed as per time unit (h-1). 
The effects of thickness, volume and flow rate on the mean residence time (= 1/D) 
expressed as hours suggests that all reactions will build up to higher degrees of completion, 
including glucose to lactate, urea to ammonia and bicarbonate to carbon dioxide. In addition 
carbonic anhydrase can permit phase changing reactions such as HCO32-  >>> CO2 (gas) and H2O 
with the effect of removing a weak acid (allowing the pH to rise). Likewise the 
reaction equilibrium between urease and urea is of interest (Mack and Villars, 1923).
(NH2)2CO  +  H2O      urease     NH3  +  H2NCOOH  2NH3 (gas)   +   CO2  (gas) 
Equation 1.1: Urease reaction 
Urease is a naturally occurring enzyme that catalyzes the hydrolysis of urea to unstable 
carbamic acid. Rapid decomposition of carbamic acid occurs without enzyme catalysis to 
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form ammonia and carbon dioxide (equation 1.1). D e p e n d i n g  o n  t h e  p H ,  t he 
ammonia will likely escape to the atmosphere unless it reacts with water to form 
ammonium ion (NH4+) according to the following reaction: 
NH3 (gas)  +  H2O NH4+   +  OH- 
Equation 1.2: Formation of ammonium ions 
HCO3-   +   H+  H2CO3  CO2   +   H2O 
Equation 1.3: Carbonic anhydrase reaction 
The reaction rate of carbonic anhydrase is one of the fastest of all enzymes, and its 
rate is typically limited by the diffusion rate of its substrates. Typical catalytic rates of the 
different forms of this enzyme range between 104 and 106 reactions per second (equation 
1.3), whilst the reverse reaction is relatively slow in the absence of a catalyst. This enzyme is 
found quite widely in nature including some species of oral bacteria and a mammalian 
source found in saliva (Supuran, 2004).  
It has been shown (Saad, 2006) that by taking tongue scrape samples and 
re-suspending them into sterile distilled water (rather than weak tryptone buffer) it is 
possible to measure the matrix pH providing measurements are taken quickly (within 2 
minutes of collection). When these data were plotted against malodour scores of 20 
subjects, a strong relationship was seen (figure 4.6) with respective R2 values between 
0.7444 and 0.7834. These results suggest that malodour generation is associated with an 
increase in the mean pH of the tongue biofilm whereas there was only a weak 
negative correlation (R2 approximately 0.4) between the pH of saliva and malodour 
parameters. 
The carbon dioxide is reversibly hydrated as shown in equation 1.3 and this reaction is 
catalysed by carbonic anhydrase (Smith et al., 1999). 
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Although there are publications regarding the co-measurement of salivary pH and 
malodour parameters, and reports of tongue surface pH (salivary layer) and malodour, 
there are none that have been described relating tongue biofilm matrix pH and malodour 
with the exception of Saad and Greenman (Patent app. WO2008GB02466). The reasons 
that an increase in biofilm pH may result in an increase in malodour parameters could 
include: (1) the pH optima for transformation of substrates into VC/VSC could be higher 
than neutral (2) the higher pH of the tongue favours volatility of VC/VSC (3) the higher 
pH of the tongue could favour the optimal pH of collective proteolytic activity.  
It is also possible that there is no causal relationship between a high pH and 
malodour but rather the other way round; a high malodour generating biofilm (indicative 
of protein and peptide metabolism) may have the tendency to cause the pH to increase. A 
high biofilm density will produce more amines, ammonia or other basic products and 
produces an alkaline condition. Yet another explanation could be that a thicker biofilm 
(that correlates with higher malodour) could hold a larger dead space volume of 
salivary coating/biofilm fluid; analogous to Kleinberg’s concept of residual salivary film 
(Kleinberg and Codipilly, 1995) with a longer mean residence time of molecules than 
occurring within a thin biofilm. The larger volume of salivary coating coupled with its 
longer turnover will shift the pH equilibrium towards base as salivary CO2 is released 
from the main bicarbonate buffer (CO2/HCO3-). 
1.1.4 The Oral Biofilm 
In a natural human birth, the neonate leaves the uterus sterile, but as soon as contact 
is made with the vaginal canal and the outside environment, colonization by bacteria begins 
(Collado et al., 2012; Costello et al., 2012). As the epithelial surface inside and outside 
the body becomes exposed to this environment and the organisms in it, a microbiome is 
built up.  By the time this process has completed, prokaryotic cells outnumber eukaryotic 
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cells by an order of magnitude. The habitats of the human body are extremely varied and 
this leads to the development of distinct microbial populations. These characteristic 
populations have varying diversity at the habitat level (alpha diversity) and varying diversity 
between the same habitats across subjects (beta diversity). Changes in diversity in either 
direction can be indicative of disease (The Human Microbiome Project Consortium, 2013). 
The environment of the human oral cavity has been extensively studied and the microbiome 
found there has been shown to be richer in variety and more conserved than others in the 
body (Stahringer et al., 2012). The first work to investigate microbial interactions during 
early biofilm formation was by Kolenbrander with various teams. (Whittaker, Klier and 
Kolenbrander, 1996; Kolenbrander and London, 1993; Kolenbrander and Andersen, 1986; 
Kolenbrander, Andersen and Moore, 1990; Kolenbrander and London, 1992). Simple assays 
utilised the decrease in turbity associated with species-to-species binding to characterise 
these interactions. The earliest colonizers of the biofilm are overwhelmingly streptococci, 
followed by Actinomyces, Capnocytophaga, Haemophilus, Prevotella, Propionibacterium and 
Veillonellae (summarised in figure 1.3).  All of these organisms possess specific cell surface 
associated adherence proteins which recognise protein, glycoprotein, or polysaccharide 
receptors on various oral surfaces, including other cell types. This strategy of attaching to 
bacteria already immobilised to hard or soft tissues may provide secondary colonisers with 
similar advantages as enjoyed by primary colonizers.  
 The oral cavity consists of a number of different habitats, including the hard and soft 
palates, the tongue, cheeks and tonsils, plus the teeth and gingival sulcus, all providing 
differing conditions and colonized by different populations of bacteria. Overall these 
comprise of over 600 prevalent taxa (Dewhirst et al., 2010). They are lubricated and irrigated 
by salivary fluid and this influences biofilm formation both positively and negatively. Some 
factors inhibit microbial growth and mediate microbial killing (eg. histatin), or bind to 
Figure 1.3: Oral biofilm co-attachment showing early colonisers as identified by Kolenbrander et al. 
(1993) (Reproduced with permission of the American Society for Microbiology)
microorganisms to facilitate their clearance from the oral cavity (eg. agglutinins). 
Conversely, salivary components serve as receptors in oral pellicles for microbial 
adhesion to host surfaces and serve as microbial nutritional substrates (Scannapieco, 
1994)  
There are many oral diseases or conditions in which the oral microbiome is 
implicated, including dental caries, periodontal disease, endodontic 
infections, dento-alveolar infections, salivary gland infections, tonsillitis and oral malodour.  
In many of these cases, the etiological agents are not single pathogens but a 
consortia of microorganisms causing a shift from 'health' to 'disease' (Kuramitsu et al. 
2007). In the case of oral malodour, its severity is likely to be associated with greater 
species diversity in the mouth (Donaldson et al. 2005). 
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1.1.5 Bacterial Second Messengers 
Second messengers are signalling molecules that act within cells in response to a 
primary trigger that is external in origin. In eukaryotes this primary trigger is usually a 
hormone or neurotransmitter, but in microbial cells a wide range of environmental stimuli 
can act as a primary messenger. Second messengers are thus principle components of 
intracellular signal transduction cascades. In recent years much biofilm research has 
focussed on the role of cyclic dimeric (3’→5’) guanosine monophosphate (C-di-GMP). 
C-di-GMP was first identified as the activator of cellulose synthase in
Gluconacetobacter xylinum (formally Acetobacter xylinum) by Ross et al., (1987). This 
important molecule has been shown to affect motility, virulence and cause an overall shift to 
and from planktonic to sessile modes of growth. Tal et al., (1998) showed that intracellular 
turnover of C-di-GMP is controlled by the dual action of diguanylate cyclases (DGC) and 
phosphodiesterases (PDE). In the seminal work of Simm et al., (2004), it was shown that these 
enzymes are identified by GGDEF and EAL domains respectively. These domains had 
previously been identified in diverse bacterial strains and were designated domains of 
unknown function;  DUF1 and DUF2 (Galperin et al., 2001). Later work by Slater et al., (2000) 
and Ryan et al., (2017) showed that a further domain, HD-GYP was associated with C-di-GMP 
downregulation.  The cycle is illustrated in Figure 1.4. Briefly, the phosphodiesterases 
dissociate C-di-GMP into either a linear diguanine polyphosphate (pGpG) or guanosine 
monophosphate (GMP) which is then converted to guansine trIphosphate (GTP). GTP 
recycled to C-di-GMP by the diguanylate cyclases. The consequences of up and 
downregulation of both C-di-GMP and GTP are shown in Figure 1.5. 
It is now apparent that a significant messaging and regulation system had been 
discovered. GGDEF, EAL and HD-GYP motifs have now been identified in all major bacterial 
phyla (Romling et al., 2013) and over 900 proteins expressing these domains have been 
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Figure 1.4: Modulation of C-di-GMP by GGDEF, EAL and HD-GYP domain proteins. 
identified (Schultz et al., 1998; Tatusov, 2001). Although details vary, the overarching 
purpose of the C-di-GMP system appears to be the transition between motile and 
sessile modes of colonisation. Increased C-di-GMP levels correspond to reduced 
motility and increased production of EPS (particularly alginates and 
polysaccharides) and fimbriae, and increased cell to cell communication (Römling et 
al., 2005).  However, knowledge of stimuli and effectors of C-di-GMP signalling remains 
Figure 1.5: Effects in the balance; upregulation and downregulation of C-di-GMP and GTP. 
GGDEF 
EAL 
HD-GYP 
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sparse. A number of effectors in various organisms have been shown to carry the PilZ motif 
(Amikam and Galperin, 2006). This is a   ̴ 100 amino acid protein domain that appears to be 
involved with production of alginate in Pseudomonas aeruginosa (Merighi et al., 2007), motility 
in Borrelia burgdorferi (Freedman et al., 2010), Caulobacter crescentus (Christen et al., 2007) 
and Vibrio cholera (Pratt et al., 2007) and fimbriae expression and biofilm production in 
Klebsiella pneumoniae (Wilksch et al., 2011). In Shewanella oneidensis MR-1, it has been 
suggested that C-di-GMP acts through MxdB, a membrane associated glycosyl transferase that is 
essential for cell attachment specifically to the matrix and not the substratum (Thormann et al., 
2006). Degenerate EAL and GGDEF domains have also been identified as effectors. LapD is an 
inner membrane effector protein that binds C-di-GMP via a degenerate EAL domain and induces 
the expression of biofilm adhesion LapA (Newell et al., 2009, 2011). C-di-GMP has also been 
shown to bind to riboswitches in limited cases (Sudarsan et al., 2008; Lee et al., 2010). Of the 
few strict anaerobes studied, Clostridium perfringens has been shown to possess C-di-GMP 
mediated expression of Type IV pili (Hendrick et al., 2017).  
The potential hinted at by the ubiquity of C-di-GMP binding domains and the 
multitude of C-di-GMP dependent systems has yet to be realised. The full extent of this 
signalling network and the proteins and RNAs that may be involved remains a mystery. A full list 
of known receptors and effectors can be examined at http://
ncbi.nlm.nih.gov/Complete_Genomes/c-di-GMP.html and a summary of 
current understanding of c-di-GMP binding is given by Chou and Galperin (2016).   
In terms of external stimuli a similar state of affairs exists. Few environmental signals that 
regulate C-di-GMP mediated pathways have been identified. One exception is nitric oxide, 
which has been shown to increase C-di-GMP levels in Shewanella oneidensis (Plate and 
Marletta, 2012), Legionella pneumophila (Carlson et al., 2010) and Vibrio fischeri (Wang 
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et al., 2010) through the GGDEF-EAL domain containing haem NO/oxygen-binding 
(H-NOX) proteins. Thormann et al., (2005, 2006) have suggested that, in S. 
oneidensis, a reduction in oxygen levels leads to biofilm detachment and dispersal 
though C-di-GMP pathways, although this is unconfirmed. 
It is obvious that these mediators and effectors are merely the tip of a large iceberg 
and the C-di-GMP mediation network will provide extensive potential for study for many 
years to come. In this respect the C-di-GMP signalling network within the tongue biofilm has 
barely been scraped. Oral organisms about which the presence of C-di-GMP related protein 
domains are known are shown in Table 1.1. This table was created by searching the 
database referenced earlier (Romling et al., 2013; Chou and Galperin, 
2016) for instances of oral organisms from the known oral microbiome (Kilian et al., 
2016). Of the organisms showing relevant domains, only Porphyromonas 
gingivalis and Treponema denticola have been investigated for C-di-GMP 
mediated traits. P. gingivalis mutants lacking GGDEF proteins showed reduced 
FimA protein production and fimbrial display, leading to corresponding reduction 
in biofilm production and host cell invasion  (Chaudhuri et al., 2014). 
Similarly, T. denticola deletion mutants for a PilZ-like protein named TDE0214 has 
been shown to be deficient in biofilm formation and virulence (Bian et al., 2013). 
Interestingly, one other oral organism, Streptococcus mutans, has shown C-di-GMP 
biofilm mediation and this is through a non-GGDEF domain protein (Yan et al., 2010). 
As far as other common oral microbes are concerned, any role of C-di-GMP and 
mechanisms by which modulation may occur are unknown. A large number of significant oral 
organisms, such as Actinomyces sp., Bacteroides sp., Bergeyella sp., Enterococci, 
Eubacterium so., Fusobacterium sp., Neisseria sp., Prevotella sp., Tannerella sp. and 
Veillonella sp. have simply not been examined for the presence of relevant protein 
domains, nor investigated for the presence of intracellular cyclases. 
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Table 1.1: Distribution of GGDEF, EAL, HD-GYP and PilZ domains in the genomes of oral bacteria, 
where known (compiled from published data) 
Do not contain GDDEF/EAL 
domains 
Do contain GDDEF/EAL 
domains 
Campylobacter concisus 
Halothiobacillus neapolitanus 
Halothiobacillus sp. 
Lactobacillus reuteri 
Lactobacillus salivarius 
Porphyromonas gingivalis 
Ralstonia solanacearum 
Selenomonas sputigena 
Staphylococcus epidermidis 
Treponema denticola 
Actinobacillus succinogenes 
Aggregatibacter actinomycetemcomitans 
Atopobium parvulum 
Bifidobacterium longum 
Corynebacterium durum 
Cryptobacterium curtum 
Enterococcus faecalis 
Filifactor alocis 
Fusobacterium nucleatum 
Haemophilus influenzae 
Haemophilus parainfluenzae 
Lactobacillus fermentum 
Lactobacillus helveticus 
Lactobacillus johnsonii 
Lactococcus lactis 
Moraxella catarrhalis 
Prevotella denticola 
Prevotella melaninogenica 
Rothia dentocariosa 
Rothia mucilaginosa 
Streptococcus dysgalactiae 
Streptococcus gordonii 
Streptococcus mitis 
Streptococcus mutans 
Streptococcus sanguinis 
Streptococcus suis 
Streptococcus thermophilus 
Streptococcus uberis 
Tannerella forsythia 
Veillonella parvula 
1.1.6 Treatments based on modulation of C-di-GMP 
The ubiquity of C-di-GMP pathways in diverse taxa, and the specificity of the signalling 
network to prokaryotic cells has led many to suggest C-di-GMP as a potential target for 
antimicrobial treatment. Effectiveness of hypothetical agents can be proved in principium 
using mutant strains that either over or under express GDDEF and EAL domains. This has 
been shown with Ps. putida (Gjermansen et al., 2006), Ps. aeruginosa (Christensen et 
al., 2013), S. oneidensis (Thormann et al., 2006), Vibrio vulnificus (Nakhamchik et al., 2008) 
and others. However, identification of actual agents has proved harder.
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  Sambanthamoorthy et al. (2011, 2012, 2014) have used high-throughput screening to 
identify compounds that antagonise DGC enzymes, and several of these have shown 
promising biofilm dispersal properties in V. cholera, Ps. aeruginosa and Staph. aureus. Ma 
et al., (2011) on the other hand, have protein engineered a potential bioreactive 
compound.  Opoku-Temeng and Sintim’s groups have also identified several potential 
small compounds that can permeate cells and influence C-di-GMP levels in bacteria (Zheng 
et al., 2014; Opoku-Temeng and Sintim, 2016a, 2016b; Opoku-Temeng et al., 2017). The 
most promising of these have been hydroxybenzylidene-indolinones . This is an active and 
promising area of study with the potential to produce novel and important broad-
spectrum antimicrobials and anti-biofilm agents. 
1.2 Oral Pathology and Malodour 
Oral malodour is a common condition defined by the presence of odorous volatile 
compounds and/or sulphur compounds (VCs, VSCs) on the breath of individuals, noticeable 
by independent objective judges and considered as objectionable by others. It affects 
humans worldwide, although tolerance of levels and opinion on what is considered 
objectionable varies greatly between countries and cultures. Volatile sulphur compounds 
(VSCs) such as H2S, CH3SH and (CH3)2S and (CH3)2S2 are the main contributors to oral 
malodour (Tonzetich, 1971). Other VOCs such as indole, skatole, cadaverine and putrescine 
are also present, but are not considered as objectionable due to their low volatility or 
high smell threshold (Tonzetich and Richter, 1964;Tonzetich et al., 1967). It is 
widely accepted that the primary source for the production of these compounds is the 
microbial community of the dorsoposterior surface of the tongue (Hartley et al., 1996b; 
Hess et al., 2008). VSCs are produced through the putrefactive action of 
microorganisms on sulphur-containing substrates namely cysteine, cystine, glutathione or
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methionine within proteins and peptides. Other endogenous and exogenous substrates 
and precursors in the oral cavity include exfoliated oral epithelium, salivary 
corpuscules, saliva, blood and food debris (Massler et al., 1951; Tonzetich and 
Kestenbaum, 1969; Tonzetich, 1977). Figure 1.6: Production of VOCs by oral bacteria 
shows a schematic summary of these processes. 
There have been several microbiological studies investigating the composition of 
the tongue microbiota of individuals with oral malodour. Additionally, there have 
been metabolic studies of groups of oral organisms to identify those with the propensity 
to cause malodour. A summary of this work is shown in table 1.2. 
Figure 1.6: Mechanisms of VOC production by oral bacteria 
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The first of these studies was by Persson et al., (1989) and used gas 
chromatography to measure the production of sulphides from known species incubated 
in serum. Next, Hartley et al., (1996) compared samples cultured from the tongue 
dorsum of low and high malodour individuals. Loesche and Kazor (2002) published a 
useful summary of the microbiology of halitosis and Tyrrell et al.,(2003) published a 
comprehensive study of eight subjects with oral malodour that gave frequencies of 
occurrence of a range of VOC producing organisms.  Salako and Philip, (2010) 
used Halimeter and OralChroma to analyse the headspace of vials various 
organisms to identify VSC producers. Haraszthy et al., (2007, 2008) completed two rRNA 
based studies that first drew attention to Solebacterium moorei as a potential 
aetiological agent of malodour and Seerangaiyan et al., (2017) also used 16S rRNA 
gene sequencing in a study study that identified some novel VOC producing 
organisms.  
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1.3 Treating Oral Malodour 
Approaches to combat oral malodour go back to ancient times and have extended 
over many cultures and religions throughout history. The use of toothpastes has played a 
significant part in oral hygiene for many centuries despite early formulations falling short of 
delivering antibacterial active compounds. Since the introduction of fluorides more than 50 
years ago in toothpastes, its role in the prevention of dental caries through a mechanism of 
remineralisation has become indisputable (Brambilla, 2001). Moreover, other compounds 
such as metal ions (Zn2+), cetylpyridinium chloride, triclosan, chlorhexidine (CHX), amine 
fluorides, and stannous fluoride can be added to toothpastes and have shown antibacterial 
activity in vivo (Addy, 1986; Arweiler et al., 2001; Paraskevas et al., 2004) and in 
vitro (Scheie, 2003). It is well accepted that CHX remains a benchmark in dental plaque 
control and in oral malodour (Addy, 1986; Jones, 1997; Scheie, 2003) and it is 
often used as a positive control in many studies. However, a long-term side effect of 
CHX is staining of the teeth (Flötra et al., 1971; Bosy et al., 1994; Quirynen, 
2003), so alternative compounds have been used including amine fluoride/
stannous fluoride (AM/SnF) combination. It is believed that fluoride 
antibacterial action can be enhanced when used in association with cations such as 
Sn2+ or amine (Loveren, 1990). Amine fluoride was shown to reinforce enamel 
remineralisation and to have an antimicrobial effect (Wiegand et al., 2007). 
Stannous fluoride is known for its anti-caries effects but is not stable when used 
alone in mouth rinse preparations or toothpastes (White, 1995). Therefore, it 
has been used in association with amine fluoride not only to address the 
instability problem but also to enhance caries protection. 
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1.4 Modelling the Oral Biofilm 
Physical modelling of the oral biofilm can be split into two different systems, batch 
culture closed systems and open or continuous flow systems. Batch culture closed systems 
were the first method used historically to model biofilms, consisting of the culture of selected 
microbial species in a liquid medium with or without a solid substratum of known surface 
area present. This method has been effective at identifying a wide variety of volatiles from 
a wide variety of species/samples (Tonzetich, 1971; Tonzetich and McBride, 1981). 
However, the method is limited by the fact that it does not model the dynamic 
nature of the in vivo biofilm. In vivo, the whole physicochemical 
environment (number of cells, concentrations of substrates, nutrients, products, 
pH and oxygen tension) is in dynamic equilibrium, whilst these parameters are 
always shifting as an inevitable consequence of growth in a closed system. 
Cell populations will expand and products of their metabolism will 
accumulate leading to unavoidable deviation from initial conditions which is not 
reflective of the processes occurring in the oral cavity. Research has tended 
therefore to shift towards continuous flow systems. 
1.4.1 Chemostat based systems 
The chemostat has been used widely in oral microbiology research and is an 
ideal device for generating steady-state homogenous culture (Marsh et al., 1983; McKee 
et al., 1985; Greenman,  1999). However, as the cells remain in the planktonic mode its 
use for studying biofilms is very limited (Greenman, 1999). 
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1.4.2 Flow cell systems 
Initial flow cell systems consisted of a modified flow cell reactor incorporating 
recirculation of media across biofilms formed on impermeable substratum (Pilch et al. 2005). 
At various time points, gas samples were withdrawn by small syringe from the head-space of 
the reactor for gas analysis by GC. These models were used to grow both pure and mixed 
culture salivary flora. However, these systems are not true continuous flow and can more 
accurately be described as circulatory batch culture with occasional replenishment. Some 
VOCs are derived from biofilm cells, but most are produced by the planktonic cells in the 
circulation loop. 
 The constant-depth film fermenter (CDFF) has been widely used in studying biofilms, 
and is a superior example of a continuous flow open system (ten Cate, 2006). Biofilms form 
within small recesses which are swept periodically to retain a constant depth of material. All 
other physicochemical parameters (medium, flow rate, atmosphere, temperature and pH) 
are carefully controlled in the system as a whole. Variability between biofilms is thus 
minimised (Hope et al., 2012) and many groups have achieved good data regarding the oral 
microbial ecosystem (McKee et al., 1985; Bradshaw et al., 1989; Kinniment et al., 
1996). However, the model is compromised by the fact that all the biofilms share the 
same bulk planktonic culture, and cell populations on the biofilm can increase by 
two different phenomena, growth from within or further accretion from without, making 
growth rates for individual biofilms poorly defined. 
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1.4.3 Perfusion systems with permeable matrix substratum 
A significant development in the in vitro modelling of biofilms was the move towards 
utilisation of a loose matrix substratum-based perfusion system. As outlined in section 
1.1.3,  perfusion biofilms behave differently to the conventional model in that the 
substratum and the channels and voids are well integrated over the mm-cm scale. The 
"biofilm matrix" thus includes the substratum as well as the biomass itself. The first such 
model was the perfused biofilm fermenter (Gilbert et al., 1989), which used Swinnex filters 
as the permeable membrane. The working volume of the biofilm in this system is however 
quite small, and the perfusion model based on the sorbarod system devised by Hodgson et 
al., (1995) is favoured since this model has a biofilm surface many times greater and can 
be retained in a steady state for periods of several days. 
The sorbarod system was the first to be used to study the effects of pH on the 
development of biofilms and the generation of VSCs from tongue inocula (Taylor and 
Greenman, 2010). Further work incorporated a carbon veil electrode into the matrix to 
assess the effects of antimicrobial compounds (Saad, Hewett and Greenman, 2012). Other 
groups have also used the model to screen anti-malodour agents (Burnett et al., 2011).
1.4.4 Flat-bed perfusion matrix 
The flat bed perfusion matrix was originally devised by Thorn and Greenman (2009) to 
study active surfaces in wound dressings, but with minor modifications has successfully been 
used to study oral biofilms and their production of volatiles (Saad et al., 2013). The model as 
originally described is illustrated in figure 1.7. 
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An inclined slope supports a cellulose matrix comprising of loosely packed strands. 
Media was fed drip-wise onto the middle of the top surface of the matrix and waste flowed 
through and over the matrix and exited the enclosure via a drain hole. The only 
modification required to enable this apparatus to be used to model the oral biofilm was a 
port to enable the enclosure to be flooded with anaerobic gas and kept under positive 
pressure.  
Figure 1.7: Original biofilm slope and enclosure as used by to study the effects of wound dressings 
(Thorn and Greenman, 2009)
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After it was proved that reproducible steady state conditions similar to within the oral 
cavity could be produced with this method, further modifications were introduced to 
increased reproducibility between enclosures and runs. Initially, the replacement of the 
complex arrangement of glued glass, rubber and plastic with milled plastic mounting slopes 
(figure 2.1) enabled the model to be more resilient to multiple autoclave cycles without 
distortion or disassembly. This further led to rapid prototyping of the slopes in nanocure 
autoclavable material and this led to optimisation of the slope shape by computer aided 
design. A later modification of this design utilised curved slope sides, which allowed for 
waste to be more efficently channelled into the drain hole preventing build up of media 
containing planktonic cells inside the enclosure. The temperature of the enclosures has also 
been more carefully controlled by placing a single box in a dedicated, small volume 
incubator. Addition of a sampling port to the box allowed sampling of the gases above 
the biofilm using the instrument based method described in section 1.5. In culmination, 
these modifications have allowed real time monitoring of volatile organic compounds 
produced by biofilms by SIFT-MS and are described in more detail in section 2.1. 
1.5 Quantifying volatile organic compounds (VOCs) 
Historically, detection of volatile compounds produced by biofilms follows the pattern 
set in breath clinics. The original method was by assessment by a suitably trained human 
breath judge. Due to the subjectivity of this method, which will be discussed later, instrument 
based methods were developed. Initially the Halimeter (Interscan) was used, which 
produced a sensor derived value corresponding to overall levels of VSC (Rosenberg and 
McCulloch, 1992). After the turn of the millennium, the OralChroma (Abilit), a 
simplified sensor-based GC system, was developed. This could detect levels of H2S, CH3SH 
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and (CH3)2S in ppb to ppm concentrations (Hanada et al., 2003). More recently, the 
Selected Ion Flow Mass Spectroscopy (SIFT-MS) has been successfully utilised to 
provide real time detection and quantification of a wide range of volatiles in oral 
gas samples. These methods will be discussed in more details in the following sections. 
1.5.1 Organoleptic assessment 
It has been famously repeated that the study of the sense of smell has had a long 
past but a short history (Boring, 1942). Although our sense of smell has been 
discussed by philosophers for centuries, objective scientific study of olfaction only really 
commenced in the last hundred years. Zwaardemaker wrote about the psychology of 
smell in 1895 and this began the era of interest in this most academically 
neglected of senses. Early work by Backman (1917) and later Jones (1958a, 
1958b) and Jones and Marcus, (1961) attempted to assess detection sensitivities of the 
human nose to various odorants. It soon became apparent that sensitivity varied 
hugely to different compounds, and that combinations of compounds had 
unpredictable consequences. Jones and Woskowt (1963) were the first to use 
logarithmic scales and mutltivarient regression to examine olfactory response to 
mixtures of odorants. They concluded that subjective magnitude was neither additive 
or averaged and suggested that olfaction be described as an "analytical" sense. 
Berglund et al., (1973) proposed a vector model to describe interaction between 
pairs of odorants and demonstrated good agreement using selected compounds. 
This model predicted that the perceived odour intensity of a mixture of 
compounds A and B, is given by equation   1.4.
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 𝜓𝜓𝐴𝐴,𝐵𝐵 = (𝜓𝜓𝐴𝐴 + 𝜓𝜓𝐵𝐵 + 𝜓𝜓𝐴𝐴𝜓𝜓𝐵𝐵 cos𝛼𝛼) 
Equation 1.4: Perceived odour intensity of a mixture of two compounds 
1
2
In the specific case where the perceived strengths of the odours are equivalent, ie 
𝜓𝜓𝐴𝐴 = 𝜓𝜓𝐵𝐵 , this equation reduces to; 
 𝜓𝜓𝐴𝐴,𝐵𝐵 = ( 𝜓𝜓𝐴𝐴 + 𝜓𝜓𝐵𝐵 ) cos 𝛼𝛼 
Equation 1.5: Special case of Eq.1 where intensities are equal 
This can be used to experimentally deduce values of α for different compounds. This 
vector model has been successfully applied to qualitatively similar (Berglund et al., 1973) 
and dissimilar (Cain and Drexler, 1974) compounds and to mixtures of up to 
four substances (Berglund, 1974; Laing et al., 1993). 
 The inherent problem with all methods of malodour detection or diagnosis stem 
from the fact that categorisation by human judge is of course subjective, and some odours 
are considered more objectionable than others. This has led to the use of the so called 
“hedonic” scale (ASTM 1968) which scores odours based on how pleasant or unpleasant the 
odour is. From a clinical point of view this is useful on the one hand as a subjective 
assessment of the problem, but does not give information about actual compounds present 
and by inference the biological processes involved in their production. The organoleptic 
scale (Allison and Katz, 1919; Rosenberg, Kulkarni, et al., 1991; Rosenberg, Septon, et 
al., 1991) is therefore considered more relevent and an extensive evaluation of its use 
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is given by Greenman et al., (2004). Because of the attempt to standardise 
through training the subjective nature of the measure, it is still considered the gold 
standard assessment for most clinical trials. However, instrument based 
measurements are by nature more objective and are therefore more useful when it 
comes to understanding the biological and chemical processes involved in VOC 
production.  
1.5.2 Halimeter 
The halimeter was developed by Interscan in the late eighties as a relatively low cost 
alternative to the standard GC-MS methods of gas analysis. It enabled dental and medical 
surgeries as well as researchers the ability to assess malodour in a standardised 
reproducible way (Rosenberg and McCulloch, 1992).  A gas pump draws air through an inlet 
tube and across a sensor at a continuous flow rate. This sensor is comprised of a metal film 
sensing electrode coupled to a reference counter-electrode. A bias voltage is applied to 
favour oxidation of hydrogen sulphide at the sensing electrode, although other 
sulphides such as methyl mercaptan and dimethyl sulphide will also be oxidised. The 
instrument can therefore give a VSC level in parts per billion without discrimination 
between different sulphur compounds. It can also suffer from false positive response to 
other compounds that may be present in the sample such as ethanol, giving a fairly crude 
evaluation of oral malodour. It has however been widely and extensively used in clinical 
and microbiological studies. 
1.5.3 OralChroma 
First decribed by Hanada et al., (2003), the OralChroma is a simplified gas 
chromatograph that uses a gold doped indium oxide sensor and a specifically constructed 
column to create a relatively portable instrument for detecting VSCs. It detects  H2S, CH3SH 
and (CH3)2S in breath to around 100ppb levels and has been well reviewed in the 
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literature, for example by Tangerman and Winkel (2008). The instruments suffers from two 
issues, one is due to the interference of acetone, ethanol, isoprene and acetylaldehyde if 
present in high amounts on the breath of the subject. This problem can be minimised by 
strict conditions on food and drink ingested prior to testing. The second issue is due to 
software related issues leading to incorrect identifying of peaks and their measurement. 
This can be minimised by analysing the raw data produced from the sensor rather than the 
software’s interpretation. If standard gases are available, calibration curves can be 
generated from the area under the peaks produced from known dilutions, giving far 
superior sensitivity and reproducibility.    
1.5.4 SIFT-MS 
The technique was first developed by Adams & Smith (1976) to study gas phase ion–
neutral reactions in the laboratory. These reactions between charged ions and uncharged 
molecules occur in a number of terrestrial (Thomas, 1974), extra-terrestrial 
(Huntress 1974;Wayne, 2009)  and extra-solar (Smith, 1992;Anicich, 2003) 
environments. The SIFT method was a development of the flowing afterglow (FA) 
method in use at the time which was itself was an improvement on stationary 
afterglow analysis. In order to study the reactions between ions and neutral atoms 
in these remote environments, a method was required to model the reactions in the 
laboratory. In the afterglow methods, ions are created by electrical discharge in a carrier 
gas such as helium and these ions are then reacted with neutral species in an introduced 
sample. A mass spectrometer can then be used to measure loss of the primary He+ 
ions and a corresponding increase in product ions. In the FA method, the carrier gas is 
relatively fast flowing enabling samples to be introduced downstream of the ionisation 
event and other reactant gases to be introduced downstream of the ionisation but 
upstream of the sample. These gases react with the He+ plasma to produce different
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primary reactant ions (figure 1.8). The ability to sequentially add several reactant gases and 
thus produce many reactant ions, both positive and negative, proved to be both an 
advantage and a disadvantage to this method. It was extraordinarily flexible, but 
secondary reactions between reactant ions and parent gases caused huge complications 
in identification of ion products and precise quantification of their reaction coefficients.  
Figure 1.8: Flowing afterglow mass spectroscopy 
The SIFT technique incorporated a significant and novel modification in that reactant 
ions were generated by an ionisation method within a seperate chamber (known as the SIFT 
chamber) and then selected using a quadropole mass filter. As the pressure in the 
downstream sample chamber, or flow tube, can be kept relatively high, there is little 
contamination of this chamber by any stray products of the ionisation process. This means 
that the reaction paths are much more well defined and therefore reaction coefficients can 
be measured with greatly increased precision and accuracy. This lead to an explosion in 
modelling of diverse plasmas such as those produced inside gas lasers and during plasma 
37 
deposition and etching. However, work with the technique also revealed its power as a 
analytical and diagnostic device. 
The D region of Earth's troposphere contains a few postive ion complexes that prove 
to be stable and relatively unreactive with the major molecular components of the 
atmosphere. These include most notably the hydronium (H3O+), nitrosium (NO+) and 
dioxygenyl (O2+) ions. The unreactive nature of these ions means that they are perfect for 
analysing trace gases in sample of moist air. By generating and selecting for these ions in the 
SIFT chamber, samples from many sources can be analysed. Where reaction coefficients are 
unknown, they can be determined with simple techniques. By controlling and knowing 
precisely the nature and concentrations of sample gases introduced into the instrument, 
reaction coefficients for numerous molecules and compounds can be deduced. Smith and 
Španěl performed a number of experiments of this kind before the turn of the millennium 
(Španěl et al., 1995; Španěl et al., 1997; Smith and Španěl, 2011a, 2011b), leading to even 
more potential applications. 
Figure 1.9: Profile3 SIFT-MS schematic (Smith and Španěl, 2011a) (Reproduced with permission from
the Royal Society of Chemistry)
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Smith and  Španěl had direct involvement in the evolution of the SIFT-MS instrument 
up to and including the production of the Profile3 device by Instrument Science. This utilised 
a microwave resonator to generate the three positive reactant ions from humid air. After 
selection by the mass filter and reaction in the flow tube, products are sorted by mass 
spectrometer and enumerated by multiplier/pulse counter.  Rate coefficients are 
calculated by the decay rate of precursor and increase of product counts, and from these 
gas levels in the sample are determined (Španěl et al., 1997; Smith and Španěl, 2005). Their 
own diagram of the Profile3 instrument can be seen in figure 1.9. 
Like other modern direct-injection mass spectrometric (DIMS) methods 
volatile compounds can be measured quantitatively in real time. Of the DIMS techniques, 
SIFT-MS is most often compared to proton-transfer-reaction mass spectrometry (PTR-
MS). SIFT-MS tends to lose out in sensitivity to PTR-MS as with the latter technique a high 
intensity high purity H3O+ beam is injected without selection or dilution in a carrier gas. 
This leads to a sensitivity two orders of magnitude greater than by SIFT-MS (Blake et 
al., 2009). SIFT-MS however, by allowing pre-selection of reagent ions, avoids the 
pitfall of not being able to ionize compounds whose proton affinity is smaller than 
that of H2O (Jordan et al., 2009). Also, SIFT-MS allows fine control of experimental 
conditions and thus determination of rate coefficients that can be routinely used 
for quantitative analysis (Biasioli et al., 2011). Literature data on rate coefficients at 
approximately room temperature can be used for SIFT-MS, but is of questionable value for 
PTR-MS (Cappellin et al., 2010). Also, rotation of reagent ions gives more selectivity 
and resolution between compounds using SIFT-MS. 
Since Smith and Španěl ceased direct involvement, the technology has been further 
refined and improved to give the Voice200 instrument constructed by Syft Technologies of 
New Zealand. The significant i mprovements brought have been stable flow tube 
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temperatures and the ability to generate negative ions in the SIFT chamber. As with the 
positive ions, the ions that have been selected are those that are relatively stable and 
unreactive in moist air. This recent development has the potential to produce a wealth of 
new data and applications for the SIFT-MS technique. So far it has mostly been used 
in industry due to the ability to quantify inorganic compounds such as 
hydrofluoric, hydrochloric and other acids.   Table 1.3 shows the mechanisms by 
which positive and negative ions react in modern SIFT-MS techniques. 
Table 1.3: Mechanisms of positive and negative reagent ions reactions in modern SIFT-MS 
Mechanism H3O+ NO+ O2+ OH- O- O2- NO2- NO3- 
Proton transfer (PT) yes no no 
Electron transfer (ET) no yes yes 
Dissociative ET no yes yes 
Hydride abstraction no yes no 
Association yes yes no yes yes yes no no 
Proton Abstraction yes yes yes yes yes 
Electron attachment no no yes no no 
Associative Detachment yes yes yes no no 
Displacement/Elimination yes yes no no no 
1.6 pH and the biofilm 
The pH of the tongue biofilm is likely to influence both the microbial composition and 
activity of some transformations (e.g. sulphur compounds into VSC) over others. McKenzie 
(2007) first used the Sorbarod perfusion model to study the interdependence between pH 
and glycolysis in Streptococcus mutans biofilms, showing reductions in pH occurring to 
varying degrees with various sugars. No effect was seen, however, with substances which 
tended to raise pH such as urea as this organism does not possess urease.  Taylor and 
Greenman (2010) used the same model to study the effects of pH on both a mixed species 
biofilm community and the production of hydrogen sulphide. Six replicate biofilms 
(inoculated from a single suspension of tongue scrape sample) were perfused with basal 
medium at 6 different pH values and the ensuing mixed community biofilms were analysed 
using conventional microbial viable count techniques, but also community level physiological 
profiling (CLPP) using Biolog AN plates. Highest levels of H2S were produced at pH 7.5 which 
were significantly higher (p < 0.05) than biofilms at pH 7.0 and 8.0. Biofilms at pH’s 6.5, 6.0 
and 5.5 produced decreasing concentrations of H2S with lower pH. It was concluded that the 
optimum pH required for highest transformation of sulphur-containing substrates to H2S 
occurs between pH 7.0 and 8.0, which correlates with the known pH optimum characteristics 
of cysteine desulfhydrase systems that change thiols into H2S with optima between 7.6 
to 8.5 (Greenman 1999; Mhlenhoff et al., 2004; Tchong et al., 2005; Wu et al., 2008). 
The authors conclude “The effects of pH on tongue-derived biofilm are therefore 
likely to have a multi-factoral effect on the ecological diversity of H2S-producing 
organisms and their physiology".
1.7 Confocal Laser Scanning Microscopy 
The origins of CLSM  can be traced to improvements in microscopy developed 
by Marvin Minsky (Minsky, 1955) at Harvard.  The problem with 
traditional wide-field fluorescence microscopy is that the subject is illuminated all at 
once, and each image point, however viewed, is partially obscured by aberrant scattered 
light from other image points not being viewed. Minsky realised that the way to avoid 
this would be to image each point separately and individually in turn, and this 
would lead to greatly increased resolution and contrast. A second microscope could 
be used instead of a condenser lens to focus a pinhole aperture at the imaged point 
thus eliminating all rays not focussed on this point. Focal brightness is thus retained 
but with a huge reduction in errant light in the specimen. A second pinhole beyond the 
usual objective lens further eliminates errant light that was originally focussed on the 
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image point but became scattered by out of focus points in the specimen. This gives 
an elegant symmetry with pinholes and objective lenses either side of the specimen. It 
is obvious how these single point illumination techniques give can achieve far greater 
resolution and contrast but the problem is that each point must be imaged or 
‘scanned’ in turn. In order for this to occur quickly enough to be practical, the 
illumination must be much brighter than standard light sources supply. Minsky first 
used carbon or zirconium arcs, and output was passed through a photomultiplier 
circuit before being visualised on a long-persistence phosphorescent screen. This 
arrangement was patented by Minsky with the help of his brother-in-law Morton Amster 
in 1957 (Minsky, 1988).  
From these beginnings, confocal microscopy took perhaps three decades before the 
potential began to be fully realised. One of the reasons for this was, as admitted by Minsky 
himself (Minsky, 1988), due to the poor imaging system. Much of the resolution and clarity 
that Minsky obtained was lost on the crude phosphorescent screen, and there was no way of 
obtaining a permanent copy.  Since then, there have been both huge advances in digital 
imaging with charge-coupled devices (CCD)  and exponentially faster computer processing 
power to analyse these images (Inoué, 2006). However, the primary advance for the 
technique was the development of the laser (Gould, 1959). The production of intense beams 
of coherent light enabled faster scanning and subsequent improvements in imaging. 
Commercially successful microscopes began to appear and were used to image immuno-
fluorescently labelled specimens (White et al., 1987). The ability of the device to scan in 
optical sections was invaluable and montages of the Z-series of scans could be examined. As 
computing power increased, the Z-series of stacks could be reconstructed into 3D 
representations of the specimen. Still later time-lapse sequences could be animated and 
rotated in real time giving true four dimensional imaging (Stephens and Allan, 2003). For a 
comprehensive review of methods of CLSM of biofilms the reader is directed to Neu and 
Lawrence (2014). 
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1.8 Aims and Objectives 
The main technical aim of this thesis was to improve and further develop the in vitro 
flat-bed perfusion matrix biofilm model. This was to enable the model to be used to study a 
wider range of biofilm conditions and states, and to facilitate the testing of a wider range of 
interventions and biologically active compounds (See chapter 3). The specific objectives were 
as follows; 
1. To measure biofilm pH in real time.
2. To extend VOC analysis by SIFT-MS from one unit at a time to six.
3. To enable biofilm interventions based on photodynamic therapies.
4. To enable biofilms incorporating bioluminescent organisms to be monitored
in real time using optical recording.
The main scientific aims of this thesis was to study the behaviour of different 
antimicrobial compounds on biofilm growth, physiology and metabolism, and compare with 
in vivo work. These studies also included compounds with biological activity but not direct 
antimicrobial effects. A further aim was to show the utility of the model as a test-bed for 
comparative assessment of other instruments or devices. The specific scientific objectives 
were as follows; 
1. Validation of the model by comparison of in vivo and in vitro case studies.
2. Characterisation of in vivo biofilm ecology and further comparison with the
microbial ecology in vitro.
3. Comparison of currently available over-the-counter antimalodour
preparations in vivo and in vitro.
4. Use of the model to assist and assess the development of a novel handheld
surface plasmon resonance based device for measuring oral volatile
compounds.
5. To investigate the effects of non-antimicrobial biofilm disrupting agents such
as D-amino acids.
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2. Methods
2.1 The Flat Bed Perfusion Matrix Model 
2.1.1 The biofilm enclosure 
The methodology followed is a further modification of that described in detail 
by Saad, Hewett & Greenman (2013). The biofilm enclosure consists of a 
modified polypropylene freezer box (Lock and Lock, Amazon, UK) within which a 
previously inoculated loose fibred 1cm2 cellulose matrix is held in place on a specially 
constructed slope. The development of this slope in particular is detailed below. Media 
is fed drip-wise by peristaltic pump (Watson-Marlow, Falmouth, UK) via a 23G 
hypodermic syringe (Terumo, Japan). The feed line for this syringe is connected to the 
pump via a grow-back inhibitor constructed as shown in 2.1. The standard media used 
was one seventh strength brain heart infusion (Becton-Dickinson, New Jersey, USA) 
supplemented with haemin (0.0001 g/100ml), dithiothreitol (0.005 g/100ml) and 
cysteine (0.1 g/100ml w/v) all supplied by Sigma-Aldrich, UK. pH was adjusted to 7.4 
prior to autoclaving. Waste flowed out of the box via silicone tubing attached to a PTFE 
elbow connector under the box. The box was filled with anaerobic gas (90% 
nitrogen, 10% carbon dioxide) from a cylinder of compressed gas (BOC) and kept under 
positive pressure by peristaltic pump. Gas sampling takes place through Poly-Ether 
Ether Ketone (PEEK) tubing of 1/16in external diameter and 0.055in internal 
diameter (Supelco, Penns., USA). This is introduced through the front of the 
enclosure and protected from contamination by a 1ml pipette tip (figure 2.2). 
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Figure 2.1: Growback inhibitor and injection port 
Figure 2.2: PEEK tubing protected by pipette tip 
2.1.2 The matrix mounting slope 
The initial design of the matrix mounting slope was the same as that used by Thorn 
and Greenman (2009). This consisted of a glass microscope slide cut to shape using a 
diamond cutter. This was glued to polypropylene supports that were then attached to the 
base of the enclosure by M1 countersunk machine screws. To retain the matrix in place, 
supports were cut from rubber sheeting and attached with extreme temperature glue 
(Bostik, UK). This slope is shown in figure 1.7. Unfortunately repeated autoclaving of this 
design caused the glued bond to break down and come apart.  
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The glass slope was then replaced with polypropylene to allow an adhesive 
specifically suited to low surface energy plastics to be used (3M, UK). This led to increased 
resilience to repeated autoclave samples, but bond failure still occurred. Next, solid plastic 
supports were milled by Philips UK using an in house CNC process. These slopes are shown 
in Figure 2.3. These proved far more reusable, but due to the planar surface of the 
mounting area, drips of media could run sideways across the slope and fail to exit the 
enclosure via the waste tubing. This led to a build-up of contaminated waste fluid in the 
enclosure which in tur led to artefactual VOC production from planktonic cells in 
suspension. To prevent this from happening the slopes were redesigned using CAD 
(Solidworks, Dassault Systems, Massachusetts, USA) and 3D printed in Nanocure 
(envisionTEC, Michigan, USA) as shown in figure 2.4. The U-shaped channel pictured 
prevents overspill and ensures that waste exits the enclosure via the waste tube. 
Figure 2.3: CNC milled polypropylene slope. 
Figure 2.4: CAD slope proptotyped in NanoCure 
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2.1.3 Inoculation of the matrix 
The inoculation of the matrix is performed as follows; a sample was typically 
taken from one individual volunteer by dorsal tongue scrape using a sterile toothbrush 
with soft nylon bristles of size 1cm2. Volunteers for this process were selected after 
assessment by trained organoleptic judge. The sample was inoculated directly into 
degassed brain heart infusion and vortexed. The cellulose matrix was placed on the 
surface of a fastidious anaerobic agar plate and a 300µl aliquot of the tongue scrape 
suspension applied to the surface. The inoculated matrix was pre-incubated 
anaerobically for 24 hours and then transferred to the support slope within the airtight 
autoclavable growth chambers. 
2.1.4 Incubation of the enclosure 
The biofilm enclosures were mounted into a modified shelf and placed inside a 
mini incubator (VWR International Ltd., Lutterworth, UK). The front panel of these 
incubators was replaced with a laser-cut polycarbonate panel allowing inlet ports for gas 
and media, and outlet ports for waste and VOC analysis. Additional ports allowed power 
to be supplied to LED illumination units and for access by pHOptica fibres. (See section 
3.2). The top port of the incubator was reserved for temperature measurement by 
either standard glass thermometer or pHOptica thermocouple.  
2.1.5 Introduction of fluid intervention pulses 
At a distance of 15cm from the enclosure the media feed line was split to allow 
the incorporation of both a growback inhibitor and a port for the introduction of 
fluid interventions. This arrangement is seen in figure 2.2. Both branches were 
constructed from syringe bodies. The top of the grow-back inhibitor consisted of a drilled 
bung through which the media line was inserted. The top of the injection port consisted of 
a self-amalgamating bung from a blood vacutainer (Becton-Dickenson, New Jersey, USA). 
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To introduce fluid pulses, the media line was closed by tube clamp, and the media line 
below this point flushed through using a syringe of anaerobic gas. Fluid was then 
introduced by second sterile syringe. The time taken for the fluid injected to flow over the 
biofilm was measured by laboratory timer.  
2.1.6 Sampling the biofilm enclosures 
Gases produced by the biofilms were monitored in real time with the use of either 
a Profile 3 SIFT-MS (Instrument Science, UK) or, later, a Voice200 SIFT-MS (Syft 
Technologies, Canterbury, New Zealand). Gas sampling was through a protected port 
in the biofilm enclosure described above. To ensure more sensitive detection of indole 
and methyl-indole by the Profile3 instrument, the primary stainless steel inlet tube was 
removed and replaced with Polyether ether ketone (PEEK) tubing to reduce adsorption of 
these compounds to the surface. An inner and outer jacket was constructed from metal 
foil with the inlet heater placed inside. This allowed heating of the inlet tube and 
vaporisation of any water vapour. These modifications were similar to those performed 
(Ross and Esarik 2013) for indole detection. To enable experiments to be performed 
with several biofilms at one time, a sequential sampling system was constructed. Details 
of this are provided in chapter 3. 
2.2 Microbiological methods 
2.2.1 Tongue scrape sampling for in vivo studies 
Tongue scrape sampling was based on the method originally described by Hartley et 
al., (1996b). A standard, soft- bristled toothrush was trimmed to give 1cm2 contact area and 
autoclaved. This was then pressed and brushed gently over a 4cm2 area of the tongue 
dorsum of a donor individual. The tongue biofilm material was then transferred to 10ml of 
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degassed brain heart infusion (BHI, Becton-Dickenson, UK) first by manual agitation on the 
inner surface of a glass universal followed by vortex mixing at full speed for 30 seconds.   
2.2.2 Destructive sampling of biofilm matrices 
Biofilm matrices were removed from their enclosures by sterile forceps, placed into 
10ml of BHI and vortexed for 30 seconds at full speed. Serial dilutions were performed in BHI 
and plated as above. 
2.2.3 Anaerobic plate counts 
Anaerobic plates counts were performed on tongue scrapes, biofilm eluates and 
biofilm matrices as required.  Two media types were used, fastitidious anaerobe agar (FAA, 
LabM, Bury) at a concentration of 46g per litre, enriched with 50ml defibrinated horse blood 
and the same agar with Vancomycin at a concentration of 0.00025% w/v (Oxoid, UK). In this 
way strict anaerobes can be distinguished by growth on both plates. Serial dilutions were 
performed in BHI and plated by spiral plater (WASP, Don Whitley Scientific, Shipley, UK.) 
2.2.4 Basic identification of organisms 
Organisms were first categorised by colony type. Further identification was 
performed by Gram's stain. Catalase reaction was performed to presumptively identify 
streptococci when required. 
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2.3 HOMIN and HOMINGS analysis of the oral microbiome 
DNA extraction and pyrosequencing was carried out fully at Molecular Research (MR 
DNA), Shallowater, Texas, and sequencing was performed at the Forsyth Institute, 
Cambridge, USA. In summary; 50ng of DNA was extracted by Nextra DNA sample 
Preparation Kit (IIlimina).  The 16S rRNA V4 variable gene region PCR primers 515 /806 
(Caporaso et al., 2011) were used in a single-step 30 cycle PCR using the HotStarTaq Plus 
Master Mix Kit (Qiagen, USA) (94°C; 3 minutes, followed by 28 cycles of  30 seconds, 53°C; 
40 seconds, 72°C; 1 minute then 5 minute elongation step).  Sequencing was performed 
on an Ion Torrent Personal Genome Machine (PGM) and data were processed using a 
proprietary analysis pipeline. OTUs were defined by clustering at 3% divergence (97% 
similarity) and taxonomically classified using BLASTn against a database 
derived from GreenGenes (http://greengenes.lbl.gov/cgi-bin/nph-index.cgi), RDPII 
(http://rdp.cme.msu.edu) and NCBI (www.ncbi.nim.nih.gov). 
The resultant percentage frequencies of target taxa to be determined were 
visualised using Circos software (Krzywinski, 2009). Taxa were plotted radially around the 
circos plot and the samples were ordered from low to high malodour starting at the centre 
of the plot. Each point was coloured by heatmap ranging from pale to dark red based on 
the percentage frequency. This meant that darker red at the outside of the circular plot 
corresponded to association with those organisms with malodour. Both Pearson’s 
Coefficient of Skewness and Kelly’s Coefficient of Skewness were calculated for each 
organism and plots created showing organisms showing positive or negative association 
with malodour.  
To investigate potential interactions between species in the oral 
microbiome, probabilistic co-occurrence tables were generated using a probabilistic 
model (Veech, 2013) implemented in Rstudio (Boston, USA) (Griffith et al., 2016).  
2.4 Analysis of the biofilm EPS 
Microbial EPS is notoriously problematic to analyse due to its complexity. The 
constituents of the EPS must be separated from the cells and dissolved into solution without 
damaging the cells and releasing their contents. After study and experimentation the 
following procedure was used. 
The biofilm matrix was suspended in EPS extraction buffer (2 mM Na3PO4, 4 mM 
NaH2PO4, 9 mM NaCl and 1 mM KCl at pH 7) and vortexed for one minute. A 1ml aliquot of 
this suspension was taken for microbial culture and 1ml for dry weight determination. The 
remaining 8ml was treated with, 0.06ml of 36.5% formaldehyde (Fisher Scientific, UK) and 
shaken at 4°C for 1 hour. This was followed by 4ml of 1M NaOH, again at 4°C with shaking, 
for 4 hours. This was then centrifuged at 20,000 G for twenty minutes and filtered through a 
0.2µm membrane. The final purification stage was to dialyse the solution through a 3500 
Dalton membrane at 4°C for 24 hours.   
Following extraction, EPS solutions were assayed for polysaccharides and proteins by 
Dubois (1960) and modified Lowry methods. The extraction method was performed on 
sterile distilled water samples to provide a baseline for calibration. 
2.4.1 Dubois assay for polysaccharides 
For the Dubois assay, 0.05ml of 80% phenol solution was added to 2ml of EPS 
solution in 20mm boiling tubes. To this was rapidly pipetted 5ml of concentrated sulphuric 
acid. The acid was pipetted by modified 5ml pipette to enable fast dispense, and directed 
directly at the fluid surface to ensure fast efficient mixing and uniform heating.  The tubes 
were allowed to stand for 10 minutes then shaken and place in a waterbath at 30°C for 20 
minutes. Absorbance was measured at 480nm and compared to distilled water blanks. 
A calibration curve was generated using known dilutions of a standard glucose 
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solution. The amount of polysaccharide is therefore given in glucose equivalents to 
compare EPS extractions rather than absolute quantitative measurement of individual 
sugars. 
2.4.2 Modified Lowry assay for protein 
For the modified Lowry assay, 2.2ml of Biuret Reagent (Sigma-Aldrich, UK) was 
added to 0.2ml of EPS extract in a clean sterile test tube, mixed and let to stand for 10 
minutes. 0.1ml of Ciocalteau's Phenol Reagent (Sigma-Aldrich, UK) was added, mixed and 
allowed to stand for 30 minutes. Contents were then transferred to cuvettes and 
absorbance read at 720nm using a Jenway 6305 spectrophotometer (Cole-Palmer, UK). 
Blank samples were aliquotted from 0.85% sodium chloride. A calibration curve was 
plotted using standards prepared with bovine serum albumin (Sigma-Aldrich, UK) and 
used to calculate protein levels in the EPS samples. 
2.5 Confocal microscopy of the biofilm 
To enable visualisation of the oral biofilm by confocal laser scanning microscopy 
(CLSM), it was necessary to mount and stain samples in a reproducible way. As cellulose 
fibres auto-fluoresce when excited by most wavelengths of laser light, portions of biofilm 
had to be separated from the main bulk of the material to be examined. To achieve 
this, 10mm diameter round glass coverslips (Fisher Scientific, UK) were first sterilised by 
autoclave and then placed underneath mature biofilms. They were incubated along with 
the biofilm in the normal way and removed after varying time periods. The coverslips were 
then inverted and placed onto glass slides. Various fluorescent stains at varying 
concentrations were added by pipette to the edge of the coverslip and allowed to migrate by 
capillary action. 
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Stain Supplier Target Concentration Incubation time 
Excitation 
wavelength 
Emission 
wavelength 
Hoesch 33258 Sigma Aldrich, UK Intracellular DNA 1µg/ml 1 hr 350nm 461nm 
Congo Red Sigma Aldrich, UK Polysaccharides  15mg/ml 30 min 497nm 614nm 
Amyloids 
Calcofluor White Sigma Aldrich, UK Polysaccharides 3.5 mg/ml 30 min 300-440nm 355nm 
Amyloids 
Sypro Orange Sigma Aldrich, UK Proteins 1µg/ml 30 min 470nm 570nm 
Thioflavin T Sigma Aldrich, UK Extracellular 7.5µM 30 min 385nm 450nm 
Amyloid 
Fluor-conjegated lectins Vector Labs, Uk Various 100µg/ml 30 min 495nm 519nm 
(ConA, WGA, AAL) 
Table 2.1: Fluorescent stains used in CLSM of the biofilm matrix 
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The slides were then incubated under anaerobic conditions for up to 1 hour, before 
examination using an Ultraview FRET H confocal microscope (Perkin Elmer, UK).  Table 2.1 
shows the various fluorescent stains used along with concentrations and incubation times. 
2.6 Sampling the oral cavity 
2.6.1 Trained Organoleptic Judge 
Organoleptic scoring by trained judge was used to assess malodour. The mouth was 
kept closed for two minutes to allow formation of headspace equilibrium in the oral cavity, 
then the head was inclined backwards and the mouth opened to allow assessment by judge. 
Malodour was categorised from 0-5 where 0 = no odour, 1 = barely noticeable, 2 = slight 
odour, 3 = moderate odour, 4 = strong odour and 5 = very strong odour 
(Rosenberg and McCulloch 1992; Greenman et al., 2004) 
2.6.2 The OralChroma 
Samples were collected from the human volunteers as recommended by 
Abilit Corporation, Japan. A  2ml volume of air from the oral cavity was collected by gas 
syringe (B. Braun Medical Ltd, Sheffield, UK) and injected into the injection port 
of the gas chromatograph (OralChromaTM Abilit Corporation, Japan). The area under 
the peaks was used to calculate levels of hydrogen sulphide and VSC concentrations 
from a calibration curve. This curve was created by diluting hydrogen sulphide from a 
standard cylinder at 3ppm (BOC gases, UK) using a precision gas diluter (Custom Sensor 
Solutions, Arizona, USA).  A calibration curve is shown in figure 2.5. 
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Figure 2.5: OralChroma calibration curve. n=3, bars represent standard error.
2.6.3 SIFT-MS 
The Profile3 instrument was used with a source pressure between 0.26 and 0.30. 
Quadrapole currents were between 5 and 7nA and 20 to 30pA. Full scans with the selected 
reagent ion (H3O+) were performed at the start of each run, and counts at 19, 37 and 55 and 
73 m/z positions compared with expected values. Sample inlet capillary was regularly 
checked and replaced when helium off pressure dropped below 0.07 Torr. 
The Voice200 instrument had capped and uncapped pressures checked each time 
before use, along with calibration gas pressure. These values were recorded. Validation with 
standard gases as recommended by the manufacturers was performed before all testing. Full 
scans were checked regularly for optimum performance of the instrument. Time and count 
55 
limits were 100ms and 10,000 counts. All settings for both instruments can be seen in 
appendix 3.   
It was necessary to modify the sampling inlet of the SIFT-MS to measure VOC levels 
in the oral cavity. The rear port of the sampling head was connected to a mini diaphragm 
pump. The front inlet was adapted to hold a disposable straw that could be introduced into 
the oral cavity. Air was thus drawn from the oral cavity and this stream was then subsampled 
by the SIFT-MS. A diagram is shown in figure 2.6. This method reduces disturbance 
introduced by breathing and minimises unwanted sampling of systemic gases. Dynamic 
calibration by flow rate adjustment was performed during sampling to give 6% water content 
in breath (Profile3). This was not necessary with the Voice200 due to the validation 
procedure with standard gas being performed for each run. 
Figure 2.6: Modifications to the Profile3 SIFT-MS sampling head 
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The subject was instructed to close their mouth and breathe through their nose for a period 
of two minutes, then to insert the straw into their mouth so that the instrument sampled 
from above the dorsal area of their tongue. They were then instructed to rest their lips 
loosely against the straw and breathe gently through their nose for the sampling period 
of one minute.  A 40 second sampling period was recorded which would typically 
include six data points for each compound. 
2.7 Selection of individuals for in vivo trials 
The effect of novel anti-malodour compounds on the biofilm was compared with 
the effect of these compounds on human volunteers. In these cases the general protocol 
was used with modifications for specific product trials. The clinical trials director 
responsible for volunteer selection and screening was Dr. Saliha Saad (UWE, Bristol).
Volunteers were selected from a larger group who have been previously 
screened for inclusion in malodour trials. In the laboratory, organoleptic, 
OralChroma and SIFT-MS assessments were made of their malodour status. On the 
basis of this screening, a health questionnaire was completed to determine any 
exclusion criteria (Table 2.2). In order to maintain anonymity, each subject was 
assigned a code number which was recorded on the questionnaire. All relevent 
documentation regarding the ethics and permissions for samples used can be examined 
in Appendix VI.
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Table 2.2: In vivo study exclusion criteria 
Eligibility criteria Exclusion criteria 
Voluntary participation  confirmed by consent form Recent medical history of infectious disease 
Availability during specified times to comply with 
sampling intervals 
Organoleptic score above 2 and greater 
than 100 ppb H2S by SIFT-MS 
Antibiotic medication within 1 month of the 
trial start date including medicated sweets 
Any change in oral hygiene practice during 
the trial prior to sampling 
Substantial false dentition 
Use of highly perfumed cosmetics at time 
of sampling 
Advanced uncontrolled caries, gingivitis, 
peridontitis or oral candidosis 
Trails were performed by crossover design with eligible volunteers assigned a 
randomised treatment schedule. Each subject was randomly assigned a numeric label and 
each treatment was allocated a code letter.  
Microbiological analysis was performed on tongue scrape samples before treatment 
and after treatment according to the specific schedule of the trial. Relevant dilutions were 
plated on fastidious anaerobe agar (LabM, Bury, UK) with and without vancomycin 
(2.5mgl-1 Sigma-Aldrich, UK) and incubated anaerobically for seven days. Plate 
counts were performed for strict and facultative anaerobes as well as total viable 
organisms. 
All statistical analysis used Prism software (Prism 5.0, GraphPad, San Diego, 
US) which was also used to calculate P-values for nonlinear regression coefficients, 
and confidence levels. 
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3 Technical developments 
3.1 Introduction 
The in vitro oral biofilm model as described has been successfully used to investigate 
the efficacy of anti-malodour compounds on volatile production (Saad, Hewett, & 
Greenman, 2013). During this process, some shortcomings of the model were identified. 
Moreover, technical adaptations were devised that would enable the model to be both more 
flexible and efficient. These elements will be discussed individually. 
3.1.1 Physiological conditions of multiple biofilms 
It was hitherto discovered that if several biofilm enclosure units are incubated 
together in one incubator, reproducibility is adversely affected (figure 3.1). Fan based air 
circulation in a relatively large internal area leads to temperature variation between the 
enclosures causing significant differences in both volatile production and uniformity of the  
Figure 3.1: Several biofilms incubated in a single large incubator with fan circulation 
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biofilms. This issue was exacerbated by opening the door to facilitate any kind of sampling. 
Not only could only one biofilm be sampled at a time, but due to the time required for the 
conditions within the chamber to stabilise, interventions of any sort could only be performed 
after a significant time delay between each sample. The increased time and variability caused 
by these factors was found to severely limit the amount of reliable data that could be 
generated from the model. Techniques to overcome these sampling issues were required. 
3.1.2 pH monitoring of the biofilm 
 As described in section 1.6, pH of the biofilm affects both microbial composition and 
chemical transformations that occur. A way of monitoring the pH within the biofilm could 
provide interesting data above what can be gleaned from mere pH measurement of media 
flowing into and out of the system. MacKenzie (2007) had experimented with pH 
microprobes but it was thought that a less invasive method may be superior. 
3.1.3 Bioluminescent organisms as reporters of metabolic activity 
Bioluminescent indicator organisms are strains of bacteria into which have been 
cloned lucifierases from other light-producing organisms. They are powerful tools for 
studying both microbial metabolism and the action of antimicrobial substances as their 
production of light reflects the actual metabolic rate of microbial cells (Beard et al., 2002; 
Koga, Harada et al., 2005; Vesterlund et al., 2004). Plasmids pGLITE and pMCS5-LITE 
containing the luxCDABE operon of Photorhabdus luminescens under constitutive control of 
the lac promoter have been used previously in perfusion based models (Lewis et al., 2006; 
Parveen et al., 2001). Modification of this flat plate system to allow the use of bioluminescent 
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organisms paves the way for interesting work examining the effects of novel antimicrobials 
in real time.  
3.1.4 Photodynamic therapy 
The effect now known as Photodynamic Therapy (PDT) was first noticed, and famously 
described by Paul Ehrlich, at the turn of the century when certain combinations of dyes and 
illumination was shown to kill bacteria. The treatment depends upon a combination of dye 
with a corresponding frequency of light which leads to the production of cytotoxic free 
radicals and found success and acceptance in the treatment of carcinomas (Robertson, 
Evans, & Abrahamse, 2009). However, Photodynamic Antimicrobial Chemotherapy (PACT) 
has found limited applications other than its use in the sterilization of blood products (Ben-
Hur & Horowitz, 1995). This may change since research has shown that this type of therapy 
can be very effective against biofilms (Hamblin & Newman, 1994; O’Neill, Hope, & Wilson, 
2002). Phenothiziniums such as methylene blue (MB), and toluidine blue O (TBP), azure A-C 
and thionin have all been used as photosensitisers effective in the wavelength range of 600-
660nm (Wainwright, 2007; Wilson, 2004). MB absorbs most effectively at 656nm and has 
been shown to be non-toxic to mammalian cells up to 1% w/v (Creagh et al., 1995). These 
factors and recent reductions in costs of high intensity LED light make this an important area 
of study with potential applications in oral healthcare. 
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3.2 Materials and methods 
3.2.1 Stabilisation of conditions and serial biofilm sampling 
Biofilms enclosures were incubated in INCU-line Digital Mini incubators (VWR 
International, UK).  Sequential sampling of several biofilms incubated at the same time in 
one experimental run was implemented by constructing a software controlled, solenoid-
operated multivalve.  A PEEK bodied valve (Cole-Palmer, Bedfordshire, UK) was selected to 
minimise contamination by volatiles, and this could be connected by PEEK tubing to both the 
biofilm enclosures and to the SIFT-MS instrument. Actuation of the solenoid valves was by 
relay board (Circad Design Ltd., Suffolk, UK). Communication with this board was by USB, and 
both board and cable were powered by the same 24VDc power supply.  
The relay board was controlled by ASCII text sent serially over USB by an application 
written in Python (PSF, Delaware, USA). The GUI front end was designed using Glade3/GTK+ 
(GNU/GPL public license).  A screen shot of the application can be seen in Figure 3.2. 
Figure 3.2: Multivalve solenoid valve control application 
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 Ports could be selected individually or cycled in sequence, with each port remaining 
on for a chosen time period. All switching was logged in a comma separated text file with 
timestamp, allowing port state at any given time to be known. A schematic diagram of the 
multiport valve is shown in figure 3.3. 
Figure 3.3: Multiport valve schematic diagram and photo. 
3.2.2 pH measurement of the biofilm 
In order to measure the pH of the biofilm in real time, a pHOptica optical 
measurement system was employed (see chapter 2, General Methods). This system relies on 
a paper optrode containing two embedded fluorophores, one whose fluorescence depends 
on pH and the other a reference to compensate for any drift. The exact nature of these 
fluorophores is proprietary information protected by the manufacturers. Excitation and 
measurement is performed by glass and fibreoptic waveguides. In order to incorporate this 
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system into the flat-plate biofilm system, it was necessary to redesign the slope by CAD and 
re-prototype in NanocureTM. A close fitting channel was made into the slope with a channel 
for sealing around the hole necessary in the base of the biofilm enclosure. At the top of the 
channel under the biofilm was a recess to accept a 10mm glass microscope coverslip with a 
further recess to allow sealing with autoclavable sealant. This arrangement is illustrated in 
Figure 3.4 and figure 2.4 in the previous chapter. Biofilms were incubated for two days after 
innoculation before the optrode disc was carefully place aseptically underneath the cellulose 
matrix over the glass window. The waveguide and attached fibreoptic cable was then 
inserted under the channel and attached to the pHOptica device. Calibration information 
was supplied by VWR for each batch of optrode discs used. The reference temperature probe 
from the instrument was inserted into the incubator by the top port. A laptop running 
pHoptica software was attached and readings taken at 1 second intervals.   
Figure 3.4: Diagram of biofilm enclosure showing port for fibre optic cable 
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3.2.3 Modifications to allow study of bioluminescent biofilmss 
To enable the flat plate perfusion system to utilise the reporter organisms described 
in section 3.1.3, one biofilm incubator was further modified to allow an overhead camera to 
record and measure light intensity. A window was cut in the inner and outer top covers of 
the incubator and a Perspex panel glued, sealed and bolted into place (figure 3.5). 
Preliminary experiments with bioluminescent E. coli strain DH5α showed that 
bioluminescence could be monitored in real time by CCD device.  
Figure 3.5: Modifications to allow the use of bioluminescence reporter organisms in the flat 
plate biofilm model 
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3.2.4 Time lapse recordings 
An additional advantage of the windowed incubator is that time lapse recordings of 
biofilm maturation and development could be made. This was achieved using a Galaxy S4 
smartphone equipped with the Android based Framelapse Pro software. 
3.2.5 Modifications to allow in vitro photodynamic treatment 
A glass window was installed in the top of the enclosure to enable a high power LED 
to illuminate the biofilm. This could be accompanied by injections of photodynamic agents. 
Power could be supplied to each LED at a time on up to six enclosures. Voltage was controlled 
by variable laboratory supply (EL301R, Thurby Thandar Instruments Ltd., Cambridgeshire, 
U.K.). The LED housings could be used with a number of different fixed wavelength LED units
(Mouser, USA).  The LED installation can be seen in figure 3.7 
. 
Figure 3.6: LED apparatus installed in biofilm enclosure window, shown from above (left) and 
below (right) 
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Figure 3.7: Biofilm enclosure with LED device installed 
3.3 Results 
3.3.1 Multisampling 
Six incubators can be seen in figure 3.8, showing PEEK tubing entering through each 
front panel. A spike in signal was often seen when switching from one biofilm to another, 
and this was trimmed out at the data analysis stage. These spikes can be seen in Figure 3.9: 
Example trace by SIFT-MS during sampling of four biofilms. 
An example of the trace obtained by SIFT-MS during a sampling period can be seen in 
Figure 3.9. These traces were separated into data from each biofilm, with all spikes or 
interference removed using iterative functions written in MATLAB code. 
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Figure 3.8: Six incubators showing equal length PEEK tubing entering each through the front 
panel. 
Figure 3.9: Example trace by SIFT-MS during sampling of four biofilms. 
3.3.2 Real time pH measurement 
It was shown that the pHOptica sensor could be used to measure the pH of an in vitro 
biofilm in real time whilst simultaneously measuring volatiles produced using SIFT-MS. Figure 
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3.10 shows example traces of volatile production accompanied by pH readings by the fibre 
optic sensor. There were however reproducibility problems with this method and this will be 
discussed later.   
Figure 3.10 Production of sulphides (left) and acids (right) from an in vitro oral biofilm 
immediately following a pulse of 2ml 200mM glucose 
3.3.3 The bioluminescent biofilm 
A graph of preliminary results can be seen in figure 3.11. In this example, methyl 
mercaptan levels from a DH5α strain of E. coli are monitored along with light intensity, and 
the production of both appear to be related in this instance. This was intended as a proof of 
principle experiment, and potential uses for this are discussed in chapter 8. 
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Figure 3.11: Methyl mercaptan and light intensity in bioluminescent E. coli DH5α 
3.3.4 Time lapse recordings 
Figure 3.12 shows the development of dark metal sulphide compounds (e.g. ferrous 
sulphide) whilst using SIFT-MS to monitor the levels of hydrogen sulphide and methyl 
mercaptan, to demonstrate a potential relationship between pigmentation and sulphides. 
The pigmentation is not visible at the introduction of the inoculated cellulose matrix (figure 
3.12A).  
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Figure 3.12: Graph showing sulphides produced by a maturing biofilm with accompanying 
timelapse images from timespoints A, B, C and D. 
A 
C 
B 
D 
. hydrogen sulphide . methyl mercaptan 
71 
Pigment is clearly visible at 4 hours of constant medium flow (figure 3.12B) and 
become most marked by 8 hours (figure 3.12C). The pigmentation remains high (figure 
3.12D) until the end of the experimental run (at 21 hours). This method can be used to 
identify possible causes of variations in VOC production during maturation of biofilms as 
complex structures and pigmentation changes occur. A similar approach of time-lapse can 
be used to describe other processes such as in situ “viable” staining methods, effects of 
fluorescent dyes and other colour absorption/desorption processes, which can be monitored 
over minutes, hours or days of operation. 
3.3.5 Photodynamic therapy 
Preliminary work showed a dose response with the photosensitizer methylene blue, 
but at concentrations and staining intensities too high for therapeutic use. The dose-
response curve for methylene blue on sulphide production is shown in figure 3.13. If 
compared to the effects on biofilm volatile production seen with proprietary mouthwash 
formulations, such as seen in figure 4.9 in section 4, it can be noticed that reductions are 
relatively inconsequential. ?????? ???? ?oncentration of methylene blue used was high 
enough that staining of the oral cavity was likely. It is for this reason that this particular 
avenue was not followed further. 
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Figure 3.13: Dose response for methylene blue and 660nm light at an intensity of 64 mWcm-2. 
3.4 Discussion 
Through these developments and experiments it has been shown that the flat plate 
perfusion model is a stable and versatile test bed for in depth analysis and examination of 
microbial biofilms in vitro. The ability to inoculate and mature several biofilms in parallel 
from an identical tongue scrape sample and monitor them sequentially by SIFT-MS provides 
a versatile test bed for the examination of the effects of many types of interventions. It has 
further been shown that the model itself can be used to study bioluminescent organisms 
thus making available the insights into biofilm physiology that this provides.  
Whilst the particular photodynamic therapy investigated here showed issues that 
suggests the development of a therapeutic regime unlikely, the model itself can certainly be 
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used to investigate the many promising combinations of light and photosensitiser that have 
been suggested elsewhere.  
In respect of the real time pH measurement that has been demonstrated, it is obvious 
that such a method would be an extremely useful way to investigate the complex interplay 
between pH, VOC production, and other aspects of biofilm physiology. However, much more 
work is needed in this area to validate and standardise the optrode based method to achieve 
reproducible results with multiple biofilms. Incorporating the optrode into the biofilm matrix 
in a standardised way that would still enable interrogation by fibre optic cable would need 
to developed and validated and this proved to be beyond the scope of this project. 
In conclusion, whilst not all avenues outlined in this chapter have been explored fully, 
there is ample potential for further study of both biofilm physiology and the effect of 
treatments or interventions thereon. The next chapter will outline further validation of the 
model and examination of the nature of the oral biofilm, and further chapters will describe 
the use of the model to evaluate both some specific treatments and a novel biosensor 
system.  
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4 The oral microbiome and volatilome 
Introduction 
By around the time of puberty the community of human oral bacteria has reached 
microbial homeostasis (Marsh, 1989) . This is a dynamic equilibrium involving the 
interaction of a large number or organisms and the human host. This microbiota is 
remarkable stable once established and has been shown to vary little over many years 
(David et al., 2015; Rasiah et al., 2005), and is probably the most stable of all sites of 
microbial colonisation on the human body (Zhou et al., 2014). However, whilst this core 
body of species remains stable over long timescales, a degree of variation over shorter 
timescales is common (David et al., 2015). This is reflected in the profile of volatile gases 
that the oral biofilm produces, as it is affected by not only microbial composition of the 
biofilm, but the particular metabolic activity it has at a given time point. The amount of 
dissolved hydrogen sulphide and methyl mercaptan in solution is highly pH dependant, 
whereas dimethyl disulphide is less so. This explains the dominance of these first two 
sulphides since acids are typically produced from food or saliva through microbial 
metabolism. The aetiology of caries is also inextricably linked to the pH of the oral cavity. 
Since experiments involving gastric tube-feeding of both animals (Haldi et al., 1953; Bowen 
et al., 1980) and humans (Littleton et al., 1967; Cooke et al., 1982; Ellison et al., 1982) it has 
been known that oral ingestion of carbohydrate components leads to carious lesions, and 
that this is dependent on the presence of oral microorganisms on the dental surfaces. It is 
now well understood that sucrose has the greatest effect, and that the major glycolytic, 
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acid tolerant organisms in the oral cavity are streptococci such as S. mutans 
(Lemos, Abranches and Burne, 2005). Imfeld and Lutz (1980) first used pH 
telemetry with electrodes implanted in dental appliances to demonstrate reductions 
in pH following ingestion of carbohydrates. Following ingestion of sucrose solutions, 
intra-oral pH is seen to fall from 7 to under 5. The association between pH and oral 
malodour has been less well studied, and there is still disagreement about how salivary 
pH may be an important factor in malodour. Saad (2007) showed no strong 
relationship between salivary pH and malodour, but it has to be accepted that the 
site of highest VSC production is the tongue biofilm interface; not the reactions in saliva. 
The biofilm matrix contains fluid, which is a completely different compartment with a 
different composition from saliva. The following compartments have been described on 
the tongue: (1) Bulk salivary volume (2) Rapidly exchanging thin salivary coating layer 
(3) the biofilm and biofilm matrix fluid (4) tongue epithelium substratum. By blotting the
surface of the tongue, the bulk saliva and thin layers are removed. A sterile toothbrush is 
then used to take two or three tongue dorsum impression samples, which are 
pooled in a small volume (2 ml) distilled water. It is the resultant pH of this suspension 
that was used by Saad (2007) to show that there is indeed a fairly strong relationship 
between the pH of the tongue biofilm matrix and malodour (figure 4.1) but that this is 
not seen from salivary samples. Thus the oral microbiome, whilst more conserved and 
stable than other sites in and on the human body, varies significantly between 
individuals. Each individual microbiome will respond differently to stimulus, 
nutrients and pH and thus will contribute in a different way to the volatilome that is 
produced. This chapter describes experiments that were performed to investigate the 
nature and differences of the oral biofilm both in vivo and in vitro. 
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Figure 4.1: Relationship between organoleptic score and pH of tongue biofilm (Saad and 
Greenman, unpublished) 
4.1.1 Periodontal malodour 
Periodontal disease is a chronic bacterial infection causing persistent gingival 
inflammation, and in some cases connective tissue destruction and bone resorption around 
the teeth. It is also characterised by pocket formation and recession. Although oral 
malodour is not caused by periodontal disease, there is ample evidence to suggest that 
periodontal disease increases the severity of malodour and also contributes to an increased 
tongue coating and higher production of VSC (Bolepalli et al., 2015). Previous research has 
shown that chronic periodontitis patients exhibited about four-time higher amount of 
tongue coating compared to healthy control subjects (Yaegaki and Sanada, 1992). 
Moreover, oral malodor is more strongly associated with tongue coating rather than the 
severity of periodontitis (Morita and Wang, 2001a, 2001b). In addition, there are significant 
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correlations reported in the literature, where periodontal malodour has been associated 
with (1) increased number and depth of periodontal pockets (Yaegaki and Sanada, 1992), 
as well as (2) increased gingival crevicular fluid (GCF) flow rate(Morita and Wang, 2001a), 
(3) increased radiographic bone loss, (Morita and Wang, 2001b) and (4) presence of
periodontal pathogens (Loesche and Kazor, 2002). In a study by Yaegaki (1997) an 
association between pocket depth of gingival pockets, amount of VSC and the CH3SH/H2S 
ratio was established. 
The collective  evidence  from  numerous in vitro and in vivo studies suggests that 
the persistence and diversity of the resident oral flora is dependent upon the range and 
rate of supply of nutrients provided by the host. For example, the salivary mucins 
(glycoproteins) act as the main source of carbohydrates for plaque and tongue biofilm 
bacteria. The degradation of the oligosaccharide side chains depends upon the concerted 
action of consortia of different species, each with complementary profiles of glycosidase 
activity (Beighton, Smith and Hayday, 1986; Ter Steeg et al., 1988; Van der Hoeven and 
Camp, 1991; Bradshaw and Marsh, 1998). Furthermore, the growth of some species can be 
dependent on the provision of nutrients by other species, such as the supply of short-chain 
fatty acids by Fusobacterium sp. to Viellonella sp. 
The specific theory of oral malodour suggests that specific microbial species are 
responsible (i.e. aetiological) whilst the non-specific theory suggests that the tongue biofilm 
“as a whole” is important, without the need for a specific agent (i.e. amount is more 
important than specific composition). In a diverse biofilm there may be many species that 
can transform substrates to VSC and many species can “substitute for others” in different 
cases.  From a modelling perspective, the tongue surface biofilm may be classed as a 
continuously perfused matrix biofilm system. However, in periodontal disease there are 
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clear differences to tongue biofilms, both in the ecological composition and likely source of 
nutrition. The location of the periodontal microflora is at the interface of hard tissue tooth 
surfaces and the non-keratinised sulcular epithelial cells. This forms the sulcus or gingival 
crevice. Most importantly, the microbes gain nutrition mainly from gingival crevicular fluid 
sources rather than from saliva. In health, the subgingival flora may be supplied with 
nutrients from a mixed domain of saliva and crevicular fluid, since the diffusion rate of 
crevicular fluid is slow. This is because flow across intact junctional epithelial cells is 
dependant on the surface area of non-keratinised epithelia, and its ratio with the volume 
or mass of microbial cells that the fluid supplies within the crevice. As periodontal disease 
progresses, the gingival crevice volume extends deeper towards the roots of the teeth and 
increases in size, to develop into what is described as a periodontal “pocket”. The microbial 
populations increase, and in addition, the microbes respond to the changing conditions (i.e. 
change their physiological state) producing more tissue-destroying hydrolytic enzymes as 
well as cytotoxic and inflammatory agents. The joint effect is to exacerbate tissue damage 
and continue to enlarge the pocket. 
4.1.2 Characterisation of the oral microbiome by nucleic acid sequencing 
There has been much work in characterising and grouping the oral microbiome with 
specific reference to periodontal disease, but less with reference to oral malodour. In their 
seminal paper, Socransky et al., (1998) used whole DNA probes and checkerboard DNA-
DNA hybridisation to generate a large dataset of microbial prevalence in 185 subjects. Using 
hierarchical clustering and correspondence analysis they split the taxa detected into five 
groups which they distinguished arbitrarily by colour. This grouping schema can be shown 
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in figure 4.2. Whilst limited in scope this grouping has remained the most common scheme 
for categorising periodontal pathogens. It is of interest to apply similar and enhanced 
techniques to nucleic based analysis, and to relate this to oral malodour. 
Human Oral Microbe Identification Microarray (HOMIM), and Human Oral Microbe 
Identification using Next Generation Sequencing (HOMINGS) techniques are 16s rRNA gene 
sequencing methods for species identification of oral organisms. HOMIM analysis was 
introduced in 2008 and used an in vitro  hybridization technique similar to DNA microarray 
technology to identify 293 predominant oral bacterial species (Paster and Dewhirst, 2009). 
The improved HOMINGS method was introduced in 2014 and relies on in silico hybridization 
to identify 597 species (Belstrøm et al., 2016).  The datasets produced by these methods 
allow powerful statistical techniques to be performed to analyse microbial ecology in the 
oral habitat. Some techniques similar to those used by Socransky, plus some novel 
techniques, will be discussed in this chapter.
Figure 4.2 Subgingival microbial complex as described by Socransky et al., 1998 (Reproduced with 
permission from John Wiley and Sons Inc.)
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Materials and Methods 
4.2.1 The volatilome in vivo 
The volatilome of the human oral cavity was sampled by SIFT-MS as described in 
section 2.6.3. Short term changes were monitored in one subject over the course of the day 
and in another during a period of voluntary fasting. These were case studies of individuals 
and are presented as illustrations of the types of changes seen in the oral cavity, rather than 
exhaustive studies. Additionally, a number of volatile profiles of human volunteers 
examined by SIFT-MS were compared to the corresponding profiles obtained from in vitro 
biofilms as described below. All microbiological analysis was performed as described in 
section 2.2. Finally, the volatile profile of 39 subjects was compared with HOMIN analysis 
of the frequency of species seen in a tongue scrape sample. These methods are outlined in 
section 2.3. This volatile profile was compared with microbial composition before and after 
treatment. 
4.2.2 The volatilome in vitro 
In vitro biofilms were inoculated from samples as described in section 2.1. Gas 
sampling of the biofilm enclosure was performed as described in section 2.1.6 and in the 
previous chapter. With these techniques, the volatile profile of healthy individuals was 
compared with the profile obtained from biofilms inoculated from their tongue scrape 
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samples. Comparison of these profiles was performed by χ2 analysis. pH of the biofilms was 
monitored in some cases, using the pHOptica optical device as described in section 3.2. 
The effect of commercially available mouthwashes on the in vitro model was 
investigated using the methods described in section 2.1. Formulations tested were off the 
shelf samples of Listerine (Johnson & Johnson, New Jersey), Meridol (GABA, Germany), 
CB12 (Meda Pharmaceuticals Ltd., UK) and BreathRX (Phillips, UK). The active formulations 
were compared with sterile distilled water as a control. Pulses of 2ml of each treatment or 
control were applied to mature biofilms over a period of one minute and the effects on 
volatile production measured by SIFT-MS. 
4.2.3 Species frequency analysis 
Species frequency analysis was performed on tongue scrape samples from 40 
individuals as described in section 2.3. The HOMIM data was analysed by a variety of 
statistical visualisation methods beginning with rank abundance plots and calculation of 
diversity indices. A novel technique, first presented here, is to plot heatmaps of organisms 
to better visualise the association between their frequency and malodour. Circos is a 
computer scripting language originally devised to visualise genomic data (Krzywinski, 2009), 
but it can be usefully employed to generate these type of heatmaps. The method is as 
follows; taxa are plotted radially around the a circular Circos plot and samples are ordered 
from low to high malodour score (by whatever measurement method has been used), 
starting at the centre of the plot. Points are coloured by heatmap ranging from pale to dark 
red based on the percentage frequency. This means that darker red at the outside of the 
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circular plot corresponds to the association of those organisms with malodour. Further 
analysis can be performed by analysing the skew coefficient for each organism ‘spoke’ of 
the circle. Positively skewed organisms are likely to be associated with malodour whereas 
negatively skewed organisms are likely to be more prevalent in low malodour individuals. 
Another powerful statistical method that can be applied to these kinds of datasets 
is co-occurrence analysis. Assessing cooperation and competition in species has a long 
history, and the use of binary matrices has its roots in the “checkerboard” theory of 
Diamond (1975). The development of the ideas is well covered by Connor et al., (2017). 
Nowadays probabilistic species co-occurrence modelling is best accomplished by computer 
algorithms (Veech, 2013) such as that implemented by Daniel Griffith in R-studio (Griffith, 
Veech and Marsh, 2016). These models are much more rapid than original techniques and 
avoid most Type I and II errors by avoiding data randomisation based comparative 
techniques. The matrix allocates ‘positive’, ‘negative’ or ‘random’ to each species pair 
combination based on whether the probability of the species pair occurring is greater than 
each species appearing with all the other species.  
Multidimensional scaling (MDS) was also used to gain insight from the large dataset 
by analysing clustering before and after treatment.  Not only can clustering in such plots 
indicate ecological associations between organisms, but the change in clustering before and 
after treatment can reveal the demographic action of a treatment.  
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The subject drank coffee at t=10 minutes (A), ate a small snack at t=25 
minutes (B) and lunch at 140 minutes (C) 
A B C 
Results 
4.3.1 The oral volatilome 
Figure 4.3 shows the progression in the profile of volatiles for a single subject over 
the course of a morning. 
Figure 4.3: Progression of the volatile profile in the oral cavity of a single subject. 
The effect of variations in food intake by the human host is illustrated in another case 
study which involved monitoring of oral volatiles in a human subject during a period of 
voluntary fasting. As can been seen in figures 4.4 to 4.6 fasting had a dramatic effect on 
volatiles detected by SIFT-MS and the composition of the tongue biofilm.  Anaerobic plate 
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Fasting Post-fasting 
counts were almost two orders of magnitude lower during the fasting period and the 
proportion of gram negative organisms twice as high. Production of sulphides was highest 
at the end of the fasting period with hydrogen sulphide production particularly 
pronounced. A further five days after recommencement of a normal diet, the profile of 
VOCs and composition of the biofilm had almost returned to the original state. 
Figure 4.4: Changes in volatile profile before, during and after a period of fasting 
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Figure 4.5: Microbiological changes before, during and after a period of fasting 
(Gram positive and negative organisms) 
Figure 4.6: Microbiological changes before, during and after 
fasting (strict and facultative anaerobes) 
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4.3.2 Comparison of in vivo and in vitro biofilms by SIFT-MS 
Figure 4.7 shows Profile3 SIFT-MS VOC profiles taken from the oral cavity of six 
volunteers, and their corresponding profiles from biofilms inoculated from their tongue 
scrape samples. In all cases where at least five compounds are seen in both samples, χ2 
analysis of the data shows the profiles to be indistinguishable (P = 0.9). In addition to 
validating the model, this data supports the hypothesis that bad breath, specifically in 
respect of volatile sulphide production, is a feature of the microcosm and the properties of 
the model reflect the different microcosms. Oral malodour is thus transplantable to the 
model. Whilst proportions of strict and facultative anaerobes and gram positive and 
negative organisms are similar in vivo and in vitro a far superior method for comparing the 
microbiological composition would be nucleic acid based techniques as discussed next. 
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Figure 4.7: Comparison of VOC profiles from in vivo and in vitro biofilms from the same 
subjects 
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4.3.3 The effect of commercial mouthwashes on the in vitro biofilm 
Figure 4.8 shows the effect on volatile profile by the application of commercial 
mothwashes to mature in vitro biofilms. Figure 4.9 shows the proportion of initial hydrogen 
sulphide production after treatment. 
Figure 4.8: The effect of various commercial mouthwashes on the hydrogen sulphide 
production of six biofilms. Treatment occurred at t=0.  
A useful comparison technique here, used again later, is to measure the total area 
under the response curve for each treatment. This is a useful measure as it takes into 
account both the initial reduction in volatile levels and the duration of that an effect. A bar 
chart showing the respective areas for each treatment is shown in 4.10. 
89 
Figure 4.9: The effect of various commercial mouthwashes on the hydrogen sulphide 
production of six biofilms, shown as a proportion of the original level 
Figure 4.10: Area under the hydrogen sulphide curve for various commercial mouthwashes. 
Overall order of effectiveness is therefore BreathRX>>CB12>>Meridol>>Listerine>>Control. 
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4.3.4 Species frequency analysis 
The dataset obtained from HOMIM analysis performed on 40 individuals before and 
after a treatment intervention consists of two 40 by 259 numerical arrays of non-integer 
values between 0 and 50. To represent this visually in ways that confer useful information 
is challenging. A common useful technique is to plot rank abundance charts. Because of the 
large number of organisms with low incidence, these charts have very long, flat tails, and it 
is more useful to plot only the most abundant organisms. The charts for the first forty 
organisms can be seen in figure 4.11. The shape of each of these charts would be reflected 
in the diversity indices calculated for each group. The Chao1 (Chao, 2016) index of overall 
species richness is not significantly different, but the Shannon diversity index (Shannon, 
1948) is 3.07 for the first group and 2.90 for the second. This is a significant difference at 
the 95% level (P=0.0008). If the change in relative abundance of organisms before and after 
treatment is plotted for those with the highest change, it appears as in figure 4.12.  
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Figure 4.11: Rank abundance chart of organism frequency by 16s rRNA analysis of tongue 
scrapes from 40 individuals. Pprevalence is shown before (top) and after (bottom) treatment 
for the 40 most abundant organisms 
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Figure 4.12: Change in relative abundance of fifty organism frequency by 16s rRNA analysis of 
tongue scrapes from 40 individuals. The species included showed the greatest positive or 
negative change after treatment with an antimalodour formulation. 
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A circus heatmap of the data, plotted as explained earlier, is shown in figure 4.13. 
Both Pearson’s and Kelly’s coefficient of skewness were calculated for each ‘spoke’ of the 
circle and the organisms showing the greatest skew are seen in figures 4.14 and 4.15.  
Figure 4.13: Heatmap of oral malodour and organism frequency by 16s rDNA analysis. Radial 
tracks represent individuals and spokes represent organisms. Higher relative frequency of 
each organism is represented by a darker red colour, and individuals are plotted radially 
outwards in order of measured malodour by SIFT-MS. 
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Figure 4.14: A select group of organisms showing positive skew by Pearson’s coefficient 
previously identified by 16s rDNA analysis of 40 individuals. Radial tracks represent individuals 
and spokes represent organisms. Higher relative frequency of each organism is represented 
by a darker red colour, and individuals are plotted radially outwards in order of measured 
malodour by SIFT-MS.  
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Figure 4.15: Positive skewed organisms (above) and negatively skewed (below) by Kelly’s 
coefficient.These are a subset of organisms analyses by 16s rRNA analysis of tongue scrapes 
from 40 individuals.  Radial tracks represent individuals and spokes represent organisms. 
Higher relative frequency of each organism is represented by a darker red colour, and 
individuals are plotted radially outwards in order of measured malodour by SIFT-MS. 
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A co-occurrence matrix of ‘positive’, ‘negative’ and ‘random’ associations between 
a subset of organisms can be seen in figure 4.16. 
Figure 4.16: Co-occurrence matrix for a subset of the organisms identified in 40 samples by 
16s rRNA analysis. Colour of the block at the intersection of the two organisms indicates if 
they are more (positive) or less (negative) likely to occur together 
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A number of MDS plots could be plotted from this data but an interesting one is 
presented here. The plot in figure 4.17 shows the distance distribution of the organisms 
before treatment and after treatment. Points are coloured according to Gram reaction. 
MDS plot a scaled transform of the Euclidean distances between points, thus a wider spread 
indicates more diversity. 
Figure 4.17: MDS analysis of species frequencies obtained by 16s RNA analysis of 40 
subjects, with grouping based on Gram stain pre and post treatment.  
K-means cluster analysis can also be performed on the Euclidean distance matrix
in a similar way to that performed by Socransky with peridodontal organisms (1998). This 
leads to a grouping schema shown in figure 4.18 and the accompanying table 4.1. The 
number of clusters was chosen using within groups sum of squares method. 
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Figure 4.18 K-means cluster analysis of species frequencies obtained by 16s rRNA 
analysis of 40 subjects. The identity of the organisms in each cluster is given in Table 4.1 
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Table 4.1 Organisms grouped as in figure 4.18 (qv.) 
Group 
1 Acetivibrio spp. Mycoplasma hyosynoviae 
Anaerobacterium chartisolvens Neisseria elongata 
Anaerophaga spp. Neisseria sp. 
Bacteroides spp. Neisseria spp. 
Bergeyella sp. Neisseria subflava 
Capnocytophaga infantium Oribacterium parvum 
Catonella spp. Peptococcus sp. 
Clostridium intestinale Peptostreptococcus stomatis 
Eubacterium sp. Porphyromonas spp. 
Fusobacterium nucleatum Prevotella aurantiaca 
Fusobacterium periodonticum Prevotella nanceiensis 
Fusobacterium spp. Prevotella shahii 
Haemophilus parainfluenzae Rothia spp. 
Haemophilus sp. Streptococcus peroris 
Kingella sp. Treponema socranskii 
Lactobacillus helveticus Veillonella parvula 
Megasphaera spp. 
Group 
2 Actinobacillus succinogenes Eikenella corrodens 
Actinomyces spp. Enhydrobacter aerosaccus 
Aggregatibacter sp. Enterobacter hormaechei 
Alloprevotella prevotella tannerae Enterococcus gallinarum 
Alloprevotella rava Enterococcus sulfureus 
Alloscardovia omnicolens Eubacterium saphenum 
Anaerosinus selenomonadaceae sb90 Faucicola moraxellaceae bacterium 
Atopobium rimae Fretibacterium fastidiosum 
Atopobium sp. Fusobacterium necrophorum 
Bergeyella spp. Gemella sanguinis 
Bifidobacterium longum Haemophilus haemolyticus 
Blautia sp. Halothiobacillus neapolitanus 
Butyrivibrio sp. Halothiobacillus sp. 
Campylobacter gracilis Johnsonella spp. 
Campylobacter showae Kingella oralis 
Campylobacter spp. Kingella spp. 
Capnocytophaga gingivalis Lachnoanaerobaculum sp. 
Capnocytophaga granulosa 
Lachnoclostridium clostridium 
symbiosum 
Capnocytophaga haemolytica Lactobacillus fermentum 
Capnocytophaga leadbetteri Lactobacillus johnsonii 
Capnocytophaga sp. Lactobacillus kalixensis 
Capnocytophaga spp. Lactobacillus reuteri 
Capnocytophaga sputigena Lactobacillus salivarius 
Cardiobacterium valvarum Lactobacillus suebicus 
Catonella sp. Lactococcus lactis 
Centipeda sp. Lautropia sp. 
Chryseobacterium moechotypicola Lautropia spp. 
Cloacibacterium spp. Leptotrichia goodfellowii 
Compostimonas spp. Leptotrichia hofstadii 
Cryptobacterium curtum Leptotrichia sp. 
Dialister invisus Leptotrichia spp. 
Dialister sp. Leptotrichia trevisanii 
Edaphobacter spp. Megasphaera sp. 
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Table 4.1 continued 
Group 
2 Meiothermus spp. Selenomonas infelix 
(cont.) Mitsuokella sp. Selenomonas sputigena 
Mobiluncus mulieris Sharpea spp. 
Neisseria canis Simonsiella muelleri 
Neisseria perflava Sneathia spp. 
Neisseria sicca Solitalea spp. 
Parvimonas micra Staphylococcus epidermidis 
Pasteurella sp. Stenoxybacter spp. 
Phocaeicola spp. Streptobacillus spp. 
Phyllobacterium trifolii Streptococcus australis 
Porphyromonas endodontalis Streptococcus constellatus 
Porphyromonas genomsp. p3 Streptococcus dysgalactiae 
Porphyromonas gingivalis Streptococcus intermedius 
Porphyromonas sp. Synergistes spp. 
Prevotella baroniae Syntrophococcus sucromutans 
Prevotella dentalis Tannerella forsythia 
Prevotella enoeca Tannerella sp. 
Prevotella intermedia Tannerella spp. 
Prevotella marshii Treponema amylovorum 
Prevotella oralis Treponema denticola 
Prevotella oulorum Treponema lecithinolyticum 
Pseudoramibacter alactolyticus Treponema sp. 
Ralstonia solanacearum Treponema spp. 
Rikenella spp. Trichococcus flocculiformis 
Roseivirga sp. Turicibacter spp. 
Rothia aeria Veillonella sp. 
Ruminiclostridium clostridium cellobioparum Veillonella spp. 
Salmonella spp. Weissella spp. 
Schwartzia sp. 
Group 
3 Actinomyces howellii Mogibacterium pumilum 
Actinomyces johnsonii Oribacterium sp. 
Actinomyces massiliensis Prevotella denticola 
Actinomyces viscosus Prevotella nigrescens 
Aggregatibacter actinomycetemcomitans Prevotella oris 
Aggregatibacter segnis Prevotella pallens 
Anaeroglobus sp. Prevotella sp. 
Atopobium parvulum Prevotella veroralis 
Atopobium spp. Rothia dentocariosa 
Campylobacter concisus Saccharibacter spp. 
Candidatus saccharimonas aalborgensis Scardovia inopinata 
Cardiobacterium hominis Selenomonas sp. 
Corynebacterium durum Selenomonas spp. 
Corynebacterium matruchotii Shuttleworthia satelles 
Dialister pneumosintes Slackia exigua 
Eubacterium brachy Solobacterium moorei 
Eubacterium spp. Stomatobaculum longum 
Lachnoanaerobaculum saburreum Streptococcus sinensis 
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Table 4.1 continued 
Group 
4 Actinomyces cardiffensis Prevotella melaninogenica 
Actinomyces graevenitzii Prevotella salivae 
Actinomyces lingnae Prevotella spp. 
Actinomyces odontolyticus Rothia mucilaginosa 
Actinomyces sp. Streptococcus gordonii 
Enterococcus sp. Streptococcus salivarius 
Granulicatella paradiacens Streptococcus sp. 
Granulicatella spp. Streptococcus spp. 
Megasphaera micronuciformis Streptococcus thermophilus 
Oribacterium sinus Streptococcus uberis 
Prevotella histicola Veillonella dispar 
Group 
5 Abiotrophia defectiva Haemophilus parahaemolyticus 
Actinobaculum spp. Haemophilus spp. 
Bacillus spp. Neisseria bacilliformis 
Citrobacter spp. Prevotella micans 
Dysgonomonas gadei Streptococcus dentirousetti 
Enterococcus faecalis Streptococcus infantis 
Enterococcus spp. Streptococcus mitis 
Filifactor alocis Streptococcus mutans 
Gemella morbillorum Streptococcus oralis 
Gemella spp. Streptococcus parasanguinis 
Granulicatella adiacens Streptococcus pseudopneumoniae 
Granulicatella elegans Streptococcus sanguinis 
Granulicatella sp. Streptococcus suis 
Haemophilus influenzae Vagococcus sp. 
102 
 Discussion 
4.4.1 The volatilome in vitro and in vivo. 
The case studies of volatile profile with food intake give an indication of the link 
between short-term changes and the metabolism of the microbiome. Figure 4.2 shows the 
progression in the profile of volatiles for a single subject over the course of a morning. As 
can be seen, the first calorific intake of the day, in the form of a cup of coffee, causes a rapid 
increase in volatiles. Subsequent food intake causes an initial reduction in volatiles followed 
by an increase. The amount of dissolved hydrogen sulphide and methyl mercaptan in 
solution is highly pH dependant, whereas dimethyl disulphide is less so. This explains the 
dominance of these first two sulphides since acids are typically produced from food or 
saliva through microbial metabolism.  
The effect of variations in food intake by the human host is illustrated in the second 
case study which involved monitoring of oral volatiles in a human subject during a period 
of voluntary fasting. As can been seen in figures 4.3 to 4.5 fasting had a dramatic effect on 
volatiles detected by SIFT-MS and the composition of the tongue biofilm.  Anaerobic plate 
counts were almost two orders of magnitude lower during the fasting period and the 
proportion of Gram negative organisms twice as high. Production of sulphides was highest 
at the end of the fasting period with hydrogen sulphide production particularly 
pronounced. A further five days after recommencement of a normal diet, the profile of 
VOCs and composition of the biofilm had almost returned to the original state. 
Unfortunately oral pH was not monitored in this period although it is expected that it 
increased during the fasting period. Figure 4.6 shows that in the biofilm model, decrease in 
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pH was associated with decreased production of H2S and CH3SH and that this could be 
induced by a pulse of glucose. 
Turning to the comparison of SIFT-MS profiles in vivo and in vitro (figure 4.7), the top 
row are low malodour individuals as scored by organoleptic judge, the second row medium 
malodour and the bottom row high malodour. It can be readily be seen that the VOC 
profiles are “transplantable” by using high, medium and low tongue scrape inoculum to 
generate the corresponding in vitro biofilm in the plate model. Absolute levels are 
significantly higher in the biofilm model, and in some cases this means that some 
compounds are seen only in the in vitro samples. 
The commercial mouthwash experiment demonstrates that the biofilm model can 
be used to test the effects of antimicrobial interventions on the biofilm and the 
corresponding effect on volatile profile. Similar results are seen as in in vivo studies and the 
medium term effects of the treatments is visualised well by the area under the curve charts. 
This in vitro method is useful in this regard and is likely to become moreso as studies 
involving human participants become more difficult. 
4.4.2 Species frequency analysis 
Species frequency analysis in the study of the tongue biofilm and oral malodour has 
lagged behind similar studies in periodontal disease. Co-occurrence of Bacteroides 
forsythus and gingivalis were first noted (Gmür, Strub and Guggenheim, 1989)  followed by 
Treponema denticola and Porphyromonas gingivalis (Simonson et al., 1992) and 
Fusobacterium nucleatum and Prevotella intermedia (Ali et al., 1994). In 1998, Socransky 
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was the first to place sub-gingival organisms into groups referred to as ‘complexes’ 
(Socransky et al., 1998) and this convention has been used widely since. These associations 
were mainly made by fairly simplistic methods such as contingency table analysis, and 
associations were not linked to other independently measureable variables such as volatile 
profile.   
The visualisation techniques outlined here when taken as a whole demonstrate 
powerful methods for characterising microbial communities and their macroscopic effects. 
The Circos plots with accompanying skew analysis (figures 4.13 to 4.15) highlight organisms 
that may not have previously been associated with malodour. These organisms, such as 
Edaphobacter sp., Oribacterium sp. or Anaerophagia sp. may not directly produce volatiles 
themselves but their role in the microbial ecosystem may lead to their association with 
malodour. Whilst further work would obviously be required to evaluate cause and effect, 
there is obviously ample direction for further study. Similar techniques could be used in the 
field of periodontal disease, not only linking volatile profiles with microbial ones, but other 
contiguous clinical measures such as pocket depth. 
Co-occurrence matrices can also reveal important interactions between organisms. 
Whilst the older contingency table methods were valid, modelling of complex 
chequerboard tables of numerous species is only possible now due to the ready availability 
increased computer processing power.   Examination of figure 4.16 shows a number of well-
known associations between groups of organisms, such as Fusobacterium sp., Prevotella 
sp., Actinomyces sp. and Tannerella sp. It is interesting, however, that Lactobacillus 
fermentum, salivarius and kalixensis are frequently seen together but are negatively 
associated with many known malodour producing organisms. It is tempting to suggest that 
such organisms may have the potential to have positive probiotic effect if administered 
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orally in combination with an antimicrobial mouthwash. This would be another area for 
further study. 
Turning to effects seen before and after treatment, the rank abundance charts 
(figure 4.11) show different profiles, and the change in Shannon index but not Chao1 
indicates that whilst overall richness is similar there is a loss of diversity which affects a 
smaller subpopulation. This is visually apparent in the difference in shapes of the primary 
rank abundance charts, the second chart appearing to have a sharper ‘peak’.  The 
subpopulation is likely to be of more common organisms rather than rare outliers. The 
change in abundance plot (figure 4.12) suggests that these organisms might be 
Fusobacteria, Neisseria and Prevotallae, whilst the frequency of Veillonella dispar and 
Streptococcus parasanguinis appears to have increased.   
Multidimensional scaling relies on mapping the scaled Euclidian distance between 
points in variable space to gain insight into clustering and relational information. In this 
instance, the change in this two dimensional metric after treatment in of interest. 
Examining figure 4.17 shows that the shape of the overall species cluster has changed 
significantly after treatment with a narrowing in the y-direction that affects Gram positive 
organisms. This is likely to be a reflection of the relative selection towards organisms such 
as S. parasanguinis previously noted. 
Comparison of k-means clustering of the organisms (figure 4.18) is 
interesting as parallels can be seen with groups proposed by Socransky for 
periodontal organisms. The so called ‘Red Group’ organisms are all seen in group 
2, whilst the ‘Orange Group’ are split between this group and group 1. The ‘Yellow 
Group’ organisms are mainly seen in group 5. If the average skew score for 
malodour as previously described is taken into account, groups 1 and 2 are most 
associated with malodour. 
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Conclusions 
The interplay between microbial ecology and physiology and the volatile profile that 
the community produces is complex and has many factors and influences. The flat plate 
perfusion system is an effective in vitro model for studying the behaviour of tongue-derived 
biofilms and how they respond to treatments. Further work is required to investigate more 
deeply the complex interplay between variables that occur in the tongue community. 
Additionally, these techniques could be applied to the human microbiome at other sites, 
both within the oral cavity and elsewhere. In the next chapter, the flat plate model will be 
applied to the study of both potential antimicrobial interventions and another device for 
analysing volatile profiles. 
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5. Comparison of a novel antimicrobial compound both in vitro and in
vivo
5.1 Introduction 
Most antimicrobial treatments commonly in use for the treatment of oral malodour 
rely on a combination of agents that target both the production of VSCs by microorganisms 
and their propensity to enter the gaseous phase once produced. Considering antimicrobial 
substances, attention quickly focussed on  membrane-active cationic compounds such as 
chlorhexidine, alexidine, cetyl pyridinium chloride and hexetidin (Roberts and Addy, 1981). 
Of these, chlorhexidine (CHX) has become the most commonly used by the dental 
profession for treating caries, gingivitis and periodontal disease as well as oral malodour 
(Jones, 1997). The second method of reducing VSC in breath has focussed on the use of 
metal salts. Ions of transition metals such as Hg2+, Cd2+, Cu2+, Zn2+ and Sn2+ all have a high 
affinity for sulphides, and their binding to VSC precursors prevents the malodourous 
compounds from being released (Young et al., 2001). Whilst many salts of these metal ions 
have been tested in vitro  only salts of copper, tin or zinc are considered safe enough for 
use clinically. Of these, zinc (II) salts show the best balance of efficiency and safety. When 
combined with chlorhexidine, zinc salts have an effective synergistic effect on oral 
malodour and this combination is very successfully used in leading commercial 
mouthwashes (Thrane et al., 2007).  
CMD is the codename given to a novel compound which had previously shown a 
positive synergistic effect with chlorhexidine against Staphylococcus aureus. The purpose 
of this study was to test the effects of this compound in concert with both chlorhexidine 
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and zinc acetate against oral biofilms both in vitro and in vivo. The three compounds were 
combined in three formulations containing between 0.1 and 0.3% of the active ingredients 
and compared with two positive and a negative controls as described below. 
5.2 Materials and Methods 
Five active treatments and a negative control consisting of distilled water 
were selected. Three of these treatments contained a combination of CMD, chlorhexidine 
acetate and zinc acetate in varying proportions as outlined in Table 5.1: Products used in 
the in vitro and in vivo Investigation of a novel antimicrobial.. Treatment 4 was a commercial 
mouthwash that also incorporated zinc acetate and chlorhexidine diacetate plus 
sodium fluoride (proportions shown in table 5.1). Treatment 5 contained only 
chlorhexidine digluconate as an active ingredient at a concentration of 0.2%.  
Selection of volunteers for the study was performed by Dr. Saliha Saad of UWE (CRIB, 
Oral Malodour group). The sample group was a subset of a larger group of 120 volunteers 
used in previous studies. The majority demographic was those working or studying at the 
University, but were of varied gender, age and ethnic background.  Preliminary organoleptic 
investigations were undertaken by judge and instrument. Eligibility and exclusion criteria 
used to select the final 39 participants are given in figure 2.2. In order to maintain anonymity 
all volunteer data was coded and randomised before being allocated a treatment. These 
procedures were scrutinised and approved by the University’s Ethics Committee and are 
covered by UWE NRES Ref: North-West Haydock 15/NW/0316. 
Trials were performed by crossover design. Before and between each treatment a 
one week washout period was performed using a proprietary toothpaste and a 
standard brush (see Table 5.1). Microbiological analysis was performed on tongue scrape 
samples before and after treatment as described 
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in section 2.2. These were taken using a standardised sterile toothbrush from a 1cm2 area 
of the tongue dorsum.  Samples were inoculated directly into degassed brain heart infusion 
and vortexed.  Relevant dilutions were plated on fastidious anaerobe agar (LabM, Bury, 
UK) with and without vancomycin (2.5 mgl-1; Sigma-Aldrich, UK) and incubated 
anaerobically for seven days. Plate counts were performed for strict and facultative 
anaerobes as well as total viable organisms. A random anonymous portion of one of 
these tongue scrape samples was used to inoculate the biofilms for the in vitro arm of 
the study.  The six biofilms were monitored sequentially by Profile3 SIFT-MS using the 
PEEK multivalve system set to a switching time of 50 seconds. Monitoring took place over 
a 48hr period and three repeat pulses of each product were introduced, giving four in 
total. Please refer to general methods chapter for more detail if required. 
5.2.1. In vivo sampling of the oral cavity 
VOC sampling occurred before treatment, 1 hour afterwards and again at 3 and 6 hrs 
afterward. Sampling was by trained organoleptic judge, OralChroma and Profile3 SIFT-MS as 
described in section 2.5. Tongue scrape samples were taken before treatment and at 3 and 
6 hrs. Plate counts were performed as for the in vitro study. 
5.2.2. Trained Organoleptic Judge 
Organoleptic scoring by a trained judge was used to assess malodour. The mouth 
was kept closed for two minutes to allow formation of headspace equilibrium in the oral 
cavity, then the head was inclined backwards and the mouth opened to allow assessment by 
judge. Malodour was categorised from 0-5 where 0 = no odour, 1 = barely noticeable, 2 = 
slight odour, 3 = moderate odour, 4 = strong odour and 5 = very strong odour. 
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5.2.3.  The OralChroma 
Samples were collected from the human volunteers as recommended by Abilit 
corporation. A 2 ml volume of air from the oral cavity was collected by gas syringe (B. Braun 
Medical Ltd, Sheffield, UK) and injected into the injection port of the gas chromatograph 
(OralChromaTM AbilitCorporation, Japan). The area under the peaks was used to calculate 
levels of hydrogen sulphide and combined volatile sulphur compounds (VSC) concentrations 
from a previously generated calibration curve. 
5.2.4. SIFT-MS 
The Profile3 instrument was used for sampling set up as described in section 2.6.3. 
It was necessary to modify the sampling inlet of the SIFT-MS to measure VOC levels in the 
oral cavity. The rear port of the sampling head was connected to a mini diaphragm pump. 
The front inlet was adapted to hold a disposable straw that could be introduced into the 
oral cavity. Air was thus drawn from the oral cavity and this stream was then subsampled 
by the SIFT-MS. Dynamic calibration was performed by flow rate as recommended. 
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Table 5.1: Products used in the in vitro and in vivo Investigation of a novel antimicrobial. 
Test Product 1: 
Reference label CMD01 
Active compounds 
Chlorhexidine diacetate 0.01% 
CMD 0.01% 
Zinc acetate 0.07% 
Test Product 2: 
Reference label CMD02 
Active compounds 
Chlorhexidine diacetate 0.03% 
CMD 0.03% 
Zinc acetate 0.07% 
Test Product 3: 
Reference label CMD03 
Active compounds 
Chlorhexidine diacetate 0.03% 
CMD 0.03% 
Zinc acetate 0.30% 
Test Product 4: 
Name of product 
Reference label 
Name of manufacturer 
Active compounds 
Chlorhexidine diacetate 
Zinc acetate 
Sodium flouride 
Positive control A 
CB12 
MEDA OTC AB, Solna, Sweden 
0.025% 
0.30% 
0.05% 
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Table 5.1 continued 
Test Product 5: 
Name of product Positive control B Chlorhexidine digluconate 
Reference label CHX 
Name of manufacturer GSK 
Active compounds 
Chlorhexidine digluconate 0.20% 
Test Product 6 
Name of product Negative control  sterile distilled water 
Reference label Control 
Name of manufacturer N/A 
Active compounds 
None 
Toothpaste (for wash-in and wash-out phase) 
Name of product 
Name of manufacturer 
Active compounds 
Sodium Monofluorophosphate,  
Sodium fluoride  
Other ingredients (qualitative) 
Colgate Cavity protection 
Colgate-Palmolive 
(1400 ppm F-) 
(450 ppm F-) 
Dicalcium Phosphate Dihydrate, Aqua, Glycerin, Sodium 
Lauryl Sulphate, Cellulose Gum, Aroma, Sodium 
monofluorophosphate, Tetrasodium Pyrophosphate, Sodium 
Saccharin, Sodium Fluoride, Calcium Glycerophosphate, 
Limonene.   
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5.3 Results 
5.3.1. In vitro study 
Treatments occurred at 1hr, 8hrs, 24hrs and 32hrs. The levels of hydrogen sulphide 
produced during this period can be seen in Figure 5.1 
Figure 5.1: Hydrogen sulphide levels produced by biofilms during repeated challenge with various 
test formulations and negative water control as described in Table 5.1. Arrows indicate the time 
points at which treatments occurred.
CMD01 
CMD02 
CMD03 
CB12 
CHX 
Control 
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Figure 5.2: Reduction in H2S levels for each product at each time point. Mean concentration drop of 
n=4 timepoints is shown by grey bar. 
The difference in hydrogen sulphide levels before and after each treatment (i.e. the 
reduction in concentration due to the inhibitory activity of the treatments) was plotted as 
a bar chart in figure 5.2. Also, each curve was normalised to a common baseline and the 
area under the curve for each product calculated. This is a useful metric, as described in 
section 3, as it gives a result in which the initial drop and the length of effect are both 
taken into account. This is shown in figure 5.3, with smaller bars thus indicating smaller 
area under the curve and therefore greater effect. Similar bar charts were produced for 
total VSC (hydrogen sulphide, methyl mercaptan and dimethyl-disulphide) and total VOC 
(total VSC plus indole, skatole, propanoic acid, butyric acid, trimethylamine, putresceine 
and cadaverine).  
Order of effectiveness is CMD03>>CB12>>CMD02>>CMD01>>CHX>>Control. 
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Figure 5.3: Bar charts showing the effect of the six formulations on (A) hydrogen sulphide 
(B) VSCs and (C) VOCs, as measured by area under the SIFT-MS trace over 48hrs
Plate counts were performed on 1ml of eluate from the biofilm before and after each 
treatment. The area under the curve method for can be used here also, and this is shown in 
figure 5.4. Again, smaller bars show a greater effect on numbers of organisms (both 
facultative and strict anaerobes). The order of effectiveness is 
CHX>>CMD03>>CB12>>CMD01>>CMD02>>Control for facultative anaerobes and 
CHX>>CMD02>>CB12>>Control>>CMD01>>CMD03 for strict anaerobes.  
A B
C
116 
5.3.2. In vivo study 
All of the treatments showed a greater effect than the distilled water control, with 
an initial reduction in malodour levels followed by a recovery rate following the treatment 
period. The results for organoleptic score can be seen in figure 5.5. As with the in vitro 
study, this data can be better represented using bar charts of the area under each 
curve. More effective treatments therefore show smaller bars. This can be seen for the 
organoleptic data shown, and the other measurements by instruments, in figures 
5.6-5.11. Direct comparison of the effects of the treatment between the in vivo and in vitro 
arms can be seen in figures 5.1 and 5.4. The area under the curve graphs further allow 
comaprison of the full cumalitive effect of the treatments in each arm of the trial.
Figure 5.4: Microbiology results showing effect of the six formulations on 
facultative and strict anaerobes on eluate from the biofilms 
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Figure 5.5: Effect on organoleptic score over time for the six formulations. 
Figure 5.6: Effect of six formulations on organoleptic
 score. Area under the curve is shown as a histogram with 
smaller bars representing larger effect.
Figure 5.7: Effect of six formulations on OralChroma 
H2S. Area under the curve is shown as a histogram 
with smaller bars representing larger effect.
Figure 5.8: Effect of six formulations on OralChroma VSC.
 Area under the curve is shown as a histogram with 
smaller bars representing larger effect.
Figure 5.9: Effect of six formulations on H2S by SIFT-
MS. Area under the curve is shown as a histogram 
with smaller bars representing larger effect. 
CMD01 
CMD02 
CMD03 
CB12 
CHX 
Control 
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Figure 5.10:  Effect of six formulations on VSCs by 
SIFT-MS. Area under the curve is shown as a 
histogram with smaller bars representing larger 
effect. 
Figure 5.11: Effect of six formulations on VOCs by 
SIFT-MS. Area under the curve is shown as a 
histogram with smaller bars representing larger 
effect.  
As with the in vitro trial, microbiology for total viable count and strict and 
facultative anaerobes were performed. Area under the curve bar charts can be seen below. 
In this case order of effectiveness is 
CHX>>CMD02>>CMD01>>CB12>>CMD03>>Control for both categories of anaerobes. 
Figure 5.12: Microbiology of in vivo data. Smaller bars indicate greater effect on microbiological counts. 
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Statistical comparison of the data shows that all treatments show significantly more 
effect than the control at the P < 0.05 level for organoleptic score and levels of volatiles 
measured by OralChroma and SIFT-MS. CMD01 showed less effect than the other active 
treatments by SIFT-MS. All of the compounds also showed significantly more effect on all 
microbial counts than the control (P < 0.05). Chlorhexidine alone was the only compound 
that outperformed the others in reducing microbial load at the same significance level. Very 
similar results were seen in the study of biofilm hydrogen sulphide production, with all 
products showing significantly more effect that water. However in the in vitro study, CMD03 
showed significantly more reduction of VOC than the other active compounds (P<0.05). 
Table 5.2: Results summary and comparison (all data is area under curve) 
in 
vitro 
in 
vivo 
H2S TVC Facultative Strict H2S TVC Facultative Strict 
CMD01 4.0 424.4 417.5 378.0 10.3 45.0 44.1 41.5 
CMD02 3.6 426.4 423.1 371.0 8.5 44.7 43.8 41.1 
CMD03 1.8 424.9 408.7 388.1 7.1 45.6 44.7 42.1 
CB12 3.1 418.1 412.6 372.7 8.5 45.2 44.4 41.4 
CHX 3.9 405.5 400.9 354.7 8.7 42.5 41.5 39.1 
Control 11.9 428.2 423.9 377.1 11.7 48.2 47.2 44.9 
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5.4 Discussion 
Chlorhexidine ((1,6-di(4-chlorophenyl-diguanido)hexane) is a membrane-
active cationic bisbiguanide antimicrobial agent. It has a wide spectrum of 
activity which is efficacious against Gram-positive and Gram-negative bacteria as 
well as some yeasts, dermatophytes and lipophilic viruses (Denton, 1991). 
Structurally it contains ten nitrogen atoms separated by a hexamethylene bridge 
and it is the positive charge distributed over these atoms which gives it affinity for 
negatively charged surfaces. This bicationic nature gives it the ability to bind to 
bacterial cell walls (Davies, 1973) and surfaces in the oral cavity (Rølla et al., 1971), 
potentially simultaneously. It has a bacteriostatic effect in low 
concentrations but becomes bacteriocidal as concentrations rise. It affects 
non-multiplying cells and persists in the oral cavity for considerable time (Jenkins et 
al., 1988). These antimicrobial effects are due to binding to the 
cytoplasmic membrane leading first to increased permeability and then 
precipitation of cytoplasmic components. These effects do not show an 
increase in ATPase inhibition suggesting only a direct effect on the 
membrane (Kuyyakanond and Quesnel, 1992). It is for these reasons 
that chlorhexidine is still considered the gold standard oral antimicrobial (Jones, 
1997). 
CMD is a novel compound which has shown broad spectrum activity and 
has been effective against methicillin sensitive and resistant Staph. aureus.  It is 
also anionic lipophilic and membrane-active, appearing to act on the 
phosphatidylglycerol containing fraction of the cytoplasmic membrane. 
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When compared with chlorhexidine it shows similar but differing effects on natural 
and model membranes of Staph. aureus. Zinc salts however operate by providing 
ions that form sulphides of low solubility with precursors of VSC such as HS-, S2- 
and CH3S-. It has also been suggested that zinc may directly inhibit cysteine 
desulphydrase or other sulphur metabolising enzymes (Greenman 1999). 
Examination of the results of both the in vitro  and in vivo arms of the 
current study shows the effects of the combination of these three 
compounds in combination in three formulations. The compound most 
effective at combating malodour, as measured by the smallest area under curve 
for VSC both in vitro and in vivo was test product 3, CMD03. It outperformed the 
industry leading oral malodour formulation even though it contained similar levels 
of chlorhexidine and zinc, and no sodium fluoride. It is interesting that this novel 
compound shows activity in these circumstances since in vitro models with their 
greater bacterial loads, larger volume of EPS and higher VSC production would 
tend to be less sensitive to the effects of membrane active compounds (Hope 
and Wilson 2004). This appears to support the view suggested by Hubbard et al., 
(2017) that chlorhexidine and CMD act in synergy by affecting different parts of 
the cytoplasmic membrane. However, it is interesting that CMD02, with a lower 
concentration of zinc, did not perform as well even though it contained the same 
amounts of CMD and chlorhexidine. This suggests that increased 
permeability of the membrane allows zinc ions better access to VSC 
precursors or enzymes before they can produce volatile malodour compounds. 
The finding that only the high concentration chlorhexidine formulation 
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acted with significant and lasting antimicrobial effect, as shown by the microbiology 
results, is not surprising. Concentrations in this range are known to be the most 
effective bacteriocides (Cumming and Loe, 1973). However, the side effects of 
chlorhexidine at this concentration, such as staining of dental enamel, prevent 
formulations such as this from being used on a regular basis as prophylaxis against 
malodour (Flötra et al., 1971).  
5.5 Conclusions 
 
 Comparison of in vitro and in vivo showed that for hydrogen 
sulphide levels as measured by SIFT-MS the order of effectiveness of 
the formulations was identical. This was, in order of decreasing efficacy;  
CMD03>>CB12>>CMD02>>CHX>>CMD01>>Water. CMD03 showed the 
greatest effect on volatiles by all measurement methods. In terms of antimicrobial 
effects, the results were more mixed, with the highest concentration of 
chlorhexidine showing the highest bacteriocidal effect. The difference in 
formulation of nutrients in the two systems meant that the in vitro 
model produced much higher transformation rates of VSC and VOC. Despite 
this, the effectiveness of the synergy between the inhibitory compounds against 
the oral biofilm was still readily apparent. 
CMD shows high potential as a broad spectrum antimicrobial agent 
against complex multispecies biofilms both in vitro and in vivo. There are also 
indications that it may improve the ability of zinc compounds to remove VSC 
precursors from the malodour generation pathway.  
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Further work is needed to investigate this, and to examine the effects of 
these combinations of treatments on specific groups of organisms in the 
biofilm, for example by use of 16s rRNA analysis (Dewhirst et al., 2010). If 
the proportion of all oral organisms were profiled before and after various 
combinations of treatments, it would be possible to assess the effect of 
each component on different organisms within the oral microbiome. By 
further examination of key organisms, accompanied by membrane modelling 
experiments, the mode of action of these compounds could be further 
elucidated. Parallel experiments with metal salts such as zinc acetate may 
provide further information on direct effects of clinical formulations on volatile 
production in the oral cavity. 
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6 The effect of D-amino acids on the tongue biofilm in vitro. 
6.1 D-amino acids as potential biofilm dispersal agents 
 It is now commonly agreed that the most likely reason for homochirality in nature is 
that circularly polarised infrared light in the early universe preferentially degraded one chiral 
form (Bonner 1991; Bailey et al., 1998). In the majority of the animal kingdom, therefore, 
amino acids are utilised in their left-handed or L-enantiomeric form, with a few exceptions in 
the form of opioid peptides (Broccardo et al., 1981), neurotransmitters (Santos et al., 1995) 
and neurotoxins (Jimenéz et al., 1996). The situation is different with prokaryotic organisms, 
the majority of which utilise the D, or right handed forms in their cell walls (Weidel et al., 
1960; Osborn 1969). The periplasmic space in Gram negative organisms and the extra-
cytoplasmic space in Gram positives is maintained by peptidoglycan (PG) layers in which the 
glycan strands are separated by short peptides that incorporate D-amino acids (Vollmer et 
al., 2008). These non-canonical d-amino acids (NCDAA) are generally produced by the action 
of racemases. Whilst D-Ala and D-Glu are the most common, D-methionine (Met), D-valine 
(Val), D-tyrosine (Tyr), D-threonine (Thr), D-tryptophan (Trp), D-phenylalanine (Phe), D-
leucine (Leu) and D-Isoleucine (Ile) have all been found in bacterial structures (Lam et al., 
2009). In 2010, Kolodkin-Gal et al., published a high profile paper describing disassembly of 
Bacillus subtilis biofilms exposed to a combination of D-Leu, D-Met, D-Tyr, and D-Trp. They 
further showed prevention of biofilm formation in Staph. aureus and Ps. aeruginosa by D-
amino acids. Hochbaum et al., (2011) went on to show the enantiomers did not prevent initial 
binding, but seemed to block the development of larger assemblies of cells by interfering 
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with the protein component of the matrix. It has been further shown that D-amino acids 
incorporated into polyurethane scaffolds can reduce biofilm formation in vitro in 
contaminated femoral defects (Sanchez et al., 2013). Work with wastewater biofilms found 
that D-tyrosine in particular interfered with biofilm formation and that D-Tyr impregnated 
membranes resisted biofilm formation. This was also shown to be due to inhibition of 
cellular communication and EPS production (Xu and Liu 2011a, 2011b).   
Many foodstuffs we consume contain D forms of amino acids that are created by alkali 
and heat treatments in food processing (Friedman 1999). This racemisation can reduce the 
nutritional value by impairing digestion, but actual toxicity appears low. Only D-serine, D-
cysteine and D-proline have shown renal toxicity in mice, and this was when relatively high 
concentrations were administered  (Kaltenbach et al., 1979; Carone et al., 1985; Friedman 
and Gumbmann 1988; Kampel et al., 1990). Furthermore, human saliva has been seen to 
contain relatively high concentrations of D-amino acids naturally (Nagata et al., 2006) 
suggesting their potential safe use in a mouthwash formulation. 
The aims of this chapter were to investigate the effects of D-amino acids on 
multispecies oral biofilms but comparing the development of biofilms exposed to them 
during maturation with control biofilms exposed to the L-forms or standard media. 
6.2 Materials and methods 
 Tongue scrape samples were obtained from a single subject with ethical approval as 
previously described (section 2.4). After anaerobic pre-incubation these were transferred to 
biofilm enclosures. Biofilms were fed either standard media or media containing amino acids 
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in either the D or L form at a concentration of 10mM (Sigma-Aldrich, UK).  All media was 
equalised to pH 7.4. 
 Analysis of the VOC profile of the biofilms was by Profile3 SIFT-MS (section 2.3). A 
value of total VOCs created from the measured levels of hydrogen sulphide, methyl 
mercaptan, dimethyl disulphide, indole, skatole, cadaverine, putrecine, trimethylamine, 
propanoic acid, butyric acid and hexanoic acid. 
EPS extraction was based on the preferred method of Liu and Fang (2002) following 
their comparative work on extraction from sludges and is outlined in section 2.4.   
Following extraction, EPS solutions were assayed for polysaccharides and proteins by 
the DuBois (DuBois et al., 1956) and modified Lowry (Redmile-Gordon et al., 2013) methods. 
To gauge further differences in EPS polysaccharide composition the extracts were assayed 
with Congo Red and absorbance was measured at 540/620nm (Fluostar spectrophotometer). 
β-glucan from barley was used to generate a calibration curve.  
Total viable counts along with counts for strict and facultative anaerobes were 
performed as described in section 2.1. Colonies were distinguished by morphology and 
Gram strain to gauge shifts in population. Dry weights were calculated by filtering 
portions of suspension onto accurately pre-dried and weighed filter paper. These were 
then dried again in an oven for 2hrs at 110°C and reweighed.  
Confocal Laser Scanning Microscopy was performed on portions of biofilm by the 
method outlined in section 2.5. A number of stains were used with varying degrees of 
success. The best images were obtained using Horsch 33258 stain for intracellular DNA, 
SYPROTM Orange for proteins and Congo Red for polysaccharides and amyloids fibres.  See 
section 6.7 and 6.8 for further details. 
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6.3 Results 
 In a preliminary experiment undertaken as a part of this thesis, biofilms were grown 
in the presence of five D-amino acids (D-Glu, D-Asp, D-Met, D-Cys, and D-Trp) compared to 
those grown in standard media. Stark differences were observed (Figure 6.1).  
Figure 6.1: Oral biofilms grown (A) in the presence of D-amino acids and (B) with 
standard media. Microbiological cell counts were not significantly different in each case. 
The next experiments with single D-amino acids showed no visible effect compared to 
controls. The simplest combination of D-amino acids seen to have an effect was a 
combination of D-Glu and D-Asp, and all further experiments tested the effects of this 
combination. 
Figure 6.2: Volatile profile of combined VOCs produced by n=18 biofilms 
exposed to D-Asp and D-Glu, L-Asp and L-Glu and standard media. Error bars 
represent standard error. 
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Figure 6.3: Proportion of proteins and polysaccharides in EPS extract from n=18 
biofilms exposed to D and L forms of Glu and Asp amino acids, plus standard media. 
Error bars represent standard error. 
Figure 6.4: Congo red assay for β-glucan polysaccharides in EPS of amino acids exposed 
biofilms. (n=12). Error bars represent standard error. 
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Figure 6.5: Proportion of facultative and strict anaerobes in D and L amino acid exposed 
biofilms compared with controls fed standard media. (n=14). Error bars represent standard 
error. 
Figure 6.6: Proportion of Gram negative organisms in D and L amino acid exposed biofilms 
compared with controls. (n=14). Error bars represent standard error. 
One way ANOVA with Bonferroni's Multiple Comparison Test shows that the D-amino 
acid exposed biofilms show significant differences (p < 0.01) from L-amino acid exposed 
biofilms for VOC, EPS polysaccharides, and strict anaerobes, and significant differences from 
control biofilms for VOC, EPS polysaccharides, EPS proteins and strict anaerobes.   
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CLSM images of biofilms treated with D-amino acids and control are shown in figure 6.7 and 
6.8. 
Figure 6.7: CLSM images of a D-amino acid exposed biofilm 
showing diffuse distribution of proteins and polysaccharides 
Figure 6.8: CLSM image of a control biofilm showing 
structured area that appears to be made up of proteins 
and polysaccharides 
Green excitation - protein 
Red excitation - polysaccharides 
Red excitation - polysaccharides 
Blue excitation – nucleic acids 
Blue excitation – nucleic acids 
Green excitation - protein 
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6.4 Discussion 
 For as long as it has been known that D-amino acids exist in the PG layer of the 
bacterial cell wall, it has also been known that prokaryotes also incorporate them into 
antimicrobial substances that they produce (Bodanszky and Perlman 1969). In some cases 
the D-amino acid moiety itself appears to be directly involved in binding to cell wall PG and 
subsequent lysis (Lark et al., 1963; Tsuruoka et al.,1985). More recent work has indicated 
that some bacteria may release D-amino acids in the stationary phase, and this causes 
morphological changes in the cell wall via the PG layer (Lam et al., 2009). It has been shown 
that in several organisms D-amino acids can be incorporated into the PG layer with both 
positive and negative consequences. This incorporation is independent of whether the amino 
acids are exogeneously or endogeneously produced (Cava, et al., 2011). It is the studies 
specifically on biofilm formation that are of interest here, of which there are unfortunately 
few. Kolodkin-Gal et al., (2010) used radioactive labelling to show that D-tyrosine was 
incorporated into the cell wall, and that the presence of D-alanine prevented this. They 
proposed that incorporation of NCDAAs into the cell wall interferes with the anchoring of 
TasA amyloid fibres thus disrupting the extracellular matrix.  An earlier study by Tsuruoka et 
al., (1984) suggested that the binding of D-Met and D-Cys inhibited lipoprotein binding to PG 
in E. coli. Cava and Lam (2011) have gone on to suggest that in mixed biofilms NDAAs my act 
as a paracrine signal which controls the architecture of the community. Nevertheless, this is 
merely conjecture since there have been no studies performed on mixed species biofilms. 
 This work shows significant differences in mixed oral biofilms grown in a flat plate 
perfusion model when exposed to D-amino acids as opposed to the L forms or standard 
media.  The effects affect Gram negative organisms more than positives, and strict anaerobes 
more than facultatives. L-amino acid exposed biofilms produce higher levels of volatile 
compounds compared to controls, and this might be expected due to them having an extra 
source of carbon energy. The D-amino acid exposed biofilms however show much lower 
production of VOCs compared to controls. It is known that many gram negative strict 
anaerobes are associated with malodour (see section 1.2) and the VOC results combined with 
the microbiology results would seem to indicate that gram negative strict anaerobes are 
affected more by the D-amino acids and that this in turn leads to lower production of VOCs. 
CLSM images of biofilms treated with D-amino acids and control are shown in 6.7 and 6.8. 
The staining procedure shows the distribution of red-orange staining polysaccharide, which 
were commonly observed in control biofilms, but much less so in biofilms treated exposed 
to D-amino acids. The distribution of stained protein (shown as green colour) is also different; 
the control does not take up as much green stain, suggesting that proteins are cryptic by 
being covered or fully bound to EPS. However, in the biofilm treated by D-amino acids, the 
cell-wall proteins are much more exposed to staining. The nucleic acid (blue) staining is again 
different, showing entire bacterial cells in the control biofilm, but a “background smear” of 
stained but fuzzy material distributed more evenly across the film. The change in EPS which 
is visible both macro- and microscopically is also evident in the analysis of the extracts. The 
D-amino acid exposed biofilms have proportionally lower levels of polysaccharides but much
higher levels of proteins by mass (figure 6.3).  This may not be supportive of the hypothesis 
that it is the anchoring of lipo- and glyco-proteins to the PG membrane that is most affected 
by the D-amino acids.  Morphological changes in the cell wall seen in previous studies usually 
occur during the stationary phase (Kolodkin-Gal et al., 2010), indicating that D-amino acids 
should have an effect on mature biofilms as well as ones in the growth phase, although so far 
this has not been shown in this model. Also, whilst D-Glu is present in the PG layer, D-Asp has 
not been previously reported as interfering with membrane synthesis, and has not been 
shown to affect biofilm formation when present in extracellular supernatant (Lam et al., 
51132 
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2009). It is interesting to hypothesise as to alternative modes by which the biofilm is being 
affected. 
 NCCDAs may be acting on multispecies biofilms either directly, through mechanisms 
such as incorporation or disruption of cellular membranes, or indirectly by affecting EPS 
production by all bacterial cells. Any effects could apply to individual species, groups of 
species or the biofilm as a whole. The complex interplay between species in such a microbial 
ecosystem means that teasing apart cause and effect is very challenging. It can be hard to 
assess whether an overall effect on EPS favours certain strains, or the absence of strains due 
to an effect on another system or structure. An alternative theory to PG involvement is that 
a combination of D-Asp and D-Glu in particular interfere with the C-di-GMP based mediation 
of the EPS matrix. Aspartic and glutamic acids are notably present in the GDDEF domains of 
diguanine cyclase, and it has been shown that it is these residues that bind to the N1 and N2 
molecules of the Watson-Crick edge of C-di-GMP (Chou and Galperin 2016). Whilst the PG 
hypothesis for NCCDA effects on biofilms is strong, this alternative is attractive as 
downregulation of C-di-GMP is known to affect biofilms in the ways observed within this 
study (see section 1.1.5). C-di-GMP levels in biofilms in response to D-amino acids, or indeed 
other interventions, have not been extensively studied, and in the case of mixed species 
biofilms not at all. 
 Quantifying intracellular levels of C-di-GMP is problematic. The gold standard 
method is HPLS-MS/MS (Spangler et al., 2010), but apart from cost and complexity of this 
method, bacterial cells must be lysed to release the compound for assay. Thiazole orange has 
been used to assay C-di-GMP fluorescently (Nakayama et al., 2011) but so far this also relies 
on lysed cells. However, given that thiazole orange is frequently used in CLSM then staining 
of viable cells may be possible. This could potentially give a powerful technique to probe the 
C-di-GMP signalling network. Another method of interest involves the use of a fluorescent
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reporter strain of Ps. aeruginosa engineered in Denmark (Rybtke et al., 2012). The advantage 
of this would be real time quantification of C-di-GMP levels by fluorescence measurement. 
Unfortunately, the major limitation is that only single species biofilms of Ps. aeruginosa can 
be studied. 
6.5 Conclusions 
It has been shown by this work that complex mixed species oral biofilms are 
significantly affected by D-amino acids in the growth phase. The mechanisms are unclear 
but affect both the microbiology of the biofilm and the production and composition of the 
EPS. This coupled with their demonstrated low toxicity in both humans and animal models 
suggests that further work in the development of a D-amino acid containing mouthwash 
formulation may be fruitful. 
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7 Assessment of a novel SPR based biosensor for the 
quantitative detection of oral malodour 
7.1 Introduction 
Surface Plasmon Resonance (SPR) has been used to investigate the properties and 
binding of thin biological films to surfaces for nearly forty years. Surface plasmons are 
coherent oscillations of electrons at the barrier between two materials of different relative 
permittivity, first theorised by R.H. Richie in 1957. In the case of thin depositions of metals 
such as gold or silver on a glass prism, photons travelling through the prism and striking the 
inside metal layer cause resonance of the plasmons via the evanescent wave. This resonance 
condition is given by equation 1, where nc and ns are the refractive indices of the prism and 
sensing layer respectively, θ is the incident angle and εmr is the real part of the metal 
dielectric constant (Dwivedi et al., 2008).  
𝐾𝐾0𝑛𝑛𝑐𝑐 sin𝜃𝜃 = 𝐾𝐾0  � 𝜀𝜀𝑚𝑚𝑚𝑚𝑛𝑛𝑠𝑠2𝜀𝜀𝑚𝑚𝑚𝑚 + 𝑛𝑛𝑠𝑠2�12 ;𝐾𝐾0 = 2𝜋𝜋𝜆𝜆
Equation 7.1: SPR resonance condition 
If the permittivity of the layer changes due to, for example, binding of additional 
molecules from within the fluid layer, then changes in the resonant condition cause changes 
in the reflectivity at a given angle (figure 7.1). This was first described by Beaglehole in March 
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of 1970 (Beaglehole, 1970) and further developed practically by Kretschmann, 
(1971). Liedberg and Nylander(1983) were the first to demonstrate that SPR could be 
used to investigate the binding of biological materials in a liquid medium to the metal 
surface above the prism. Their work with Pharmacia and later Pharmacia Biosensor led to 
the development of the BIAcore and BIAlite in 1990 and 1994. These devices used the 
SPR technique to facilitate real time analysis of binding interactions (Jönsson et al., 1991; 
Liedberg et al., 1995). Resulting kinetic association and disassociation curves can be 
used to calculate binding constants and other thermodynamic parameters. 
Miniaturisation of prism based SPR techniques was further accomplished by groups 
such as Foster et al. (1994) and Cahill et al. (1997). Pharmacia continued to develop the 
technique and became Biacore AB Corporation in 1996, releasing increasingly advanced 
SPR based devices into the next decade. SPR biosensors have since been used in food 
analysis, immunogenicity, proteomics and drug discovery (Karlsson 2004). 
Figure 7.1: The principle of surface plasmon resonance. 
Aryballe Technologies were founded in 2014 and are developing a SPR based 
biosensor to detect and quantify volatile compounds in gaseous phase from a variety of 
sources. Gaseous volatiles interact with both surface bound biologically active molecules and 
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the metallic surface itself. This causes a measureable change in the reflectance of incident 
LED light.  
It was the purpose of this study to evaluate the potential application of the 
instrument (the NeOse) to the assessment of oral malodour. In order to assess the ability of 
the instrument to detect and quantify oral malodour it was compared to both a trained 
organoleptic judge and gas analysis by SIFT-MS.  
7.2 Materials and Methods 
7.2.1 In vitro study 
 Tongue scrape samples were obtained from two individuals with high and low 
organoleptic score. Two biofilms were inoculated with each sample as described in section 
2.1. Sequential sampling was performed as described in section 3.2.  
7.2.2 In vivo study 
7.2.2.1 Selection of participants 
Participants in the study were selected from a group of volunteers from the University 
of the West of England. They were of good oral hygiene and dental health and possessed a 
minimum of 20 original adult teeth. Exclusion criteria were; smoking; medical history of 
infectious diseases; active severe caries, gingivitis or periodontitis; antibiotic medication 
within one month prior to attendance; consumption of sweets or other products known to 
contain antimicrobial substances; history of diabetes mellitus, bronchitis, tonsillitis, sinusitis 
or any other conditions known to affect oral malodour. Subjects were instructed to perform 
their usual oral hygiene routine until the evening before sampling, but abstain on the day of 
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attendance. They were also instructed not to consume odorous foodstuffs such as garlic, 
spices or alcohol on the day before sampling, and any food on the attendance day. Subjects 
were permitted to drink water whenever desired when not in the laboratory.  
7.2.2.2 Sampling of the oral cavity 
Subjects were assessed and scored for oral malodour by organoleptic judge and 
Voice200 SIFT-MS as described previously in sections 1.5.1 and 1.5.4 respectively. 
Additionally, they were assessed using the NeOse instrument. As with the other methods, 
the mouth was kept closed for two minutes to allow headspace equilibrium to be reached. 
The inlet of the NeOse was modified to enable a disposable straw to be inserted into the oral 
cavity of the subject (figure 7.2). The instrument was set to take 10 seconds of background 
followed by 30 seconds of static signal measurement. After the first ten seconds the subject 
placed the straw in their mouths so that the opening was held near the dorsal part of the 
tongue. Sampling was performed for ten to fifteen seconds then the straw was removed for 
the remaining seconds.  
Figure 7.2: Sampling from a human subject by NeOse 
In order to facilitate co-sampling with both instruments, a T-junction was introduced 
upstream of the disposable straw allowing both the NeOse and the SIFT-MS to draw gases 
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from the oral cavity and to subsample from the side branch.  Sampling was performed as 
above. 
7.2.3 Statistical Analysis 
 Multidimensional Scaling (MDS) were performed using R studio (Boston, USA) and 
plotted with MATLAB (MathWorks Inc., Massachusetts, USA). Correlation between SPR signal 
and SIFT-MS results was performed by the following method. Difference between plateau 
and baseline was calculated for each sample. These values were compared with the SIFT-MS 
values given for hydrogen sulphide, VSCs, total VOCs, amines, acids and indoles. The R2 
correlation values were plotted on three-dimensional surface and contour plots to reveal 
biosensor spots most accurately responding to VOC concentration. 
7.3 Results 
A typical signal obtained from a single biosensor following exposure to biofilm 
headspace is shown in figure 7.3. MDS analysis of the low and high VOC producing biofilms 
showed good separation of the two groups. Figure 7.4 shows the distance plot, with 
hydrogen sulphide concentration by SIFT-MS shown on the Z axis. Figures 7.5 and 7.6 show 
correlation plots generated as described previously. Higher bars in the Z direction correspond 
to regions of the biosensor matrix that have responded in a more accurate way with respect 
of the concentration of the corresponding group of compounds. A relatively lower response 
was observed with the in vitro experiments and this is thought to be due to high 
concentrations of sulphides blocking the surface of the biosensor. It can be seen, however, 
that the general pattern of response is the same in each group. 
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Figure 7.3: Typical response to signal by a single biosensor spot. 
Figure 7.4: MDS analysis of in vitro biosensor data showing high and low VOC producing biofilms. X 
and Y-axes show Euclidean multidimensional spacing of biosensor data and the Z-axis shows hydrogen 
sulphide concentration as measured by SIFT-MS. 
Injection Desorption 
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Figure 7.5: Biosensor correlation plot (in vitro). High bars indicate better response to that group of 
compounds. Grouping is described in Table 7.1. 
Figure 7.6: Biosensor correlation plot (in vivo). High bars indicate better response to that group of 
compounds. Grouping is described in Table 7.1. 
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Following these experiments with high VOC producing biofilms, the response 
observed by the prism was reduced. A fresh prism was installed for the in vivo experiments 
and a significant increase in response was seen. This response can be seen in figure 7.6. 
The biosensor that responded in the most appropriate way to sulphides in the oral 
cavity was number 42.  The correlation between this spot and the SIFT-MS data can be seen 
figure 7.7. MDS analysis of in vivo NeOse data, are shown in figure 7.8, with hydrogen 
sulphide concentrations as measured by SIFT-MS shown on the Z-axis. Table 7.1 shows a 
summary of the human volunteer data for all subjects.  
Figure 7.7: NeOse biosensor 42 response to hydrogen sulphide 
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Figure 7.8: MDS analysis of in vivo data. X and Y-axes show Euclidean multidimensional spacing of 
biosensor data and the Z-axis shows hydrogen sulphide concentration as measured by SIFT-MS. 
Table 7.1:  Human volunteer data obtained from SIFT-MS analysis and NeOse breath measurements. 
VSC = H2S + CH3SH + (CH3)2S; VOC = sum of all detectable VOC compounds; Acids = acetic + propionic 
+ butyric + valeric and isovaleric acids; Amines = putrescine + cadaverine + trimethylamine; Indoles =
indole + skatole; NeOse signal = response (Biosensor 42) 
SIFT-MS NeOSe Organoleptic
H2S VSC VOC Acids Amines Indoles Water Signal Judge
P01 3.99 25.49 799.63 7.16 3.72 0.31 1277.57 2.43 2
P02 4.62 15.29 403.37 10.78 7.53 0.28 1361.44 1.67 3.25
P03 6.61 17.47 721.50 9.64 4.37 0.34 1341.62 2.36 1.5
P04 8.15 36.80 698.01 9.41 6.30 0.42 1287.78 2.24 2.5
P05 190.57 313.43 1437.39 14.62 8.09 1.28 1515.56 3.35 4
P06 70.52 102.61 898.13 8.43 4.98 0.70 1349.54 3.87 2
P07 20.41 75.29 1191.66 8.97 4.39 0.66 1454.83 2.26 N/A
P08 3.18 18.97 841.34 8.64 4.02 0.27 1687.80 2.41 2.5
P09 272.99 486.55 1151.38 12.83 7.23 1.27 1324.22 4.15 3.5
P10 20.82 55.40 730.30 10.47 4.55 0.25 1378.73 2.91 3.5
P11 151.25 241.77 1369.40 7.03 4.40 1.79 1354.64 3.50 4
P12 13.73 41.28 1412.18 12.34 3.19 0.54 1525.83 2.62 5
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7.4 Discussion 
The in vitro and in vivo studies both show that the SPR based biosensor 
responds to a mixture of volatile compounds. Furthermore the biosensor spots respond 
differentially, meaning that both qualitative and quantitative discrimination can be made 
between different compounds present in breath. The surface and contour plots show that 
the biosensors in the region 0-15 and 40-55 respond most accurately to sulphides and 
possibly to a lesser extent, indoles. There is a less accurate response to indoles and amines, 
although the response is better in a prism that has previously been exposed to high levels of 
sulphides, suggesting that blocking of the prism occurs preferentially in certain sites. The 
binding of sulphides to gold surfaces is well understood and known to be difficult to reverse 
and so the blocking of the biosensor by high levels of sulphides is predicted. This cannot be 
the full picture, though, and further work is required.  
However, in the human oral cavity sulphide levels are much lower than those found 
in the in vitro biofilm model and discrimination of high and low malodour human subjects is 
reliable and reproducible.  Good clustering by high malodour individuals is seen in the MDS 
plots and it is likely that unknown samples could be well categorised. By incorporating a 
flushing and cleaning stage this behaviour should be reproducible as long as very high (ppm) 
levels of VSCs do not contaminate the prism. 
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7.5 Conclusions 
The multiple spot SPR based biosensor has demonstrated sensitivity in the detection 
of VSCs in the human oral cavity with a limit of detection below 10 ppb. It has also shown the 
ability to reliably discriminate between low and high malodour individuals in a sample group. 
Specific areas of the biosensor surface can be seen to be responding preferentially to subjects 
with a higher relative malodour. 
The approach used could also be used to assess the very many other potential 
applications for this SPR based technology. By comparing the response of the biosensor to 
results obtained by SIFT-MS, machine-learning algorithms can inform current and further 
sensor development.  
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8 General Discussion and Further Work 
8.1 General Discussion 
At the beginning of this work the flat plat perfusion biofilm model was at an early stage 
of development and only preliminary work had been done towards adapting the system to 
modelling the oral biofilm. In order to fulfil the potential of the technique, a number of 
significant technical challenges had to be overcome (Chapter 3). By installing each biofilm 
enclosure in a separate mini-incubator and routing all connections through the door, the 
stability of physiological conditions of the biofilm was much more readily maintained. It also 
facilitated the creation of  a bank of six incubators that could be set up in parallel and sampled 
sequentially. A software controlled PEEK bodied solenoid valve allowed this process to be 
automated so that volatile profiles of six biofilms could be monitored for extended periods. 
Redesign of the slope allowed contamination of the interior of the enclosure to be minimised, 
and allowed a window to be installed under the biofilm. This allowed a fibre optic pH sensor 
to be installed to allow pH to be measured in real time. A modification to the lid of the 
enclosures allowed the installation of LED illumination and the ability to test photodynamic 
interventions on the oral biofilm. An accompanying window cut in the top of one of the 
incubators allowed timelapse recording of the biofilm, and the ability to use engineered 
bioluminescent organisms to monitor metabolic processes and their relationship to volatile 
production.   The combination of all these modifications has resulted in a versatile model for 
the study of biofilms in vitro. Whilst the remainder of this work has focussed on human 
tongue dorsum derived biofilms, the model could be applied to the in vitro study of many 
other biofilms of mammalian or environmental origin.  
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Turning to the scientific aims, the primary goal of this study was to validate the flat 
plate perfusion model as a method of studying tongue-derived biofilms, to examine the 
effects of various interventions on biofilm growth, physiology and metabolism, and to 
compare this with similar interventions performed in vivo. It has been shown that biofilms 
derived from the tongue biota of individuals is transplantable to the model (chapter 4) and 
that the volatilome of the biofilm is conserved. It has further been shown that the physiology 
of the biofilm and it’s response to interventions is similar to that expected, both by theory 
and in vivo experiment. In the course of this investigation, new methods of analysing and 
visually representing the oral microbiome have been devised. 
 Whilst the effects of a number of different antimicrobials were investigated, including 
photodynamic therapy and several commercial mouthwashes, attention has focussed on two 
areas. One was a novel compound shown to act in synergy with chlorhexidine in disrupting 
cell membranes (chapter 5), and the second was a combination of D-amino acids that was 
also shown disrupt biofilms in a way that did not occur with the L-forms or with standard 
media (chapter 6). The mechanism by which this occurs is currently unconfirmed. These two 
main studies have given insight into the way multispecies biofilms develop and mature, and 
have indicated novel ways in which interventions can influence their growth and 
characteristics. These valuable techniques have the potential to investigate many types of 
chemical and physical interventions on diverse types of microbial biofilm, as well as those of 
human oral origin. As the metabolism and physiology of complex, mixed species biofilms is 
still relatively poorly understood techniques which allow this kind of study are important. 
The methods could lead to valuable new formulations to treat oral malodour or other 
conditions caused or influenced by microbial biofilms. As issues of cost, ethical approval and 
legislature continue to plague in vitro studies, in vitro modelling is likely to become more 
important as a tool. Additionally, multisampling of replicate innocula allows statistically 
significant results to now be obtained relatively rapidly. 
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The flat plate perfusion model has also been shown to be a very useful method for 
assessing the performance of other sensors for volatile compounds. The NeOse device 
described in chapter 7 is a SPR based sensor that incorporates almost one hundred different 
biosensors into one device. Whilst this gives the device enormous potential for detection of 
many volatile compounds, characterisation of each individual biosensor on the prism is 
challenging. The ability of the flat plate model to generate complex profiles of volatiles that 
are similar to those found in vivo, and the abiilty to quantify these volatiles in real time by 
SIFT-MS, gives an invaluable technique for assessing the response of the biosensors to the 
gases. By using techniques such as MDS and correlating individual biosensors with volatiles 
as measured by SIFT-MS, the performance of the device can be assessed, and prisms can 
therefore be tailored to the specific application. By learning in this way, accompanied by 
algorithmic MDS techniques, the NeOse device has the potential to become an extremely 
sensitive and discriminatory biosensor for multiple compounds and with multiple 
applications.  
8.2 Further Work 
Whilst it has been shown that the flat plate perfusion model satisfactory it would be 
extremely interesting to undertake a large rRNA based study of oral biofilms in vivo and the 
corresponding biofilms transplanted into the in vitro model. A combination of cost and 
commercial sensitivity of data has so far meant that this has been impossible. Combined with 
the techniques outlined in chapter 4, rRNA analysis of the model biofilms has the potential 
to investigate changes to the transplanted microbiome and volatilome in many important 
ways. For example, shifts in volatile production away from those gases considered 
objectionable can be linked not only to those organisms which are directly responsible, but 
149 
by cooccurence analysis other organisms which may not have been previously identified as 
important. This kind of study is also extremely important in the respect of the interventions 
investigated in chapters 5 and 6. Any potential intervention will influence different species in 
different ways, and knowing the exact nature of these factors allows now only tailoring of 
treatments to specific key organisms, but also scientific advancement through knowledge 
gained about mechanisms and pathways of antimicrobial resistance and sensitivity. As it 
becomes increasingly obvious that multispecies biofilms are the norm rather than the 
exception in nature, techniques which allow us to investigate the interaction and interplay 
between species within them is of paramount importance.   
Turning specifically to the effects of D-amino acids, investigation of processes within 
biofilms exposed to NCDAAs, by performing 16s rDNA analysis of biofilms exposed to the 
different enantiomers and controls, it may be possible to learn which species are affected 
most and least, and thus gain information on the mode of action. The effect of the 
enantiomers on single species biofilms grown from key species could then be investigated. 
By what method NCDAAs act, and whether or not c-di-GMP is involved, this area of study is 
still very important in it’s own right.  As knowledge of GGDEF domain expression in oral 
bacteria is incomplete, more work to investigate the presence of these domains is needed.  
If C-di-GMP is implicated, either in the effect of NCDAAs or in other biofilm disrupting 
agents, an assay of intracellular C-di-GMP would be a powerful tool given that the importance 
of this signalling network is now apparent. Various types of staining and assay techniques, 
both destructive and non-destructive have been suggested and could be investigated. 
Cloning of bioluminescent reporter genes has been achieved with Ps. aeriginosa and whilst 
single of multispecies biofilms incorporating this organism might be interesting, more 
relevant organisms might be more useful. Cloning bioluminescent report genes into 
anaerobic organisms is problematic as the technique can only be used with facultative or 
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microaerophilic organisms due to the involvement of oxygen. If bioluminescent clones of oral 
organisms were developed, the flat plate perfusion model as described would be extremely 
well suited to such work.  
Whatever the process by which NCDAAs act, their potential as biofilm disruptors is 
obvious, and synergistic effects between them and other antimicrobials (e.g CHX), anti-
malodour components (e.g. zinc compounds) and disrupting agents (e.g. CMD) should be 
investigated. 
Another technique that has showed promise in this work, but requires much more 
development in this specific application is CLSM. The ability to image living biofilms in three 
dimensions is extremely powerful, but there are two main hurdles to overcome. The first is 
to do with issues of sample preparation and presentation to the microscope. In this model, 
biofilms grow on a perfusable cellulose matrix, and this is one of the reasons the model is a 
good representation of in vivo  conditions. However cellulose autofluoresces and must be 
excluded from the CLSM preparation. There are two possible solutions to this problem. 
Firstly, another matrix could be used that does not fluoresce. Some other biofilm subtrates 
were tested very early on in the course of this thesis but did not adequately model the 
conditions of the oral biofilm. It is possible that other perfusable materials could be found 
that would be non-fluorescing and able to be mounted on the stage of a confocal microscope. 
Such a material would have to be thin enough and light permeable enough to allow sufficient 
illumination of the biofilm for microscopy. If such material could be found, and there are 
plenty of candidates, then it is possible that a laminated biofilm substrate could be 
constructed from layers of the material, allowing the biofilm to be pulled apart and imaged 
at varying depths.  
The second way to develop confocal techniques is development of the method 
described in chapter 2, whereby a removable glass coverslip is placed under the biofilm 
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matrix during maturation and growth. It did however prove difficult to ensure that enough 
biofilm material adhered to the glass surface, and that it was a true representation of the 
structure of the main biofilm. Chemically or biologically treating the glass surface in different 
ways may improve adhesion, and this could be explored. 
 Development of the NeOse is expected to continue apace and the biofilm model will 
continue to play a role in this. More data needs to be gathered from human subjects to 
improve the power of the device in discriminating between low, medium and high malodour 
individuals. Using data gathered from further in vitro studies it should become possible tailor 
the device to discriminate between specific classes of compounds from the oral cavity. The 
device has great potential in other areas of interest, and the ability to diagnose other types 
of microbial infections or colonisations will be investigated. As with studies of antimicrobial 
agents, the in vitro model should prove very useful in identifying which areas are most 
promising before time or money is committed to specific in vivo projects involving humans 
or animals. 
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III. Incubator door panel and shelf plans 
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IV. Multivalve port Python code 
 
import sys 
import os 
import gtk 
import pango 
import time 
from Tkinter import * 
import serial 
from serial.tools import list_ports 
import threading 
from msvcrt import getch 
 
 
class SequentialSampler2: 
 
    def __init__(self): 
        self.filename = None 
        self.about_dialog = None 
        list_ports.comports() 
        self.ser = serial.Serial( 
            port="COM4", 
            baudrate=9600, 
            parity=serial.PARITY_ODD, 
            stopbits=serial.STOPBITS_TWO, 
            bytesize=serial.SEVENBITS 
            ) 
        self.locked = False 
        self.cycling = False 
        self.PortOpen = False 
        self.OpenPort = 1 
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        self.RelayOn = "*RELAY 1%s ON<>0x0d>" 
        self.RelayOff = "*RELAY 1%s OFF<>0x0d>" 
        self.InitialisePorts = '*SET 0000010000000000\r\n' 
        self.ResetPorts = "*SET 0000000000000000\r\n" 
        spinbuttons = 
["spinbutton1","spinbutton2","spinbutton3","spinbutton4","spinbutton5","spinbutton6"] 
        GladeFile = "Sequential Sample 2.glade" 
        LoadFailMsg = "Failed to load UI XML file:" 
        self.ser.close 
        self.ser.open 
 
        # Set all relays to closed except number 1 
        self.ser.write(self.InitialisePorts)           
 
        # use GtkBuilder to build our interface from the XML file  
        try: 
            self.builder = gtk.Builder() 
            self.builder.add_from_file(GladeFile)  
        except: 
            self.error_message(LoadFailMsg) 
            sys.exit(1) 
             
        # get the widgets which will be referenced in callbacks 
        self.builder.connect_signals(self) 
        self.window = self.builder.get_object("main_window") 
        self.statusbar = self.builder.get_object("statusbar") 
        self.text_view = self.builder.get_object("text_view") 
        for spinbutton in spinbuttons: 
            self.thisbutton = self.builder.get_object(spinbutton) 
            self.thisbutton.set_value(5) 
        self.statusbar_cid = self.statusbar.get_context_id("SeqSamp") 
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        self.reset_default_status() 
         
 
    # When the window is requested to be closed, we need to check if they have  
    # unsaved work. We use this callback to prompt the user to save their work  
    # before they exit the application. From the "delete-event" signal, we can  
    # choose to effectively cancel the close based on the value we return. 
    def on_window_delete_event(self, widget, event, data=None): 
        if self.check_for_save(): self.on_gtk_save_activate(None, None) 
        return False # Propogate event 
     
    # Called when the user clicks the 'New' menu. We need to prompt for save if  
    # the file has been modified, and then delete the buffer and clear the   
    # modified flag.     
    def on_gtk_new_activate(self, menuitem, data=None): 
     
        if self.check_for_save(): self.on_gtk_save_activate(None, None) 
         
        # clear editor for a new file 
        buff = self.text_view.get_buffer() 
        buff.set_text("") 
        buff.set_modified(False) 
        self.filename = None 
        self.reset_default_status() 
     
    # Called when the user clicks the 'Open' menu. We need to prompt for save if  
    # thefile has been modified, allow the user to choose a file to open, and  
    # then call load_file() on that file.     
    def on_gtk_open_activate(self, menuitem, data=None): 
         
        if self.check_for_save(): self.on_gtk_save_activate(None, None) 
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        filename = self.get_open_filename() 
        if filename: self.load_file(filename) 
        
    # Called when the user clicks the 'Save' menu. We need to allow the user to choose  
    # a file to save if it's an untitled document, and then call write_file() on that  
    # file. 
    def on_gtk_save_activate(self, menuitem, data=None): 
         
        if self.filename == None:  
            filename = self.get_save_filename() 
            if filename: self.write_file(filename) 
        else: self.write_file(None) 
         
    # Called when the user clicks the 'Save As' menu. We need to allow the user  
    # to choose a file to save and then call write_file() on that file. 
    def on_gtk_save_as_activate(self, menuitem, data=None): 
         
        filename = self.get_save_filename() 
        if filename: self.write_file(filename) 
     
    # Called when the user clicks the 'Quit' menu. We need to prompt for save if  
    # the file has been modified and then break out of the GTK+ main loop           
    def on_gtk_quit_activate(self, menuitem, data=None): 
     
        if self.check_for_save(): self.on_gtk_save_activate(None, None) 
        gtk.main_quit() 
     
    # Called when the user clicks the 'Cut' menu. 
    def on_gtk_cut_activate(self, menuitem, data=None): 
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        buff = self.text_view.get_buffer(); 
        buff.cut_clipboard (gtk.clipboard_get(), True); 
         
    # Called when the user clicks the 'Copy' menu.     
    def on_gtk_copy_activate(self, menuitem, data=None): 
     
        buff = self.text_view.get_buffer(); 
        buff.copy_clipboard (gtk.clipboard_get()); 
     
    # Called when the user clicks the 'Paste' menu.     
    def on_gtk_paste_activate(self, menuitem, data=None): 
     
        buff = self.text_view.get_buffer(); 
        buff.paste_clipboard (gtk.clipboard_get(), None, True); 
     
    # Called when the user clicks the 'Delete' menu.     
    def on_gtk_delete_activate(self, menuitem, data=None): 
         
        buff = self.text_view.get_buffer(); 
        buff.delete_selection (False, True); 
     
    # Called when the user clicks the 'About' menu. We use gtk_show_about_dialog()  
    # which is a convenience function to show a GtkAboutDialog. This dialog will 
    # NOT be modal but will be on top of the main application window.     
    def on_gtk_about_activate(self, menuitem, data=None): 
     
        if self.about_dialog:  
            self.about_dialog.present() 
            return 
         
        authors = [ 
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        "Keith Hewett <keith2.hewett@uwe.ac.uk>" 
        ] 
 
        about_dialog = gtk.AboutDialog() 
        about_dialog.set_transient_for(self.window) 
        about_dialog.set_destroy_with_parent(True) 
        about_dialog.set_name("Sequential Sampler") 
        about_dialog.set_version("1.3") 
        about_dialog.set_copyright("Copyright \xc2\xa9 2014 Keith Hewett") 
        about_dialog.set_comments("GTK+, Glade3 and Python") 
        about_dialog.set_authors            (authors) 
        about_dialog.set_logo_icon_name     (gtk.STOCK_EDIT) 
         
        # callbacks for destroying the dialog 
        def close(dialog, response, editor): 
            editor.about_dialog = None 
            dialog.destroy() 
             
        def delete_event(dialog, event, editor): 
            editor.about_dialog = None 
            return True 
                     
        about_dialog.connect("response", close, self) 
        about_dialog.connect("delete-event", delete_event, self) 
         
        self.about_dialog = about_dialog 
        about_dialog.show() 
 
     # We call error_message() any time we want to display an error message to  
    # the user. It will both show an error dialog and log the error to the  
    # terminal window. 
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    def error_message(self, message): 
     
        # log to terminal window 
        self.print_to_box  (message) 
         
        # create an error message dialog and display modally to the user 
        dialog = gtk.MessageDialog(None, 
                                   gtk.DIALOG_MODAL | gtk.DIALOG_DESTROY_WITH_PARENT, 
                                   gtk.MESSAGE_ERROR, gtk.BUTTONS_OK, message) 
         
        dialog.run() 
        dialog.destroy() 
         
    # This function will check to see if the text buffer has been 
    # modified and prompt the user to save if it has been modified. 
    def check_for_save (self): 
     
        ret = False 
        buff = self.text_view.get_buffer() 
         
        if buff.get_modified(): 
 
            # we need to prompt for save 
            message = "Do you want to save the changes you have made?" 
            dialog = gtk.MessageDialog(self.window, 
                                       gtk.DIALOG_MODAL | gtk.DIALOG_DESTROY_WITH_PARENT, 
                                       gtk.MESSAGE_QUESTION, gtk.BUTTONS_YES_NO,  
                                       message) 
            dialog.set_title("Save?") 
             
            if dialog.run() == gtk.RESPONSE_NO: ret = False 
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            else: ret = True 
             
            dialog.destroy() 
         
        return ret     
     
    # We call get_open_filename() when we want to get a filename to open from the 
    # user. It will present the user with a file chooser dialog and return the  
    # filename or None.     
    def get_open_filename(self): 
         
        filename = None 
        chooser = gtk.FileChooserDialog("Open File...", self.window, 
                                        gtk.FILE_CHOOSER_ACTION_OPEN, 
                                        (gtk.STOCK_CANCEL, gtk.RESPONSE_CANCEL,  
                                         gtk.STOCK_OPEN, gtk.RESPONSE_OK)) 
         
        response = chooser.run() 
        if response == gtk.RESPONSE_OK: filename = chooser.get_filename() 
        chooser.destroy() 
         
        return filename 
     
    # We call get_save_filename() when we want to get a filename to save from the 
    # user. It will present the user with a file chooser dialog and return the  
    # filename or None.     
    def get_save_filename(self): 
     
        filename = None 
        chooser = gtk.FileChooserDialog("Save File...", self.window, 
                                        gtk.FILE_CHOOSER_ACTION_SAVE, 
12 
 
                                        (gtk.STOCK_CANCEL, gtk.RESPONSE_CANCEL,  
                                         gtk.STOCK_SAVE, gtk.RESPONSE_OK)) 
         
        response = chooser.run() 
        if response == gtk.RESPONSE_OK: filename = chooser.get_filename() 
        chooser.destroy() 
        filename = filename + ".mvl" 
        return filename  
         
    # We call load_file() when we have a filename and want to load it into the  
    # buffer for the GtkTextView. The previous contents are overwritten.     
    def load_file(self, filename): 
     
        # add Loading message to status bar and ensure GUI is current 
        self.statusbar.push(self.statusbar_cid, "Loading %s" % filename) 
        while gtk.events_pending(): gtk.main_iteration() 
         
        try: 
            # get the file contents 
            fin = open(filename, "r") 
            text = fin.read() 
            fin.close() 
             
            # disable the text view while loading the buffer with the text 
            self.text_view.set_sensitive(False) 
            buff = self.text_view.get_buffer() 
            buff.set_text(text) 
            buff.set_modified(False) 
            self.text_view.set_sensitive(True) 
             
            # now we can set the current filename since loading was a success 
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            self.filename = filename 
             
        except: 
            # error loading file, show message to user 
            self.error_message ("Could not open file: %s" % filename) 
             
        # clear loading status and restore default  
        self.statusbar.pop(self.statusbar_cid) 
        self.reset_default_status() 
 
    def write_file(self, filename): 
     
        # add Saving message to status bar and ensure GUI is current 
        if filename:  
            self.statusbar.push(self.statusbar_cid, "Saving %s" % filename) 
        else: 
            self.statusbar.push(self.statusbar_cid, "Saving %s" % self.filename) 
             
        while gtk.events_pending(): gtk.main_iteration() 
         
        try: 
            # disable text view while getting contents of buffer 
            buff = self.text_view.get_buffer() 
            self.text_view.set_sensitive(False) 
            text = buff.get_text(buff.get_start_iter(), buff.get_end_iter()) 
            self.text_view.set_sensitive(True) 
            buff.set_modified(False) 
             
            # set the contents of the file to the text from the buffer 
            if filename: fout = open(filename, "w") 
            else: fout = open(self.filename, "w") 
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            fout.write(text) 
            fout.close() 
             
            if filename: self.filename = filename 
 
        except: 
            # error writing file, show message to user 
            self.error_message ("Could not save file: %s" % filename) 
         
        # clear saving status and restore default      
        self.statusbar.pop(self.statusbar_cid) 
        self.reset_default_status() 
         
    def reset_default_status(self): 
         
        if self.filename: status = "File: %s" % os.path.basename(self.filename) 
        else: status = "File: (UNTITLED)" 
         
        self.statusbar.pop(self.statusbar_cid) 
        self.statusbar.push(self.statusbar_cid, status) 
          
    def LockButton_toggled(self,widget): 
        if widget.get_active(): 
            self.locked = True             
        if not widget.get_active(): self.locked = False 
 
    def CycleButton_toggled(self,widget): 
        if widget.get_active(): 
            print  ("Cycle Start") 
            self.cycling = True 
            self.StopTimer = False 
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            ##self.t2=threading.Thread(target=self.ESC_pressed()) 
            ##self.t2.start() 
            self.t=threading.Thread(target=self.main_loop()) 
            self.t.start() 
             
        else: 
            print  ("Cycle Stop") 
            self.cycling = False 
            self.StopTimer = True 
             
 
    def print_to_box (self, prstr): 
        buff = self.text_view.get_buffer() 
        buff.insert_at_cursor(prstr+"\r") 
        self.text_view.scroll_to_iter(buff.get_end_iter(),0.0, False, 0, 0) 
        print prstr 
         
    def button_toggled(self, widget): 
        self.ButtonToggled = gtk.Buildable.get_name(widget)[-1:] 
        print ( "button toggled, current port is: " + self.ButtonToggled) 
        if widget.get_active(): 
            SendText = self.RelayOn % self.ButtonToggled 
            self.OpenPort = int(self.ButtonToggled) 
            setstamp = True 
        if not widget.get_active(): 
            SendText = self.RelayOff % self.ButtonToggled 
            #if self.locked: widget.set_active(True) 
            setstamp = False 
        #if not self.locked: 
        self.ser.write(SendText + '\r\n') 
        out = '' 
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        ## device time delay 
        time.sleep(0.5) 
        while self.ser.inWaiting() > 0: 
            out += self.ser.read(1) 
        if out != '': 
            print  ("Board responds:>> " + out) 
        print  ("SWITCH: Port Number is now:" + str(self.OpenPort)) 
        if setstamp: 
            stamp = str(int(time.time()*1000)) #time.strftime("%d/%m/%Y,%X", 
time.localtime()) 
            stamp = stamp + "," + str(self.OpenPort) 
            self.print_to_box (stamp) 
 
             
    def switch_port(self, addport=1): 
        if not self.PortOpen: 
            print ("switch_port says port Number is:" + str(self.OpenPort)) 
            button = self.builder.get_object("button"+str(self.OpenPort)) 
            if button.get_active() == False: 
                button.set_active(True) 
            if self.OpenPort + addport < 7: 
                self.OpenPort = self.OpenPort + addport 
            else: 
                self.OpenPort = self.OpenPort + addport - 6 
         
    def ESC_pressed(self): 
        print "t2 start" 
        while self.cycling == True: 
            key = ord(getch()) 
            if key == 27: #ESC 
                print "ESC" 
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                self.cycling = False 
         
    def main_loop(self): 
 
        print "t1 start" 
        while self.cycling == True: 
            spinbutton = self.builder.get_object("spinbutton"+str(self.OpenPort)) 
            interval = spinbutton.get_value_as_int() 
            self.switch_port(1) 
            while gtk.events_pending(): 
                gtk.main_iteration() 
            timestart = time.time() 
            checkstop = open("checkstop.txt","r") 
            if checkstop.read(4) == "STOP": 
                self.cycling = False 
            while time.time() - timestart < interval: 
                stamp = str(int(time.time()*1000)) #time.strftime("%d/%m/%Y,%X", 
time.localtime()) 
                stamp = stamp + "," + str(self.OpenPort-1) 
                self.print_to_box(stamp) 
                time.sleep(8.41) 
             
                 
             
             
    def on_window_destroy(self,object,data=None): 
        self.ser.write(self.ResetPorts) 
        self.cycling = False 
        self.ser.close() 
        self.print_to_box  ("quit with cancel") 
         
18 
 
        gtk.main_quit() 
 
    def main(self): 
        self.window.show() 
        gtk.main() 
         
         
 
     
if __name__ == "__main__": 
    selector = SequentialSampler2() 
    selector.main() 
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V. Documents relating to ethics and permissions 
 
 
 
Study Number: 
Patient Identification Number for this trial: 
 
 
CONSENT FORM 
 
 
Title of Project: The effects of oral formulations on oral malodour and tongue 
microbes 
 
REC reference:  
IRAS ID:  
 
Name of Researcher:  
 
       Please initial box 
 
1. I confirm that I have read and understand the information sheet dated ............................ 
  (version ............) for the above study. I have had the opportunity to consider 
the information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, 
 without giving any reason. 
 
3.   I understand that relevant sections of my medical notes and data collected during                 
 
the study, may be looked at by individuals from Colgate-Palmolive and the University of the 
West of England, from regulatory authorities where it is relevant to my taking part in this 
research. I give permission for these individuals to have access to my records.  
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4. I understand that the information collected about me will be used                                 
 
to support other research in the future, and may be shared anonymously  
with other researchers. 
 
5. I agree to take part in the above study.       
 
 
________________________ ________________
 ____________________ 
Name of Patient   Date
 Signature 
 
 
_________________________ ________________
 ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
_________________________ ________________
 ____________________ 
Researcher   Date 
 Signature 
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Health Questionnaire 
 
 
Name: 
Age:  
 
Before beginning this study we need you to complete this form. Please tick or mark 
the appropriate boxes. 
 
Are you presently participating in any other dental or medical study?    
  Yes/No 
Has your medical status changed in any significant way since your last UWE breath 
odour trial? Yes/No 
Do you suffer from any medical illness (heart disease, chest disease, liver disease, 
kidney disease, diabetes, intestinal disease)?     
   Yes/No 
Are you taking any medically prescribed drugs or medicines for any reason? 
  Yes/No 
Do you smoke and if so how many a day?    
Yes (number)/No 
Have you had any significant dental treatment since your last UWE breath odor 
trial? 
(e.g. Rampant caries, crowns, caps, bridges, dentures, severe gingivitis, periodontal 
disease, dental abscesses, oral thrush)? 
 Yes/No 
Are you taking any medicated sweets containing anti microbials? 
Yes/No 
 
Date of last visit to dentist       
 Date: 
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Please confirm that you agree to us retaining this information for 1 month after the 
trial has been completed. Thereafter, these forms will be destroyed. Information 
extracted from these forms will be devoid of any links to any individual (made 
anonymous). For instance we might report that 48% were male 52% were female, 
the median age was 32, none were taking medically prescribed drugs, all volunteers 
were in good health etc. but there would be no actual link to any named individual. 
Until destroyed, this form will be treated as confidential by the chief investigator 
and stored securely.  
 
I agree to the short term (1-month) retention of the above information by the chief 
investigator 
 
Signed:                                                                          . 
Date:                                        . 
 
 
Chief investigator:                                                                          . 
 
  
23 
 
Invitation Letter 
 
Participant Information Sheet 
 
Project Title: The effects of oral formulations on bad breath and tongue microbes 
 
This project has been reviewed and approved by NRES Committee North-West-Haydock 
REC reference: 13/NW/0316 
IRAS project ID: 178410 
You are being invited to take part in the study “The effects of oral formulations on bad 
breath and tongue microbes” 
 
 Before you decide it is important for you to understand why the research is being done 
and what it will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear or if you would 
like more information.  Take time to decide whether or not you wish to take part. 
 
1. Aim of the study 
This three month study aims at looking at the potential changes in the numbers of 
microbes from the tongue, and in bad breath levels following the use of oral formulations; 
three test formulations plus two positive controls and one negative control. 
 
2. Who are we, who is funding this study and why we are asking for your help? 
We are the Centre of Oral malodour Research at UWE and have been working on this field 
for the last 22 years. This particular study is funded by a company in the UK Helperby 
Therapeutics Limited. Oral malodour or bad breath can affect any individual during their 
life and although not life threatening can cause a lot of distress in some. Bad breath may 
arise from microbes on the surface of the tongue. It is believed that certain types of 
microbes have the capacity to transform sulphur containing food into hydrogen sulphide 
and other malodorous gases. By measuring breath levels and sampling the tongue scrape 
for numbers associations may be seen between breath odour and quantity of microbes 
present on the surface of the tongue. The results obtained from this study could 
substantially influence the development of oral hygiene formulations (e.g. mouthwashes, 
lozenges or toothpastes) that could be used to reduce bad breath and subsequently relieve 
the stress and discomfort that this condition may cause in many humans.  
 
3. Who can participate? 
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Anyone over the age of 18 and who has given informed consent. Participants should not 
have untreated caries or gum inflammation. Participants must not have received antibiotic 
therapy within at least one month prior to the study.  
 
4. Do I have to take part? 
Your participation in this study is entirely voluntary. If you decide to take part you will be 
given this information sheet and will be asked to sign a consent form. If you decide to take 
part you are still free to withdraw at any time without giving any reason. 
 
5. What are we testing? 
We are testing three different oral formulations and comparing them to two positive 
controls (Cordosyl and CB12) and to one negative control (Water). Of the three test 
formulations, one contains chlorhexidine diacetate, one contains zinc acetate, and the third 
contains HT61.  
Some of the oral formulations you will be testing may or may not freshen the breath to the 
same extent as others.  
 
6. What are the possible benefits of taking part? 
Participation in this study may not benefit you personally.  The results of this study may 
help other individuals in the future. 
 
 
7. What are the side effects of any treatment received when taking part? 
In general, no adverse side effects are anticipated from the use of either of these test 
toothpastes.  However, you might experience tongue or gum irritation with the use of the 
test products. If either of these conditions occurs, it is expected they will be reversed upon 
cessation of the oral formulation use. If you experience any problems or any research 
related injury, you will have to contact Dr. Saliha BM Saad (117 328 2515 (day) or 
07717723968 (mobile). You understand that if any physical injury results from your use of 
the test products, the funding company will be responsible for medical costs provided you 
seek medical attention as directed by the funding company or as directed by the Study 
Investigator (Dr. Saliha BM Saad). 
 
 
8. What will happen to me if I take part? 
Screening and Selection of Subjects: Candidates who have signed an Informed Consent 
Form and a Health Questionnaire will be screened by the examiner to identify those 
subjects who meet the inclusion / exclusion characteristics.  Candidates will also be 
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examined by a qualified Dentist. The first 30 subjects that meet the inclusion/exclusion 
characteristics and sign an Informed Consent Form and a health questionnaire will be 
entered into the study.  Baseline measurement described below will be completed at 
screening visit. 
 
This crossover double-blind study will take place at the University of the West of England in 
our laboratory. A group of thirty participants will be taking part in this study which will last 
for three months. Before the start of the trial each participant will be examined by a 
qualified dentist who will assess their oral and dental status. The Dentist will advise each 
participant on the best way to use the oral rinse. Participants will be assessed and will use 
one type of treatment one day a week for six consecutive weeks. Each participant will 
receive one of the six oral formulations in a randomized manner. Neither the investigator, 
nor the participant will know which oral formulation has been allocated to you. You will be 
asked to visit the laboratory on six occasions, in the morning and afternoon for six 
consecutive weeks. 
The study will be conducted as follows: 
Prior to the study, you should continue with your normal oral hygiene routine (brushing 
your teeth and flossing using dental floss) 
First visit to the laboratory: 
The night before your first visit to the lab you must not consume any strong food (e.g. 
garlic, spices) and you must not drink alcohol. 
You can brush your teeth at night before going to bed. 
 
Morning of day1: 
- You must not take food or drinks or brush your teeth 
- You will have your breath assessed by a trained organoleptic judge 
- You will have your breath measured by two different instruments 
- You will give a tongue-scrape sample using a sterile toothbrush 
- You will receive an oral formulation and you will be asked to use it straight away in 
the laboratory 
- You will return to the lab 30 minutes, 3 hours and 6 hours after using the treatment 
to have your breath assessed by an organoleptic judge and by instruments 
- You will be given a washout toothpaste to use twice a day for the duration of the 
trial 
 
On day 7: The night before your second visit to the lab you must not consume any strong 
food (e.g. garlic, spices) and you must not drink alcohol. 
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You can brush your teeth at night before going to bed. 
 
One day per week and for six consecutive weeks you will come to the lab to use one oral 
formulation and you will have to visit the lab four times on that same day (T0, 30 min, 3 
hours and 6 hours after treatment). 
 
Your sampling days will be: Day 1, Day 8, Day 15, Day 22, Day 29 and Day 36 
 
 
9. How will anonymised samples be collected and mouth air analysed? 
Each participant will be informed by email about the day and time of the visit at their 
convenience. On the day of the study, you will be asked to fill in a health questionnaire 
prior to your samplings and assessments and sign an informed consent form. This will be 
administered by the principal investigator. 
Once you have consented to participate in the study, you will be asked to give a sample of 
your tongue scrape for microbiological analysis, and have your breath assessed by a trained 
breath judge and by instruments. Each sample taken (tongue scrape and breath) will be 
labelled with a code allocated to you. Thereafter, all samples are known by code number 
and not by name. 
All these procedures will be performed under instruction and supervision of the 
investigator. All the samples and tests together should not take more than 30 minutes in 
total, so we hope that this should not interfere too much with your normal working day. 
You will need to visit our laboratory once a week in the morning only for three consecutive 
weeks.  
 
On the sampling day you will be asked NOT to wear strongly perfumed cosmetics, nor to 
consume food associated with bad breath (for example garlic, onions, curry) on the day 
prior to and on the day of sampling. Your normal oral hygiene practice should continue 
the day before the study, but on the morning of testing you should not brush your teeth 
or use mouthwash or ingest food 2 hours prior to the tests. Drinks should be restricted to 
water during this period 
 
 
10. What will happen next to my sample? 
 
Coded microbial samples will be analysed using conventional microbiology methods and 
results (data) will be stored. Each sample will be coded. The results (data) from mouth air 
measurements will likewise be identified only by your code number, NOT your name.  
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Microbilogical samples will be disposed of, in accordance with the Human Tissue Act.” 
Any samples which are not correctly labelled with the code will be destroyed in accordance 
with the Human Tissue Act.   
 
11. What happens next? 
If having read the information (and any outstanding questions answered fully from our 
discussions) and you are happy to participate in the study, you may sign the consent form.  
This form states that you have read and understood this information sheet, that the 
participation is entirely voluntary, and that the samples are completely anonymised. You 
may also, if you prefer, take this information sheet away and think about whether you wish 
to take part.  Please do not hesitate to contact me via the details below with any further 
questions and/ or when you are happy to consent.   
Once consented you will be provided with; your protocol, your diary and appointment date 
& time for attending the laboratory, your informed consent code which needs to be written 
on any donated sample, and my contact details. 
Consent forms will be kept for the duration of the study in a locked cabinet in a secure 
office. If at any point you wish to formally withdraw consent, please contact me (details 
below) and I will ensure your consent form is immediately destroyed and samples 
withdrawn and destroyed in accordance with the Human Tissue Act.  
 
In the very unlikely event that an adverse reaction occurs in response to the procedure the 
University of the West of England will consider the possibility of no fault compensation 
without admitting liability. UWE confirms that it has in place all appropriate Professional 
Indemnity Insurance and Public Liability Insurance to cover any claims for negligence on the 
part of UWE staff and students in performing UWE’s role in the study.  
 
 
12. Who can I contact if I have any complaints? 
In case you are not happy about the way the team dealt with you on the day of your 
assessment, or about the procedure used in this study, please do not hesitate to contact an 
independent person, the Research and Innovation Associate Dean: Pr Jenny Ames, 
University of the West of England, Frenchay Campus, Coldharbour Lane, Bristol e-mail: 
jenny.ames@uwe.ac.uk. Tel: 0117 3288409. 
 
 
Oral Malodour Group would like to thank you for your time to help with the aims of our 
research. If at anytime you have further questions please do not hesitate to contact me. 
